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Summary 
 
Schizophrenia is a highly complex psychiatric disorder with a lifetime risk of 
approximately 0.4-0.7%. Alterations in the major inhibitory neurotransmitter 
GABA have been identified in the brains of those with schizophrenia. Studies 
examining the nature of these differences have given variable results 
depending on the type of patient group, medication and the brain region where 
in vivo MRS GABA was measured. Chapter 5 of this thesis utilises the non-
invasive imaging tool magnetic resonance spectroscopy (MRS) to investigate 
differences in GABA levels in two distinct areas of the brain of those with 
schizophrenia, whilst adjusting for important potential confounds such as 
antipsychotic medication dosage.  
 
GABA is also of interest due to its link with synchronised oscillatory activity, 
primarily gamma activity that is implicated in connectivity between different 
brain regions as well as cognitive functioning, thus demonstrating its potential 
relevance to schizophrenia research. Chapter 6 investigates differences in 
gamma activity between those with schizophrenia and controls induced by a 
static stimulus and a moving radial stimulus, both known to induce strong visual 
gamma responses, using magnetoencephalography (MEG) imaging methods. 
 
Because GABA and gamma measures are robust for visual cortex measures, 
we used visual psychophysics tasks thought to be dependent on inhibitory 
processes - orientation discrimination and the tilt illusion, to see if there is a 
behavioural deficit in schizophrenia and if this also relates to changes in GABA 
and gamma measures. Chapters 3 and 4 set out to validate the psychophysics 
and to establish whether they were appropriate paradigms for the patient group 
for which they were intended. Chapter 7 brings together the imaging and 
psychophysics to see if a relationship exists between them in both the patient 
and control groups. 
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Glossary 
 
The following abbreviations are used throughout this thesis: 
 
AMPA - Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
 
GABA – Gamma-amino butyric acid 
 
GAD – Glutamic acid decarboxylase 
 
MEG – Magnetoencephalography 
 
MRI – Magnetic resonance imaging 
 
MRS – Magnetic resonance spectroscopy 
 
OD – Orientation discrimination 
 
PO – Preferred orientation 
 
PSE – Perceived subjectivity equality 
 
SAM – Synthetic Aperture Magnetometry 
 
TI – Tilt illusion 
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Chapter 1 - Introduction 
1.1 Rationale 
Schizophrenia is a highly complex psychiatric disorder with a lifetime risk of 
approximately 0.4-0.7% and is currently the seventh most costly disorder to 
society. It is split into three symptom categories; positive symptoms which 
include perceptual hallucinations and delusions, negative symptoms including 
emotional blunting, negative thought disorder and social withdrawal and finally 
cognitive deficits which span all cognitive domains. 
 
Environmental and genetic factors appear to play a role in the development of 
the disorder and so pinpointing a target for treatment development has not been 
easy. Current treatments focus on the dopamine system and whilst they treat 
the positive symptoms effectively, they do little to reduce the negative and 
cognitive symptoms, arguably the most debilitating. Therefore new treatment 
targets are needed to treat these additional symptoms. 
 
The GABAergic system first became a candidate target for treatment 
development due to human post-mortem studies showing a reduction in the 
GABA synthesizing enzyme GAD-67 in the brains of patients with 
schizophrenia. Recent genetic research has also supported the idea of GABA 
being implicated in this disorder.  
 
GABA is also of interest due to its link with synchronised oscillatory activity, 
primarily gamma activity. Gamma oscillations are implicated in connectivity 
between different brain regions and cognitive functioning so are of relevance to 
schizophrenia research. In vivo measurement of GABA in patients has 
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produced mixed and inconsistent results but in chronic patients reductions are 
shown in differing brain regions. Gamma activity in patients is also shown to be 
reduced in patients.  
 
It is important to relate the imaging measures to behaviour in both healthy and 
disease populations. Behavioural tasks can then be used as additional markers 
in relation to the imaging measures and be used as proxy measures in clinical 
settings. This thesis will therefore investigate if there are between group 
differences in measures of in vivo MRS GABA and gamma activity measured 
using MEG methods. It will also incorporate psychophysics to test whether there 
is a relationship between imaging and behavioural measures in the hope of 
developing these into possible biomarkers of schizophrenia. 
 
1.2 Schizophrenia  
Schizophrenia is a highly heritable psychiatric disorder with a lifetime risk of 
approximately 0.4-0.7% (Prince, Patel, Saxena, Maj, Maselko, Philips et al., 
2007). It is a neurodevelopmental disorder characterised by three major 
symptom groups. Firstly positive symptoms, which include delusions and 
perceptual hallucinations, secondly negative symptoms including emotional 
blunting, lack of motivation and paucity of speech, and lastly marked cognitive 
impairment typically across cognitive domains. A diagnosis of schizophrenia 
can encompass different combinations from these symptom groups but there 
has to be a severe impairment to the patient’s daily life in areas such as 
employment and social functioning for more than 6 months for a diagnosis to be 
given based on the Diagnostic and Statistical Manual of Mental Disorders 
Version 5 (DSM-V) criteria (American Psychiatric Association, 2013).  
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Schizophrenia is a complex disorder with differences in gender distribution and 
women more likely to experience onset of symptoms in their late twenties/early 
thirties compared to late teens/early twenties for men (Goldstein, 1997). Women 
are also more likely to have an affected family member and to experience more 
positive and affective symptoms, whereas men tend to experience more 
negative symptoms and have poorer long-term outcomes (Goldstein, 1997; 
Ochoa, Usall, Cobo, Labad, and Kulkarni 2012).  
 
Whilst some patients can experience one episode of psychosis and recover well 
for the rest of their lives, for others the symptoms associated with schizophrenia 
can be highly debilitating for both the person affected and family members, with 
50% of patients attempting suicide and 10% succeeding (Meltzer and Fatemi, 
1995). Furthermore, it is estimated that only 30% of people diagnosed are 
classed as having a positive outcome with no long-lasting impairment after an 
acute psychotic episode, with another 30% experiencing persistent, progressive 
symptoms causing increasing impairment and most likely permanent 
hospitalisation (Ross, Margolis, Reading, Pletnikov and Coyle, 2006). Due to 
the early onset of the disorder and its frequently chronic debilitating nature, it is 
the seventh most costly disorder to society due to hospitalisation costs, lack of 
employment and medication (Pearlson, 2000). It is thus evident why research 
has and is still focusing on the aetiology and risk factors associated with this 
disorder.  
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1.3 Risk factors 
1.3.1 Environmental 
Several environmental risk factors have been identified relating to the 
development of schizophrenia. They fall into the following categories: place/time 
of birth, infection, prenatal complications and obstetric complications (Sullivan, 
2005; see Figure 1). As demonstrated in Figure 1, the largest risks are related 
to maternal health during pregnancy, including contracting influenza in the 2nd 
semester, suffering a bereavement during pregnancy or obstetric complications 
resulting in central nervous system damage to the child. All of these can 
increase the risk of the child developing schizophrenia by at least 5 times that of 
the healthy population (Sullivan, 2005; see Figure 1.1).  The issue of maternal 
influenza could be linked to the increased risk of developing schizophrenia if 
birth occurs in the winter months and in an urban population, as there is an 
increased likelihood of contracting flu during these months especially in densely 
populated areas. Cannabis use also infers an approximately two-fold increase 
in the likelihood of developing schizophrenia, although it does not appear to be 
necessary or sufficient in the development of the disorder, more it’s part of a 
number of factors than can lead to psychosis (Arseneault, Cannon, Witton and 
Murray, 2004; Arendt, Rosenberg, Foldager, Perto, and Munk-Jørgensen, 
2005). However, the main risk factor highlighted in Figure 1.1 is family history. 
This strongly suggests there is a genetic component to the disorder. 
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Figure 1.1. Environmental risk factors associated with schizophrenia (taken 
from Sullivan, 2005) 
 
1.3.2 Genetic risk 
Evidence for a strong genetic component to the development of schizophrenia 
is shown by the high concordance rate amongst first-degree relatives of a 
person with a diagnosis of schizophrenia. For example estimates of the 
concordance for schizophrenia in monozygotic (MZ) twins are 40-70%, and 
17% for dizygotic (DZ) twins (Gottesman, 1991 see figure 1.2; Pearlson, 2000; 
Sullivan, 2005). Thus, the risk of developing schizophrenia increases with the 
degree of genetic relatedness to the proband (the person with the diagnosis). 
However, with a maximum 70% concordance in MZ twins, these results also 
point to the importance of environmental factors. 
 
 6 
Figure 1.2. Genetic risk of schizophrenia (taken from Gottesman, 1991) 
 
Unfortunately, unlike other disorders such as Huntington’s disease, research 
has not been able to identify a definitive association of a single gene variant 
with the development of schizophrenia (Ross et al., 2006). Instead it would 
appear that there is a polygenic risk picture of multiple genetic variants that 
confer a small level of risk, which can combine to produce a cumulative risk for 
development of the disorder (Schizophrenia Working Group of the Psychiatric 
Genomics Consortium, 2014). In line with the odds ratios of environmental 
factors, the involvement of these susceptibility genes for schizophrenia can at 
times only account for an increase in the risk of as little as 1.1 to 3 times. In 
recent years there has been the discovery of large (>1 megabase), rare (<1%), 
duplications or deletions of chromosomal regions found to increase the risk of 
developing schizophrenia. These copy number variants are associated with 
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odds ratios between 2 and over 30, so confer substantial increased risk - 
though collectively are seen in only around 2.5% of those with the disorder 
(Rees, Walters, Georgieva, Isles, Chambert, Richards et al, 2014).  
 
The development of the disorder is now thought of as a combination of a 
genetic predisposition i.e. carrying risk genetic variants, which then interacts 
with environmental factors during early brain development causing possible 
structural or neurochemical abnormalities (Tsuang, 2000; Owen, Craddock, 
O’Donovan, 2005). 
 
1.4 Aetiological theories 
1.4.1 The Dopamine hypothesis 
Neurotransmitter dysregulation, especially within the dopaminergic system, as a 
possible mechanism for the development of schizophrenia, and particularly 
psychosis, has been one of the most popular and lasting theories regarding this 
illness. This hypothesis arose from the observation that administration of 
amphetamines, dopamine agonists that increase the level of dopamine in the 
synapse, induces psychotic-like symptoms in healthy controls (Randrup and 
Munkvad, 1967) and exacerbates existing symptoms in patients (Crayton, 
Meltzer and Goode, 1968; Snyder, Banerjee, Yamamura and Greenberg, 
1974). Particular attention has been paid to the dopamine D2 receptor, as it 
emerged that D2 receptor blockade, which reduced dopamine binding at the 
receptor, was the mechanism behind prescribed anti-psychotics (Seeman, 
Chau-Wong, Tedesco and Wong, 1975). Further, in first episode patients, the 
density of D2 is elevated by ~10% to 30% in the frontal cortex (Kessler, Ansari, 
Riccardi, Li, Jayathilake, Dawant and Metzler 2006) and striatum (Wong, 
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Pearlson, Tune, Young, Meltzer, Dannals et al 1997). Hyperdopaminergia was 
therefore the focus of this theory of the development of schizophrenia.  
 
1.4.2 Challenges to the dopamine hypothesis 
All current licensed antipsychotic drugs work by blocking D2 receptors. The 
number of D2 receptors also predicts the speed and the nature of a subject's 
response to the antipsychotic (Abi-Dargham, Rodenhiser, Printz, Zea-Ponce, 
Gil, Kegeles et al, 2000). These antipsychotics, however, are most effective at 
treating the positive symptoms but do not impact cognitive deficits and negative 
symptoms experienced by those with schizophrenia. This is still a major 
obstacle to the treatment of this disorder and the reduction of these cognitive 
deficits and negative symptoms is, therefore, a new treatment target.  
 
A further problem arises when one considers that the administration of anti-
psychotics that block dopamine receptors does not ameliorate psychotic 
symptoms in all cases, with as many as 30% of patients relapsing whilst taking 
anti-psychotics (Harding and Hall, 1997). Additionally, of those who do respond 
well, the vast majority still experience symptoms In addition it has been 
demonstrated that not all patients experienced heightened symptoms when 
administered amphetamines, with some patients actually reporting an 
improvement in their symptoms (Van Kammen and Boronow, 1988; Dickson, 
Allen and Werner, 1995). This suggested that there is a wide-ranging diversity 
in the pathophysiology of schizophrenia and that additional biological 
mechanisms should be considered. 
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1.4.3 GABA and Glutamate 
GABA is the major inhibitory neurotransmitter in the mammalian brain. It is 
synthesised by the process of decarboxylation of glutamate, the major 
excitatory neurotransmitter in the brain, via the enzyme glutamate 
decarboxylase (GAD; Olsen and DeLorey, 1999). Some of the principal 
pathways of the GABA/glutamate cycle are schematised in Figure 1.3. Calcium-
dependent release of GABA results in an increase of GABA concentration 
within the synapse and therefore an increase in receptor binding at the post-
synaptic neuron, in this case on the GABAa receptor site as this is the active 
site for GABA binding. The difference between the two types of GABA receptors 
are that GABAa receptors are fast acting whereas GABAb receptors are slow 
acting and have been linked to processes such as behavioural aspects of 
ethanol (Dzitoyeva, Dimitrijevic, & Manev, 2003) and pain response (Manev and 
Dimitrijevic, 2004).  Removal of GABA occurs rapidly by way of the GABA 
transporter (GAT) via reuptake processes into the presynaptic neuron and/or 
surrounding glia cells. GABA is then broken down into metabolites, which are 
subsequently used in the resynthesis of GABA via glutamate and glutamine.  
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Figure 1.3. Red dots represent GABA synthesis and green dots represent 
glutamine to glutamate synthesis. 
 
Cortical neural circuits are comprised of both excitatory neurons, mostly 
glutamatergic pyramidal cells, and inhibitory neurons, mostly GABAergic 
parvalbumin containing (PV+) neurons. It is these PV+ neurons that are of 
interest as it is widely accepted that inhibition arising from this sub-type of 
neurons is essential for synchronisation of neural activity (Bartos, Vida and 
Jonas, 2007; Gonzalez-Burgos, Hashimoto and Lewis, 2010).  
 
1.4.4 The GABA hypothesis 
A gamma-amino-butyric-acid (GABA) disturbance in cases of schizophrenia 
was first suggested by Roberts (1972). It was hypothesised that the symptoms 
associated with schizophrenia could be accounted for by low levels of GABA in 
the brain leading to a state of disinhibition. Since this theory was postulated, 
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there have been many studies investigating the link between GABA and 
dopamine. Application of the GABA agonist muscimol inhibited the firing of 
dopamine neurons in both the substantia nigra and the ventral tegmental area, 
where dopamine tracts are thought to be overactive in schizophrenia. Thus 
leading to an increase in GABA and reduction in downstream dopamine. Figure 
1.4 depicts the opposite direction of effect with the introduction of a 
benzodiazepine (GABA antagonist) reducing GABA levels and increasing 
dopamine levels downstream. This finding therefore closely relates to the idea 
of a reduction in GABA and hyperdopaminergia in schizophrenia. 
 
 
Figure 1.4. The effect of GABA antagonists on GABA and dopamine levels 
indicated by arrows. 
 
1.4.5 GABAergic theory of schizophrenia 
The idea of a reduction in GABA levels or GABAergic properties in patients with 
schizophrenia is widely supported. The most consistently reported finding is a 
reduction in the 67-kDa isoform of the GABA synthesising enzyme glutamic acid 
decarboxylase (GAD67); (Curley, Arion, Volk, Asafu-Adjei, Sampson, Fish et al 
2011; Guidotti, Auta, Davis, Gerevini, Dwivedi, Grayson et al, 2000), which is 
thought to synthesise ~70% of brain GABA (Soghomonian and Martin, 1998). 
Figure 1.5 illustrates the reductions in inhibitory basket cells and how this 
relates to excitatory pyramidal cells. Work with GAD67 knockout mice (i.e. mice 
GABA 
antagonist 
downstream 
Dopamine GABA 
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that express no GAD67) supported these findings by showing that these mice 
produced only 7% of the GABA concentrations produced by wild-type mice 
(Asada, Kawamura, Maruyama, Kume, Ding, Kanbara et al, 1997). This strongly 
suggested that a reduction in the expression of this enzyme would lead to a 
reduction in GABA levels overall. In addition to this finding, a single-nucleotide-
polymorphism (SNP) in the GAD1 gene, which encodes for GAD67, is 
associated with reduced mRNA expression in the prefrontal cortex of patients 
with schizophrenia (Straub, Lipska, Egan, Goldberg, Callicott, Mayhew et al, 
2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5. Alterations found in cortical circuits in patients with schizophrenia. 
Arrows indicate the direction of effect. 
 
 
A further compelling finding is the reduction in expression of neuregulin-1, a 
tropic factor important for brain development and encoded by the schizophrenia 
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susceptibility gene NRG1 (Munafo, Thiselton, Clark and Flint, 2006). PV+ 
neuron signalling is strongly mediated by neuregulin-1 with one of its receptors, 
ErbB4, being enriched in GABA neurons and in particular PV+ neurons. Fisahn, 
Neddens, Yan and Buonanno (2009) demonstrated how expression of NRG-1 
increased gamma power, neural oscillations that occur at a frequency of 30-
150Hz, in the hippocampus with these effects blocked by a pan-specific ErbB 
receptor antagonist. This showed that gamma power is mediated by ErbB4 
receptors as mice bred with a mutation of ErbB4 did not respond to increased 
expression of NRG-1. 
 
Recent advances in genetics research mean that Genome-Wide Association 
Studies (GWAS) has discovered a new class of genetic variation, large 
deletions and duplications of DNA called copy number variants (CNVs). CNVs 
are very rare and work utilising GWAS chip methods has discovered that a 
small number CNVs are associated with the disorder (Walsh, McClellan, 
McCarthy, Addington, Pearce, Cooper et al, 2008; Need, Ge, Weale, Maia, 
Feng, Heinzen et al, 2009). These are alterations of the DNA that results cells 
having an abnormal number of copies of one or more sections of the DNA. 
CNVs within one gene in particular, neurexin-1, have been confidently identified 
(Rujescu, Ingason, Cichon, Pietiläinen, Barnes Toulopoulou, et al., 2009) with 
several others, spanning many different genes, also imparting risk (Rees et al., 
2014). Because of the different genes involved it has been hard to pinpoint the 
mechanism by which they contributed to the development of the disease. 
However, Pocklington, Rees, Walters, Han, Kavanagh, Chambert et al (2015) 
have, for the first time demonstrated, using over 11,000 cases, that CNVs are 
enriched for genes involved in GABAergic transmission, most of which relate to 
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GABAa receptor complexes. This shows that GABAergic signaling is of causal 
relevance to the disorder. In addition they also replicated previously found 
enrichment of CNVs for glutamatergic transmission. This lends further support 
to the idea that an imbalance of the inhibitory/excitatory activity of neurons 
contributes to schizophrenia. 
 
It is important to determine the processes that underlie these irregularities in 
cortical inhibition in humans using in vivo methods. Whilst animal 
studies/models are extremely useful, the methods used are invasive and it is 
not certain if the results are directly transferable to humans and their behaviour. 
Biomarker development is now a key aim of research into disease as these can 
be used as a non-invasive indicator of a particular physiological state. Imaging 
biomarkers can and have been extremely useful in many different areas 
including cancer detection using MRI spectroscopy methods (Fischer, Kettunen, 
Würtz, Haller, Havulinna, Kangas, et al, 2014), the identification and treatment 
of heart disease (Caplan, Waxman  Nesto and Muller, 2006; Wang, Balu, 
Canton and Yuan, 2010) and ) and potentially prediction of responsiveness to 
treatment using EEG in schizophrenia patients (Khodayari-Rostamabad, Hasey, 
MacCrimmon, Reilly and de Bruin, 2010) although this does need replication 
studies. These examples demonstrate a number of ways biomarkers can help: 
identification of a disease, predicting responsiveness of treatment and 
monitoring the effects of treatments. All of these are needed for the diagnosis 
and management of schizophrenia. I will now provide a summary of relevant in 
vivo imaging studies related to schizophrenia. 
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1.5 Imaging studies of schizophrenia 
For the purpose of this introduction only a very brief overview of each imaging 
method will be provided. Relevant approaches will be discussed more fully in 
Chapter 2.  
 
1.5.1 Magnetic Resonance Imaging (MRI)  
Structural differences in the brains of patients with schizophrenia are well 
established. Early encephalogram and computerised tomographic (CT) studies 
found significantly enlarged ventricles in patients compared to controls (Haug, 
1962; Johnstone, Frith, Crow, Husband and Kreel, 1976). Post-mortem studies 
have also verified this finding (Pakkenberg, 1987). Pakkenberg also identified 
whole brain volume, hemisphere volume, the cortex and gray matter volume 
were all reduced in patients compared to controls. These findings have been 
widely replicated with the reduction in volume and tissue content, predominantly 
gray matter, appearing to be present in different brain regions including the 
thalamus, caudate nucleus and prefrontal cortex (Haijma, Van Haren, Cahn, 
Koolschijn, Hulshoff Pol and Kahn (2013), the dorsolateral prefrontal cortex, 
inferior parietal lobe and superior temporal gyrus (Peng, Lee, Federman, 
Chase, Barta and Pearlson, 1994) and the hippocampus and amygdala 
(Velakoulis, Wood, Wong, McGorry, Yung, Phillips et al, 2006; van Erp, Hibar, 
Rasmussen,Glahn, Pearlson, Andreassen et al., 2015).  
 
 
1.5.2 Functional MRI 
Functional MRI (fMRI) is a method used to infer brain activity by measuring the 
associated changes in blood oxygenation level (Huettel, Song and McCarthy, 
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2004). Brain activity is assessed through a proposed indirect haemodynamic 
correlate, specifically the difference in magnetic properties of oxygenated and 
deoxygenated blood leading to differences in the MR signal. Neuronal firing 
causes a need for more energy to be brought in quickly. Through a process 
called the haemodynamic response, blood releases oxygen to them at a greater 
rate than to neurons not firing. This causes a change of the relative levels of 
oxygenated and deoxygenated blood that can be detected by the MRI (Ogawa, 
Lee, Kay and Tank (1990). 
  
Within patient groups abnormalities within resting-state networks, as evidenced 
by reduction in spontaneous BOLD signals, have been reported (Bluhm, Miller, 
Lanius, Osuch, Boksman, Neufeld et al, 2007; Woodward, Rogers and Heckers, 
2011), as have reductions in the BOLD signal during cognitive tasks (Rasser, 
Csernansky, Gado and Barch, 2014). 
 
However, there are limitations with using fMRI. Firstly it has not been 
determined whether the BOLD response truly relates to activity or if it is just a 
proxy measure. Secondly the magnitude of the BOLD response has been linked 
to physiological parameters such as cardiovascular fitness; the fitter you are the 
stronger the BOLD signal (Gonzales, Tarumi, Mumford, Ellis, Hungate, Pyron et 
al, 2014). Obesity is a major issue within patients with schizophrenia due to 
sedentary lifestyle, unhealthy eating habits, the illness itself and medication 
(Hjorth, Davidsen, Hilian and Skrubbeltrang, 2014). Therefore, the use of other 
imaging methods to determine levels of neural activity would be more 
appropriate to this patient group.  
 
 17 
1.5.3 Magnetic resonance spectroscopy (MRS) 
MRS is an MRI technique that allows the non-invasive in vivo measurement of 
concentrations of different metabolites within the brain, including creatine, 
alanine, choline, N-Acetyl Asparate (NAA), glutamate/glutamine (Glx) and 
GABA (Jansen, Backes, Nicolay and Kooi, 2006).  
 
A reduction in NAA has been reported and replicated throughout the brain in 
patients with schizophrenia (Rowland, Bustillo, Lauriello, 2001), as has a 
reduction in glutamate levels coupled with an increase in glutamine (Marsman, 
van den Heuvel, Klomp, Kahn, Luijten and Pol, 2013) and creatine (Öngür,, 
Prescot, Jensen, Cohen, Renshaw, 2009). However, many of these studies do 
not have enough power to reliably detect a difference in metabolites between 
groups and so these findings may not be as reliable as first thought (Steen, 
Hamer and Lieberman, 2005) 
 
These metabolites can be difficult to measure using a 3 Tesla MRI scanner due 
to poor signal-to-noise and relatively broad spectral line-widths for many of the 
desired molecules. GABA, however, can be measured using a scanner of this 
strength when using the PRESS method making it a reliable metabolite for 
research (Mullins, Chen, Xu, Caprihan and Gasparovic, 2008) 
 
When looking at GABA levels in vivo, results for patients are mixed, with some 
reporting an increase in GABA in chronic patients (Öngür, Prescot, McCarthy, 
Cohen & Renshaw, 2010) while others report a reduction (Yoon, Maddock, 
Rokem, Silver, Minzenberg, Ragland and Carter, 2010; Marsman, Mandl, 
Klomp, Bohlken, Boer & Andreychenko et al, 2014). One possible reason for 
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these differences is the level and variety of antipsychotic medication being 
taken by patients. Whilst evidence from clinical studies suggests that 
antipsychotic medication could affect the GABAergic system, either at the 
receptor level or by altering GABA concentrations (Wassef, Baker & Kochan, 
2003), in vivo results however, are mixed. Tayoshi, Nakataki , Sumitani, 
Taniguchi, Shibuya-Tayoshi, Numata  et al (2010) reported a significant 
difference in GABA levels between patients taking typical versus atypical 
antipsychotics suggesting the type of antipsychotic could be a factor. 
Administration of clozapine has been associated with an increase in GABA-B 
transmission (Kaster, Jesus, Radhu, Farzan, Blumberger, Rijji et al, 2015) 
whereas Rowland, Krause, Wijtenburg, McMahon, Chiappelli, Nugent et al 
(2015) demonstrated that after converting antipsychotic medications to their 
chlorpromazine equivalents, and when included as a covariate in their analysis, 
it did not change their finding of a reduction in GABA levels in patients with 
schizophrenia. These findings are very mixed and it is difficult to compare 
groups, as they are quite different in terms of length of illness and studies 
usually only account for current and not lifetime medication use. This could be 
very important when standardising medications to add as a covariate because 
lifetime exposure could also affect GABA levels. 
 
The brain region where GABA is measured can produce different results. 
Although post-mortem studies suggest that GAD67 expression is reduced 
throughout the brain in patients. Kegeles, Mao, Stanford, Girgis, Ojeil, Xu et al 
(2012) found conflicting results from two voxels positioned in the dorsolateral 
and medial prefrontal cortex, with an increase in GABA levels in unmedicated 
patients in the medial prefrontal region but not in the dorsolateral prefrontal 
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cortex. This study also reported no differences in GABA levels between healthy 
controls and medicated patients in both voxels, suggesting medication within 
these brain regions, may reduce GABA in patients. Marsman et al., (2014) also 
found reductions in GABA, in relation to creatine, in the prefrontal cortex of 
patients compared to controls, but found no difference in parietal-occipital 
cortices. These findings again suggest that the differences found in GABA 
levels in patients are highly variable across studies and are not consistent 
throughout the brain. These changes appear to be most common in the 
prefrontal cortex, which could potentially account for the deficits in high-level 
functioning experienced by patients. More research investigating GABA levels 
in different areas of the brain is needed to determine the true extent of this 
reduction. 
 
1.5.4 Neural oscillations 
Neural oscillations are the repetitive or rhythmic firing of neurons within the 
brain, which results in the production of oscillations. These can be measured 
using either electroencephalography (EEG) or magnetoencephalography 
(MEG) measures. MEG is a non-invasive imaging technique used to measure 
activity generated in the brain. It measures the synchronised firing of tens of 
thousands of neurons and maps this activity back to its source within the brain. 
Outputs from such data include, but are not limited to, transient amplitude and 
frequency, which is the initial spike in activity generated by the presentation of a 
stimulus, and sustained amplitude and frequency which is the sustained level of 
activity for a specified amount of time after stimulus onset. The frequency 
measures at which these can be measured are as follows; delta (1-4Hz), theta 
(4-8Hz), alpha (8-13Hz), beta (8-30Hz) and gamma (30-150Hz). Gamma 
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oscillations are of particular interest as they have been implicated in cognition 
and connectivity between different brain regions (Montgomery and Buzsaki, 
2007; Colgin, Denninger, Fyhn, Hafting, Bonnevie, Jensen et al, 2009). In 
addition, they are known to be the product of interplay between GABA and 
glutamatergic principal cells (Traub, Bibbig, LeBeau, Buhl and Whittington, 
2004). Therefore this thesis will focus only on gamma band oscillations. 
 
1.5.5 Gamma oscillations 
Gamma (γ) oscillations occur at a frequency of between 30-150Hz and are 
heavily implicated in information transfer between different brain regions and 
with the idea of 'connectedness' within the brain (Montgomery and Buzsaki, 
2007; Colgin, et al, 2009). They are of particular interest due to their link with 
synaptic inhibition with GABA-mediated inhibition from PV+ neurons heavily 
implicated in their generation (Gonzalez-Burgos and Lewis, 2008; Sohal, 
Zhang, Yizhar, and Deisseroth, 2009).  
 
PV+ neurons provide strong inhibition onto excitatory pyramidal cells and other 
GABAergic neurons, including other PV+ neurons. Computational models have 
shown how mutual inhibition between PV+ neurons is essential for the 
generation of γ oscillations (Bartos et al., 2007) but in studies using genetically 
modified mice with GABAa receptor mediated inhibition removed from PV+ 
cells, the amplitude and frequency of γ activity was the same suggesting mutual 
inhibition is not necessary for γ activity (Wulff, Ponomarenko, Bartos, 
Korotkova, Fuchs, Bähner, et al., 2009) 
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Neuron excitation, however, does appear to be necessary for the generation of 
γ activity and in computational models glutamatergic pyramidal cells provide 
excitation, which are in turn inhibited in a feedback loop. Recent work has 
identified the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
subtype of glutamate receptors as being necessary to provide normal 
oscillations as mice bred with a deletion of AMPA receptor subunits GluR-D or 
GluR- -type mice 
(Fuchs, Zivkovic, Cunningham, Middleton, LeBeau, Bannerman et al, 2007). 
 
GAD67 expression discussed previously has been localised to PV+ GABAergic 
interneurons, which has been confirmed in post-mortem studies in the motor 
and visual cortex (Hashimoto, Bazmi, Mirnics, Wu, Sampson & Lewis, 2008), 
the hippocampus (Knable, Barci, Webster, Meador-Woodruff ,Torrey and 
Stanley Neuropathology Consortium, 2004) as well as the dorsolateral 
prefrontal cortex (Akbarian, Kim, Potkin, Hagman, Tafazzoli, Bunney et al, 
1995). This finding suggests that the reduction in synthesis of GABA is specific, 
though not exclusive, to the sub-population of neurons necessary for the 
 
 
1.5.6 Visually-induced gamma 
Induced activity refers to activity generated in the brain that is non-phase locked 
to the stimulus presented (Galambos, 1992). It is also referred to as a self-
generated activity (Uhlhaas and Singer, 2010). This is compared to evoked 
responses that are phase-locked to the stimulus.  
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Visually-induced gamma activity has now become one of the most studied 
areas in relation to neural oscillations largely because simple high contrast 
static grating stimuli have been shown to elicit consistent and repeatable 
occipital γ -band oscillations in healthy controls (Muthukumaraswamy, Singh, 
Swettenham & Jones, 2010). Annulus grating stimuli and larger full screen 
stimuli has been shown to increase gamma power compared to square-wave 
grating stimuli (Muthukumaraswamy and Singh, 2013). A reduction in amplitude 
is also seen when using a plaid grating stimulus (Hermes, Miller, Wandell & 
amplitude and frequency, whilst additionally producing results with a clearer 
induced sustained effect in healthy controls at approximately 65-70Hz 
(Swettenham, Muthukumaraswamy and Singh, 2009; Muthukumaraswamy and 
Singh, 2013).  
 
frequency (Vidal, Chaumon, O'Regan, & Tallon-Baudry, 2006) and, when used 
in conjunction with contracting radial moving stimuli, produces similar results 
with a clear sustained effect between 65-70Hz as well as an additional separate 
pants (Hoogenboom, 
Schoffelen, Oostenveld, Parkes & Fries, 2009). 
Gamma oscillations are related to cognition and the ideas of ‘connectedness’ 
within the brain (Montgomery and Buzsaki, 2007; Colgin, et al, 2009) and so 
have become a prime area of research for psychiatric disorders. A reduction in 
gamma oscillatory activity has been widely reported in patients with 
schizophrenia with recent work showing a general reduction in induced gamma 
amplitude both at rest and during working memory tasks (Haenschel, Bittner, 
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Waltz, Haertling, Wibral, Singer et al, 2009; Chen, Stanford, Mao, Abi-Dargham, 
Shungu, Lisanby et al, 2014) and backward-masking tasks (Wynn, Light, 
Breitmeyer, Nuechterlein & Green, 2014). Additional reductions in high gamma 
power (60-120Hz) have been recorded during perception of Mooney faces 
(Grutzner, Wibral, Sun, Rivolta, Singer, Maurer et al, 2013), auditory stimulation 
(Hamm, Gilmore, Picchetti, Sponheim & Clementz, 2011) and perceptual 
organisation (Tillmann, Wibral, Leweke, Kohler, Singer, Koethe et al (2008). 
 
Antipsychotic medication has been shown to modulate gamma activity 
irrespective of disease state. Rats under the influence of both first and second-
generation antipsychotics showed inhibited hippocampal gamma power due to 
the medication's interaction with D3 dopamine receptors (Schulz, Heidmann, 
Mike, Klaft, Heinemann & Gerevich, 2012). However, the same pattern of 
results have been found irrespective of medication state as unmedicated first 
episode patients have demonstrated impaired cognitive control related gamma 
activity and also reduced evoked prefrontal gamma-band responses during an 
auditory task (Minzenberg, Firl, Yoon, Gomes, Reinking & Carter, 2010; 
Gallinat, Winterer, Herrmann & Senkowski, 2004 respectively). It could be the 
case that both antipsychotic medication and the disorder itself independently 
affect oscillatory mechanisms and that the combination amplifies the effect.  
Brain structure has been implicated as a mediating factor in the disruption of 
neural oscillations and has been related to gamma frequency with the surface 
areas of V1 and V2 positively correlating with visually induced gamma in 
healthy controls (Schwarzkopf, Robertson, Song, Barnes, & Rees, 2012). 
Cortical thickness in area V1, peak transient and peak sustained gamma 
frequency have been negatively correlated with age (Gaetz, Roberts, Singh, 
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Muthukumaraswamy, 2011). Reductions in cortical volume, thickness and 
surface area in patients have also been reported (Rimol, Nesvåg, Hagler Jr, 
Bergmann, Fennema-Notestine, Hartberg et al, 2011; Edgar, Chen, Lanza, 
Howell, Chow, Heiken et al (2014). Any investigation of how modulations of 
gamma oscillatory dynamics relates to behaviour and/or disease state needs to 
therefore properly account for possible structural changes (area/thickness) that 
are also co-occuring. GABAergic deficits can therefore account for the 
abnormalities observed in gamma rhythms as well as the disruption of efficient 
information transfer between brain regions seen in patients.  
 
One potential problem with using neuroimaging exclusively is that the results 
could always just be probing a non-functionally relevant correlate of the 
disease. There is therefore a need to demonstrate that there is a behavioural 
deficit in Sz and that this is also related to changes in our non-invasive 
biomarkers. Because MRS and MEG markers are so robust for visual cortex 
measures, we need visual behavioural tasks that probe this at the behavioural 
level. Certain visual psychophysics tasks such as the orientation discrimination 
task and the tilt illusion can do this as they are thought to be dependent on 
neural inhibition and have been previously linked to both MRS and MEG 
markers. 
 
1.6 Visual processing 
The visual system is the largest in the brain and is responsible for processing 
the visual image. This system is widely studied and thus much is known about 
its anatomy and structure. Information from the left and right visual fields enters 
both eyes and is carried along the optic nerve where the information from the 
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corresponding visual field to that eye crosses over to the contralateral 
hemisphere through the optic chiasm. Information then travels through the optic 
tract to the lateral geniculate nucleus (LGN), then to the primary visual cortex in 
the occipital lobe of the brain for further processing. Thus, information from the 
right visual field received from both eyes will be processed in the left 
hemisphere of the visual cortex and vice versa (see Figure 1.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Visual system pathway. As shown in the above image the visual 
cortex receives images from the contralateral eye. 
 
A simple cell in the primary visual cortex is a cell that responds primarily to bars 
of a preferred orientation (Hubel and Wiesel (1959). These cells were termed 
simple because they shared the following properties; they have distinct 
excitatory and inhibitory regions, their excitatory and inhibitory regions balance 
themselves out in diffuse lighting and it is possible to predict responses of 
moving stimuli given the map of excitatory and inhibitory regions. Complex cells 
are also found in V1 and like a simple cell will respond to a preferred 
orientation, however it has a degree of spatial invariance. This means that its 
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receptive field cannot be split into excitatory and inhibitory zones. Rather, it will 
respond to patterns of light in a certain orientation within a large receptive field, 
regardless of the exact location (Hubel and Wiesel, 1962).  
 
Cells in V1 are also responsive to certain aspects of the visual field; in particular 
orientation, spatial frequency and colour. Different cells within the visual system 
such as the ganglion cells within the optic nerve are responsive to different 
aspects of the visual field; M cells have large centre-surround receptive fields 
and are sensitive to depth, P cells have smaller centre-surround receptive fields 
and are sensitive to colour and shape and K cells have very large centre only 
receptive fields that are sensitive to colour. Information from these cells is sent 
to V1 for processing and then onto different areas of the extrastriate visual 
cortex.  
 
1.7 Visual psychophysics  
Psychophysical tasks are designed to investigate how changes in stimulus 
change what we perceive. They are low-level, inexpensive and quick and easy 
to administer making them useful tasks to administer to challenging groups 
such as psychiatric patients or participants with reduced cognitive abilities. For 
the purpose of this thesis I will focus on two psychophysical tasks; the 
Orientation Discrimination task (OD task) and the Tilt Illusion task (TI task).  
 
1.7.1 Orientation discrimination task 
The orientation discrimination (OD) task measures the threshold at which a 
participant can no longer discriminate the orientation of two sequentially 
presented grating circles. The starting mean orientation for this task can vary 
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with cardinal orientations or oblique orientations being used. In healthy control 
participants, the thresholds when using a cardinal starting orientation are on 
average 0.5°+/- 0.3° but when using an oblique orientation average thresholds 
increase by 3.5-5x that of cardinal thresholds to approximately 1.8°+/- 0.5° 
(Tibber, Guedes & Shepherd, 2006; Edden, Muthukumaraswamy, Freeman & 
Singh, 2009). This strong performance benefit for cardinal orientations is known 
as the oblique effect. One's ability to perform well on this task is dependent on 
the orientation selectivity of cells in the visual cortex. 
 
1.7.2 Orientation tuning and neuronal selectivity 
The tuning of visual cortical neurons to different orientations is one of the best 
understood examples of visual selectivity since it was first described by Hubel 
and Wiesel (1959). Cells within the visual cortex respond maximally to a bar or 
grating of a given orientation, also known as the cell's preferred orientation 
(PO). The level of response drops the further the orientation of the stimulus is 
away from the cell's PO, thereby allowing that cell's tuning curve to be plotted 
(see Figure 1.7). 
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Figure 1.7 Orientation tuning curve of a single cell with a PO of 0° (vertical) 
Hubel and Wiesel (1962) developed the early theory of orientation selectivity, 
which stated that this arose from the convergence of excitatory afferents from 
the lateral geniculate nucleus (LGN). In this model LGN cells are aligned in a 
row along the receptive field of the orientation selective neuron and this 
feedforward connectivity would account for any increase in the response for the 
cell's PO when compared to other orientations. However, whilst this model was 
good at predicting a cell’s PO it was not good at predicting the tuning curve of 
orientation selective cells. 
 
Inhibition became of interest for orientation selectivity due to studies showing 
that the blocking of cortical inhibition, using GABAa antagonists, impacted the 
tuning of both simple cells (Sillito, Kemp, Milson and Beradi, 1980) and complex 
cells (Sillito, 1979) to stimulus orientation with the vast majority of simple cells 
completely losing their orientation selectivity. This, therefore, suggested that 
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GABAergic inhibition was necessary for the tuning of orientation selective 
neurons. However, there was the problem of ceiling effects with these studies 
as they were ultimately suggesting that stimulus-specific inhibition arises from 
cells with different POs to that of the target cell. Further, Nelson, Toth, Sheth 
and Sur (1994) showed how excitation is sufficient for orientation selectivity of 
visual cortical cells. Inhibitory GABA receptors were blocked intracellularly and 
the tuning curves of 18 neurons were measured. They found all 18 neurons 
remained selective for their preferred orientations with solely excitatory inputs 
suggesting inhibition is not necessary for orientation selectivity. 
 
However, inhibition still remained a topic of research with pharmacology 
research demonstrating that blocking inhibition to orientation selective neurons 
using GABA antagonists, increased the firing rate of that neuron to non-
preferred orientations, thus broadening their tuning curves (Crook, Krisvardy 
and Eysel, 1998). Troyer, Krakowski, Priebe and Miller (1998) expanded these 
results to propose a model for orientation selectivity based on cortico-cortical 
inhibition whereby there are broadly tuned LGN convergent excitatory inputs 
with more broadly tuned inhibitory inputs which cancel out the wide angle 
responses and leave a sharper tuning curve.  
 
Support for the cortico-cortical inhibition model comes from several studies 
demonstrating how administration of bicuculline, a GABAa antagonist, to the 
visual cortex resulted in diminished orientation selectivity for moderately and 
strongly orientation selective cells whereas administration of GABA resulted in 
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improved orientation selectivity within weakly orientation-selective cells along 
with a slight improvement in moderately orientation-selective cells (Li, Yang, 
Liang, Xia, Yang and Zhou, 2008; Katzner, Busse and Carandini, 2011).  
 
Since the ability to make orientation-based judgements depends on the width of 
the tuning curve (Regan and Beverly, 1985; Beaudot and Mullen, 2006), 
psychophysical tasks that depend on the ability to make orientation judgements, 
such as the OD task, should demonstrate the strength of cortical inhibition.  
Supporting evidence for the role of GABAergic inhibition in orientation 
judgement using an orientation discrimination task comes from Edden et al., 
(2009) who showed a negative correlation between in-vivo GABA levels within 
the visual cortex and OD thresholds thereby demonstrating that increased 
GABA levels resulted in lower oblique thresholds. They found no relationship 
between GABA and vertical thresholds, a point that will be taken up in Chapter 
3. A recent study (Dickinson, Bruyns-Haylett, Jones and Milne, 2015) 
investigated the relationship between autistic traits, OD thresholds and peak 
gamma frequency in a healthy sample. In line with Edden and colleagues 
findings, they found significant negative correlations between OD thresholds 
and peak gamma frequency and autistic traits. This lends further support to the 
idea that inhibition plays a major role in orientation selectivity and performance 
on the task. 
 
When considering the oblique effect, its neural mechanisms are still under 
discussion. It has been shown that the oblique effect is not due to the optics of 
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the eye (Maffei and Campbell, 1970), the retina (Mitchell, Freeman and 
Westheimer, 1967) or eye movements (Nachmias, 1960), which suggest that 
the visual cortex or feedforward mechanisms from the LGN are more likely the 
origins of the oblique effect. In support of this idea, Li, Peterson and Freeman 
(2003) demonstrated in the cat visual cortex that there are more cells with a 
preferred orientation of horizontal or vertical compared to oblique angles. In 
addition, the tuning curves of those neurons preferring oblique angles were 
much broader. Other studies have shown less cortical area devoted to cells with 
oblique POs (Coppola, White, Fitzpatrick and Purves, 1998; Wang, Ding and 
Yunokuchi, 2003) and fMRI studies have demonstrated increased activity in 
relation to vertical and horizontal angles than to oblique.  
 
Whilst this research all points to a cortical origin of the oblique effect the effect 
sizes are modest and do not match the size of the oblique effect. A study 
measuring cortical representation of oblique orientations in visual area 17 in the 
cat visual cortex showed how this was greatly increased by glutamate excitation 
in area 21a. Cortical representation was also decreased by GABA inhibition in 
this area (Liang, Shen and Shou, 2007). This study suggests that the oblique 
effect may be due to feedback from higher-level visual areas. This could 
account for Edden et al’s (2009) finding being specific to oblique orientations 
because participants with more GABA within these higher-level visual areas 
may have increased inhibitory control of these feedback processes. However, 
work to date has yet to investigate this possibility, as studies addressing this 
question would need to measure several smaller voxels within the visual cortex, 
which can have implications for available acquisition time and thus the quality of 
data. 
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1.7.3 Orientation discrimination and schizophrenia 
Orientation discrimination has also been related to psychiatric disorders and, 
consistent with findings of a reduction in occipital (visual cortex) GABA levels in 
patients with schizophrenia, patients have been found to have significantly 
wider orientation tuning curves compared to healthy controls (Rokem, Yoon, 
Ooms, Maddock, Mizenberg & Silver, 2011). However, there has been very little 
research conducted with patients using the OD task discussed previously in this 
thesis to ascertain whether a deficit occurs and whether an oblique effect is 
present within this patient group. 
 
1.7.4 Tilt Illusion 
The Tilt Illusion (TI) task is a perceptual phenomenon whereby a participants’ 
perception of vertical can be altered by the introduction of a grating surround 
(Gibson, 1937). This produces either a repulsive or attractive affect depending 
on the orientation of the surround relative to a central test patch. The surround 
affecting the perception of a central patch is also referred to as contextual 
modulation. Repulsion occurs when the surround is oriented between 10° and 
25° clockwise or anticlockwise relative to the centre circle with the peak effect 
occurring at 15°. This is known as the direct effect. Attraction occurs when the 
surround is oriented between 55° and 90° relative to the centre circle with the 
peak effect occurring at 70°. This is known as the indirect effect. The results are 
more pronounced for the direct effect which generally produces a change in 
perceived tilt of approximately 3° compared to baseline with no surround, 
whereas the attraction effect usually produces a change of approximately 0.5°.  
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1.7.5 Contextual modulation 
Evidence for a psychophysical theory of contextual modulation first came from 
Gibson and Radner (1937) who suggested that the direct and indirect effects 
occur because the inspection of the tilted surrounding stimulus results in the 
participant adapting to the nearest vertical or horizontal axis. They called this 
shift in perception ‘normalisation’. Thus if a grated stimulus was tilted 15° 
clockwise from vertical it would be normalised towards vertical so that it 
appeared less tilted, 10° for example. A subsequent vertical grating would then 
appear 5° anticlockwise if the 15° difference was still seen. The main problem 
with this theory is that it cannot account for the fact that the indirect effect is 
consistently weaker than the direct effect.  
 
To try and explain this difference in the size of effects, lateral inhibition was 
discussed to account for the direct effect (Blakemore, Carpenter and 
Georgeson, 1970). Lateral inhibition is the capacity of an excited neuron to 
inhibit the activity of a neighbouring neuron, thus sharpening the response of 
that particular neuron. In the relation to the TI, the orientation of the surround 
causes inhibition from the most excited orientation neurons, which in turn 
produces a short-lived reduction in the output of neurons that prefer 
neighbouring orientations. Thus when the surround is present the neurons 
giving the greatest output may not be those whose preferred orientation 
corresponds to the centre circle, thus producing the shift in orientation 
perception. The idea was that the direct effect was the sum of both this and 
normalisation, accounting for the stronger effect, and the indirect effect was the 
result of normalisation alone. 
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The idea of lateral inhibition was extended to include disinhibition as an 
explanation for the indirect effect, a process termed gain control. Specifically, 
inhibition between neurons tuned to specific orientations at the same location, 
as well as those tuned to specific orientations but at different locations, can lead 
to disinhibition of neurons remote in both position and orientation (Clifford, 
2014). This in turn leads to the responsiveness of the orientation selective 
neurons being normalized by the responses of similar neurons (Goddard, 
Clifford and Solomon, 2008). It is an appealing idea as it refers to a process that 
allows, in this instance, the visual system to adapt its responses to stimuli to 
take into account spatial and temporal context (Butler, Silverstein and Dakin, 
2008). In the gain control model of the TI, the magnitude of disinhibition never 
exceeds that of inhibition. Therefore, the magnitude of the indirect effect 
(disinhibitory) will never exceed that of the direct effect (inhibitory) thus 
accounting for the difference in magnitude of effects. 
 
 
There is now a growing body of evidence that the direct effect can occur with no 
conscious awareness, but the indirect effect cannot. Tomassini and Solomon 
(2014) prevented awareness of the stimulus in his participants by using 
adaption-induced blindness and demonstrated how a strong direct effect, using 
a surround of 15° relative to the centre, remained whereas the indirect effect, 
using a surround of 70°, disappeared. This lends further support to the idea of 
different mechanisms for each effect.  
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1.7.6 GABA and Tilt illusion 
Context modulation has been linked with GABA by Yoon et al., (2010), who 
reported patients with schizophrenia had lower levels of GABA in the visual 
cortex and also showed weakened contrast gain control, as evidenced by 
reduced orientation-specific surround suppression. These results were 
irrespective of anti-psychotic medication use (calculated using chlorpromazine 
equivalents). 
 
The TI specifically has also been linked to GABA as work using Lorazepam, a 
GABA potentiating benzodiazepine, showed a dose related increase in the 
magnitude of the direct effect (Gelbtuch, Calvert, Harris and Phillipson, 1986). 
In other words the higher the participants' GABA levels were, the more impact 
the surround had and the bigger the direct effects. However, this only occurred 
for the TI, as Lorazepam dose had no effect on the tilt after effect, suggesting 
that the link with GABA is specific to particular visual phenomena. This result 
fits quite neatly with the finding of a reduction in GABA in patients with 
schizophrenia and the psychophysics literature, which has shown for different 
surround suppression tasks including contrast, motion, orientation etc, that the 
introduction of the surround has little to no effect on patients.  
 
1.7.7 Contextual modulation and schizophrenia 
The level of gain control is proposed to be weaker in patients with 
schizophrenia than in controls (Butler et al, 2008; Phillips and Silverstein, 2013) 
leading to a reduction in contextual modulation as demonstrated by Dakin, 
Carlin and Helmsley (2005); Serrano-Pedraza, Romero-Ferreiro, Read, 
Diéguez-Risco, Bagney and Caballero-González (2014) who found reduced 
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contextual modulation in a patient group when measuring perceived contrast 
and by Yoon, Rokem, Silver, Minzenberg, Ursu, Ragland and Carter (2009) 
when measuring orientation selectivity. Results from Yang, Tadin, Glasser, 
Hong, Blake and Park (2013) show normal contextual modulation of luminance 
but impaired modulation of contrast which provides further evidence of 
dysfunctional inhibitory, possibly GABAergic, circuitry in the early visual cortex. 
 
Imaging studies have supported the idea of reduced levels of contextual 
modulation in schizophrenia with recent fMRI studies providing strong 
neurophysiological evidence for this theory having shown abnormally weak 
orientation specific surround suppression in the visual cortex of patients with 
schizophrenia (Seymour, Stein, Sanders, Guggenmos, Theophil and Sterzer, 
2013). From the results referenced above it would be expected that patients 
would have weaker direct effects when using the TI task. However, when 
investigating the direct effect in patients the results are mixed. Both Yang et al 
(2013) and Tibber, Anderson, Bobib, Antonova, Seabright, Wright et al (2013) 
found no difference between patients and controls in the magnitude of the direct 
effect. In addition, Yang et al (2013) found that larger direct effects within the 
patient group were associated with higher symptom severity whereas Tibber 
and colleagues (2013) found the opposite direction of results. 
 
These results are contrary to what intuitively would be expected given the 
results of Butler et al, 2008; Philips and Silverstein, 2013 and Dakin et al., 
(2005), and also Gelbtuch et al (1986) who positively correlated GABA with the 
size of the direct effect in healthy controls. Given the previous findings of a 
reduction in GABA levels in patients with schizophrenia it would be expected 
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that this group would demonstrate weaker contextual modulation compared to 
healthy controls thereby resulting in weaker direct effects. There is limited 
specific research into the TI task and schizophrenia. More research is needed 
using this task within this patient group to investigate how contextual 
modulation relates to this disorder and how this could be mediated by 
neurophysiological factors.  
 
1.8 Objectives 
The measurement of neural activity, neurotransmitter concentration and 
behaviour is essential for the understanding of how this behaviour arises in both 
healthy and disease populations. This thesis will investigate group differences 
in gamma band activity using MEG methods to achieve a time-resolved 
measure of oscillatory dynamics, in-vivo GABA levels using MRS methods and 
psychophysical methods, specifically the orientation discrimination task and the 
tilt illusion, to derive a behavioural measure known to relate to both the imaging 
outcomes. The first experimental chapter investigates how stimulus duration 
affects orientation discrimination thresholds in healthy controls. The second 
investigates the reliability of the tilt illusion task and how the results relate to 
visually induced gamma frequency and amplitude. The third examines whether 
there is a between group difference in GABA levels in an occipital (visual) voxel 
and a sensory motor voxel for comparison. The fourth investigates between 
group differences in gamma measures using two visual tasks. The final 
experimental chapter aims to bring the experimental measures together in order 
to look at the relationship between groups for the imaging and psychophysics 
measures. The hope is that if a relationship does exist between the imaging and 
psychophysics, then instead of patients undergoing lengthy and expensive 
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imaging scans these behavioural measures could be developed as potential 
biomarkers and used in a clinical setting as a proxy measure for levels of 
cortical inhibition.  
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Chapter 2 - Methods 
 
2.1 Psychophysics 
2.1.1 Orientation discrimination 
The Orientation discrimination task is designed to determine a participant’s 
threshold for discriminating the orientations of two sequentially presented 
circularly-windowed gratings of different orientations (Edden et al., 2009). For 
example stimulus see Figure 2.1. Participants are instructed to respond which 
of two sequentially presented grated circles is orientated more to the right in a 
two-alternative forced choice design. Thresholds are calculated using two 
adaptive staircases running simultaneously with both converging on ~71% 
correct performance. A 2up-1down staircase system is used whereby the 
participant has to answer correctly twice in a row for the task to get harder 
(orientation difference between the two circles gets smaller) but only have to 
answer incorrectly once for the task to get easier (orientation difference 
between the two circles gets bigger). The task switches randomly between the 
two staircases so that participants cannot monitor or predict upcoming trials. 
The task will continue until there have been 12 reversals in each staircase with 
thresholds calculated only from the last 10.  These are then averaged to get an 
overall orientation discrimination threshold. 
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Figure 2.1 – Orientation discrimination experiment (adapted from Edden et al, 
2009) 
 
2.1.2 Tilt illusion 
The tilt illusion is designed to measure to what extent the perceived orientation 
of a test grating is altered by the introduction of a surrounding grating of 
different orientations (Gibson, 1937). For an example of the stimulus with 
surround see Figure 2.2. Two conditions are performed; one with an oblique 
surround and one with no surround, which is considered as a baseline 
measure, with each block split into two parts. The first part uses a Method of 
Adjustment (MA) design to calculate what the participant perceives as vertical 
over four trials. Participants are presented with a flashing circularly-windowed 
grating stimulus of different orientations and are instructed to rotate the 
stimulus, using mouse button presses, until they perceive the lines as being 
vertical. The mean orientations from each of these trials are then averaged to 
get a mean perceived vertical for that participant.  
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The second part of the task is designed to assess how well the participant can 
judge the orientation of a quickly presented circularly-windowed grating 
stimulus. The stimulus used is the same as in the first part of the task but is only 
presented once.  A Method of Constant Stimuli (MOCS) procedure is used for 
the second part of the task. The mean perceived vertical output is used as a 
mid point for seven orientations, with a fixed step size, from which participants 
must judge whether they are left or right of vertical. These orientations would be 
presented randomly for a set number of trials each.  
 
A psychometric function is calculated with the Point of Subjective Equality 
(PSE) being the output of interest. In this instance the PSE refers to the point at 
which the participant can no longer discriminate between left and right and 
perceives the test grating as vertical. It is the shift or difference in the PSE 
between the no surround/baseline condition and the surround condition that is 
recorded and referred to as the direct effect (Gibson, 1937) 
 
 
 
 
 
 
 
Figure 2.2 – Example Tilt Illusion stimulus with surround 
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2.2 Imaging Methods 
2.2.1 Magnetoencephalography 
Magnetoencephalography (MEG) is a non-invasive functional brain imaging 
technique used to measure electromagnetic activity generated by synchronised 
neuronal firing within the brain (Singh, 2006). It has both high temporal and 
spatial resolution of neuronal activity, something MR imaging does not have.   
 
2.2.1.1 MEG signal generation 
The externally measured MEG signal is generated by post-synaptic potentials 
(PSPs) within pyramidal cells. Electric currents are generated through these 
action potentials changing the permeability of the post-synaptic membrane to 
potassium (K+) and calcium (Ca+) ions. This electric current creates a magnetic 
field perpendicular to the current, which when measured outside the head 
constitutes the MEG signal. The magnetic field generated by a single neuron is 
extremely weak, a factor of 1 million to 1 billion smaller than environmental 
magnetic noise (Vbra and Robinson, 2001), and would not be detectable on its 
own thus the MEG signal is the synchronised firing of up to tens of thousands of 
neurons. Environmental noise cancellation is, therefore, a major problem when 
using MEG. Magnetically shielded rooms (MSR) are used to stop as much 
environmental interference as possible with superconducting devices needed 
inside the room to filter the noise further and measure the signal with adequate 
sensitivity. 
 
Superconducting QUantum Interference Devices (SQUIDs) were developed to 
be able to detect such small magnetic fields.  Modern MEG systems consist of 
hundreds of SQUIDs arrayed around the head – the system used in this thesis 
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has 275, As SQUIDS are superconducting and must be constantly super cooled 
and stored in liquid helium, the signals received from these sensors are 
transmitted to room temperature and amplified. Each SQUID sensor although 
very sensitive, consists of a small loop of material that only collects flux from a 
small area. For this reason, SQUIDs used in MEG are inductively coupled to a 
larger set of coils. These are also superconducting and consist of pickup coils 
containing a single loop of wire. This wire within the pickup coil acts as a 
magnetometer and is sensitive to magnetic fields perpendicular to its area but 
also to environmental magnetic noise. Two magnetometers with wires of 
opposing orientations can be joined together and connected to the same 
SQUID sensor to create a first-order gradiometer, which is sensitive to the 
spatial gradient of the field.  As magnetic fields rapidly decay the further from 
the source they become, gradiometers are less sensitive to signals from distant 
sources compared to the signals generated from activity within a closer source; 
in this example the brain. Second and third-order gradiometers, using 
increasingly complex combinations of coils, produce even better signal to noise 
but are bulky, difficult to manufacture and reduce the signal from deeper brain 
sources. For these reasons most MEG systems use first-order gradiometers 
within the scanner itself and higher order gradiometers synthesised in software 
for further noise cancellation purposes (Vrba and Robinson, 2001). 
 
2.2.1.2 MEG analysis 
Once the SQUID sensors collect data, the signals need to be converted from 
sensor space (the position of the sensors) to source space (the brain). There 
are two main problems with this process; the forward problem and the inverse 
problem. The forward problem refers to reliably identifying the magnetic field 
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generated from a particular source of known position, magnitude and 
orientation – this is known as the lead field for this location and, if known, allows 
the simulation of what magnetic field this current source would generate in 
every SQUID sensor. 
 
The inverse problem is more problematic and refers to being able to reliably 
determine the location of electrical activity within the brain from the magnetic 
fields measured outside the head. This has no unique solution, as there are an 
infinite number of solutions that could generate the recorded electrical activity. A 
solution can only be produced by the addition of extra a priori information 
regarding the spatial and temporal nature of the source distribution within the 
head. Several different approaches to solving the EEG/MEG inverse problem 
have been developed and are currently in common use. The solutions yielded 
by each approach depend both on the data and their underlying assumptions 
about the source. 
 
Beamforming is an analysis tool that creates a 'virtual sensor' over a particular 
area of interest.  The timeseries of the current at this virtual sensor is estimated 
as a weighted sum of the timeseries of each MEG sensor. Synthetic aperture 
magnetometry (SAM; Vrba and Robinson, 2001) is the beamformer technique 
that is used throughout this thesis. SAM makes two assumptions; First, that 
data are generated by discrete dipolar sources and second, that the time series 
of these sources are not temporally correlated. Thus, SAM analysis is not 
recommended for experiments where discrete sources are known to be highly 
temporally correlated over significant periods of time. Data is split into baseline 
and stimulation blocks with t-tests calculated to determine if there is any 
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difference in activity between the two for each virtual sensor.  
 
 
An important consideration of MEG data analysis is whether the experiment is 
measuring evoked or induced responses. Both experimental designs tend to 
repeat a stimulus over many trials and average the signal over all the trials. 
Evoked responses are phase-locked to the stimulus onset. When 
all the trials are analysed, the peaks and troughs (i.e. the phase of the 
response) line up during analysis. This type of evoked analysis is referred to as 
event-related field (ERF) analysis. Alternatively, some responses are time-
locked but not phase-locked to the stimulus. Because the phase of the 
response is essentially random on each trial, simple averaging of response over 
trials will result in little or no average response. For this type of data, frequency 
or time-frequency estimation is needed. This is done by analysing the amount of 
power within a certain bandwidth before averaging the signal. This type of 
response is referred to as induced with increases in power termed event-related 
synchronisation (ERS) and decreased power termed event-related 
desynchronisation (ERD) (Singh, 2006). This thesis will focus on induced 
responses. Beamformers are particularly well suited to localalise changes in 
induced oscillatory power, which is why this method is used throughout the 
thesis. 
 
In order to produce time-frequency plots of induced data from the virtual sensor 
of interest, it has to be subjected to a spectral estimation based on the Hilbert 
transform, which yields the time-varying envelope of band-pass filtered data 
(Figure 2.3). By band-pass filtering the data into many different ranges, each 
8Hz wide, centred on increasing frequencies, these HIlbert envelopes can be 
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‘stacked’ to generate a time/frequency/amplitude spectrogram of the data. 
These can be baselined to show percentage changes from a defined baseline 
period (Figure 2.4) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Procedure for fitting the positive amplitude peaks to the Hilbert 
transform envelope. 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 Example time/frequency/amplitude spectrogram generated by 
multiple Hilbert amplitude envelopes. From this spectrogram we can define 
time/frequency region-of-interests (ROI) (such as the visual gamma response) 
and calculate summary measures, such as the peak amplitude and frequency of 
the response, within each ROI. 
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2.2.2 MRI signal 
MRI takes advantage of different molecules behaving differently when exposed 
to a strong magnetic field. Hydrogen is most widely used because there is a 
high quantity of it in the body (~70% of the body if made up of water- H2O) and 
only nuclei with an odd number of protons produces a magnetic field. This is 
referred to as ¹H MR imaging.  
 
Hydrogen protons spin on their own axes pointing in different directions but 
when exposed to a strong magnetic field they align with this magnetic field in 
two ways, parallel and anti-parallel.  The distributions of parallel and anti-
parallel atoms are not the same, as atoms prefer to be in the parallel state 
pointing in the same direction as the magnetic field. Therefore, there are slightly 
more atoms aligned parallel to the magnetic field, the sum of which is referred 
to as the net magnetisation.  When exposed to this strong magnetic field the 
protons precess (wobble) at a define frequency due to the magnetic moment of 
the proton at the Larmor frequency. This frequency is given by the 
gyro/magnetic ratio (MHz/T) multiplied by the strength of the magnetic field (B0) 
measured in Tesla (T). This equation is important as it calculates the operating 
radio frequency of the MRI system (Blink, 2004). 
 
When the atoms are presented with a RF pulse at the resonant frequency 
described by the above Larmor equation, the net magnetisation can be rotated 
into a plane perpendicular to the magnetic field (see Figure 2.5). This process is 
called excitation and can also be explained as shifting the protons into a higher 
energy state through them absorbing the energy from the RF pulse. Protons will 
decay back to the lower state, aligning with the magnetic field and in doing so 
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release the absorbed energy in the form of RF energy at the same frequency – 
this is known as relaxation.  
 
Once the RF pulse stops the net-magnetisation will now rotate back along the 
direction of the magnetic field. As the signal measured by the RF coil is 
generated by the transverse magnetisation, this will appear to decay with a time 
constant known as T1. T1 relaxation is defined as the time it takes for the 
longitudinal magnetisation to recover 63% of the original magnetisation. This 
will depend on the molecule as well as the tissue type as hydrogen atoms are 
bound very tightly in fat tissue but much looser in water. Tightly bound protons 
will release their energy a lot quicker than those that are bound loosely. As well 
as the T1 relaxation time, another fundamental mechanism of MR signal 
relaxation is governed by the T2 decay constant. T2 relaxation occurs because 
although all the nuclear (proton) spins are initially in phase after RF excitation, 
generating a bulk coherent signal, as time progresses random dephasing of the 
spins occurs leading to a weaker, non-coherent, signal. This dephasing is also 
reflective of the local tissue characteristics. 
 
The emission of these radio frequencies are received and measured by a 
receiver coil placed over the area being scanned. The contrast between 
different tissues can be generated by MR sequences that are designed to be 
sensitive to different aspects of the T1 and T2 decay processes (Hashemi, 
Bradley and Lisanti, 2010). 
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Figure 2.5 Excitation from RF pulse causing rotation of net-magnetisation 
 
2.2.3 Magnetic Resonance Spectroscopy 
Magnetic Resonance Spectroscopy (MRS) uses the same principals as MRI, 
but focuses on producing information regarding concentrations of different 
molecules within the voxel of interest. ¹H MRS detects signals that arise from 
hydrogen spins within tissue metabolites after being subjected to a strong 
magnetic field. These signals have chemically specific resonance frequencies 
as the chemical environment of the hydrogen spins cause small modulations of 
the main magnetic field (Puts and Edden, 2012). For example, if the electrons 
within the molecule are relatively close to the hydrogen atom then this has a 
shielding effect resulting in the proton being subjected to a weaker magnetic 
field.  This is known as the Chemical shift.  As each molecule will have its own 
unique resonant frequency, which is consistent over time, MRS can be used to 
focus on certain peaks (metabolites) of interest. 
 
RF Pulse 
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Chemical shift is reported on the Chemical shift axis, or MRS spectra (see 
Figure 2.6). The x axis is plotted from high to low frequency and reports the 
chemical resonance spectrum in parts per million (ppm), quantified as the 
difference in frequency between the molecule of interest and a reference 
(usually water or creatine as these are generally stable over time and easy to 
distinguish from other molecules in the MRS spectra), divided by the operating 
frequency of the scanner, with the y axis reporting signal intensity 
corresponding to proportional metabolite concentration. Molecules, or 
metabolites, with more electrons and more shielding will therefore be on the 
lower end of the spectrum.  
 
 
 
 
 
 
 
 
 
Figure 2.6 Example MRS spectra/Chemical shift axis 
 
Quantification of the reference molecule is acquired through internal 
referencing, whereby both the molecule of interest and the reference are 
acquired from a voxel within the participant during the same scanning session. 
This minimises possible confounders such as participant movement, voxel 
position and possible software or hardware abnormalities between scans.  
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In order to get good quality spectra the signal to noise ratio needs to be high to 
get good height on the signal peaks. This can be increased by longer 
acquisition times; over 5 minutes preferably, larger voxel size to obtain more 
signal; typically 8cm³, or the positioning of the voxel to try to exclude as much 
bone, cerebrospinal fluid (CSF) or water as possible, as these can affect the 
quality of the signal (Provencher, 2001).  
 
2.2.4 MRS GABA analysis 
Isolating one particular metabolite is not easy as some can overlap on the same 
point in the spectra (e.g. GABA and Creatine both peak at 3ppm) or the same 
metabolite can spread across the spectra at lower intensities. The latter is 
known as multiplets or coupling and are associated with signals from a single 
hydrogen environment that are split into a number of sub-peaks, for example 
GABA also appears at 1.9ppm and 2.3ppm on the MRS spectra.  
 
To filter out specific metabolites, spectral editing analysis tools can take 
advantage of the fact that coupling occurs and can be used to separate signals 
from the rest of the spectra. The GABA peaks at 1.9ppm and 3ppm are coupled 
whereas other signals at this point in the spectra, such as creatine, are not 
meaning it is possible to separate the signals. A frequency-selective pulse 
targeted at 1.9ppm would also indirectly affect the GABA 3ppm signal without 
affecting the other metabolites due to this coupling. MRS experiments will, 
therefore, conduct two experiments; one with and one without the frequency-
selective pulse (also known as the editing pulse) and take the difference 
between the two. This will give an edited spectrum that contains only those 
signals that are affected by the editing pulse; signals that occur at 1.9ppm and 
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those arising due to coupling (Puts and Edden, 2012). This technique is 
referred to as J-difference editing and is used in the mostly widely used method 
for analysing GABA data; MEGA-PRESS (Mescher, Merkel, Kirsch, Garwood 
and Gruetter, 1998), which is used in this thesis. Although this method does 
have its issues, as the quality of the spectra can be greatly affected by 
participant movement, for example, it is the best measure of GABA currently 
possible and has been validated by correlation with chromatographic 
measurements of GABA (Bielicki, Chassain, Renou et al (2004). 
 
2.2.5 Recruitment of participants with schizophrenia 
The patient group for this thesis was recruited from a previous Cognition in 
Psychosis study research conducted at Cardiff University (Schizophrenia 
Working Group of the Psychiatric Genomics Consortium, (2014). As part of 
participating in this project, researchers would administer the Schedules for 
Clinical Assessment in Neuropsychiatry (SCAN) interview. This went through 
core symptoms associated with psychosis, depression, mania and anxiety. The 
interviewer would rate each symptom with a provisional diagnosis given after 
completion and review of the interview as a whole. The diagnosis would then be 
verified by clinical consensus rating in line with the DSM-V (American 
Psychiatric Association, 2013). For this thesis only those with a DSM-IV 
diagnosis of schizophrenia were recruited. Of those patients that had given 
consent to be re-contacted about future projects, those that had this verified 
diagnosis were contacted by a letter of invitation with a reply slip included. Once 
I had received the reply slips indicating they would like more information, I 
would contact the participant directly by phone. 
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Chapter 3 - Individual variation in orientation discrimination 
thresholds as a function of stimulus duration 
 
3.1 Rationale 
Performance in psychophysical tasks such as orientation discrimination have 
been linked to GABA inhibition, in vivo GABA levels and gamma frequency in 
healthy controls but there is a potential problem with the task itself. In this study 
we investigated whether the results in previous research were confounded by 
possible ceiling effects.  
 
3.2 Background  
The orientation discrimination task asks participants to discriminate the 
orientation of two sequentially presented circular grating patches to obtain a 
threshold for discrimination for that participant. It is easy to administer and short 
in duration making it appropriate for both healthy and patient populations.  
 
The use of this task usually consists of cardinal conditions, where the mean 
angular difference between two test patches will equal either 0°, 90° or 270°. 
Oblique conditions are also used which usually use a mean angular difference 
of 45° or 315°. The human, and animal to some extent, visual system is much 
more finely tuned to cardinal orientations, in particular in the horizontal plane, 
than to oblique orientations (Li et al., 2003). Thus, discrimination thresholds 
calculated in healthy controls using cardinal conditions are generally between 
0.5-1.5°, but when using oblique orientations participants’ thresholds are 3-5 
times higher generally being between ~1.6-3.3° (Appelle, 1972; Vogels and 
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Orben, 1985; Tibber et al., 2006; Edden et al., 2009). In a select few 
participants, the oblique condition is simply too hard to complete to a 
satisfactory standard with results having to be discarded (Edden et al, 2009).  
The reason for such a strong ‘oblique effect’ is still relatively unknown, with 
animal work suggesting it’s simply due to more neurons within the visual system 
being tuned to cardinal orientations than oblique (De Valois, Yund & Hepler, 
1982; Celebrini, Thorpe, Trotter & Imbert, 1993) or more cortical area is 
dedicated to cardinal orientations compared to oblique (Coppolo et al., 1998; Xu, 
Collins, Khaytin, Kaas, & Casagrande, 2006). 
 
The oblique effect has been linked to GABAergic processes, with one theory 
suggesting GABA inhibition influences the oblique effect by acting on higher-
level visual areas. After administration of GABA to area 21a of the cat visual 
cortex, the areal representation of cardinal orientations decreases compared to 
oblique in the visual cortex, abolishing the oblique effect (Liang et al., 2007; 
Shen, Liang & Shou, 2008). This suggests a feedback mechanism from higher-
level areas within the visual cortex contributes to the oblique effect. Thus, if a 
participant had increased levels of GABA in the visual cortex they would have 
increased levels of inhibition, reducing the oblique effect in these individuals.  
 
This link between the oblique effect and GABA could account for results 
obtained by Edden et al (2009), who showed resting GABA negatively 
correlated with oblique discrimination thresholds in healthy controls. However, 
this relationship was not significant when looking at vertical orientation 
discrimination thresholds. This result suggests increased levels of GABAergic 
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inhibition could lead to increased control over inhibitory mechanisms leading to 
a reduction in the oblique effect.  
 
The lack of relationship with vertical thresholds could be for a number of 
reasons including measurement error or lack of between-subject variation 
leading to very similar results. However, it could also indicate a problem with the 
task itself. Ceiling effects could be present whereby the vertical condition 
administered is too easy and therefore wouldn’t be able to tap into the variation 
within the sample. As far as I am aware, there has been no research in how to 
increase the difficulty of this task and investigate these possible ceiling effects.  
 
3.3 Aims and hypotheses 
The purpose of this research was to investigate why this lack of relationship 
between GABA and vertical thresholds occurred. Consequently, this experiment 
also refined this task within a healthy control sample. One further problem with 
this task was the oblique condition was simply too hard for some participants to 
complete. Therefore we also investigated whether there was an equivalent 
vertical condition that produces comparable thresholds to the oblique condition 
without the associated loss of data.  
 
To increase the difficulty of the task for vertical stimuli, we progressively 
reduced the length of time they were presented and compared performance to 
an oblique condition presented for the same duration as Edden et al (2009). It 
was hypothesised this decrease in stimulus duration would increase the 
difficulty of the task and therefore increase the discrimination thresholds. The 
relationships between thresholds of each condition were investigated to show if 
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ceiling effects were present at the slower durations. Finally, vertical conditions 
will be compared to the oblique condition to see if any of the thresholds are 
comparable. 
 
3.4 Methods  
3.4.1 Participants 
Participants used were majority undergraduate students recruited through the 
School of Psychology’s Experimental Management System (EMS)  for course 
credit (n=37) with the remaining participants recruited opportunistically from 
CUBRIC, also within the School of Psychology (n=9). The sample as a whole 
was males n=6 and females n=40 (mean age = 20.91 years of age). 
 
3.4.2 Inclusion and exclusion criteria 
The inclusion criterion was having normal to corrected vision and aged 18-65. 
The exclusion criterion was having a diagnosis of photosensitive epilepsy. 
 
3.4.3 Stimuli 
Orientation discrimination thresholds were measured using a two-alternative 
forced choice procedure as shown in Figure 3.1. Stimuli were programmed 
using DELPHI and consisted of two sequentially-presented circular grating 
patches (width 4°, contrast 80%, 3 cycles per degree, refresh rate 80Hz, mean 
luminance 44.5 cd/m2). The task used vertical conditions where the mean 
orientation between the two patches was kept at 0°. There was also an oblique 
condition where the mean orientation between the two patches was kept at 45°.   
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Figure 3.1 – Task outline obtained from Edden et al (2009)   
 
One trial consisted of a fixation dot presented for 250ms, followed by a circular 
grating test patch, a second fixation spot for 500ms, a second test patch and 
finally a response fixation spot. The final fixation spot had no time limit and the 
task only progressed once the participant had responded. The task gave 
feedback to the participant by beeping once and flashing a green dot should the 
participant respond correctly to that trial.  
 
The difference in orientation between the two test patches in each trial was 
determined using two randomly-interleaved 1-up 2-down adaptive staircases. 
This is described in detail in Chapter 2 section 2.1.1. Thresholds were 
calculated from the average of the last 10 reversals of both staircases in log 
steps, which were then converted to linear units in degrees (See Figure 3.2).  
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Each staircase was locked to 5-log units maximum angular difference (i.e. 32 
degs) to avoid large orientations that might be called at the beginning of each 
session wrapping around.  
 
 
Figure 3.2 – Staircase procedure obtained from Edden et al (2009) 
 
Participants were seated 54.3cm from the stimulus presentation screen and 
asked to put their chins on a chin rest to stabilize their head and standardise the 
distance from the screen between participants as best as possible. The room 
was kept in complete darkness to try and block as many external orientation 
cues as possible, which may have influenced participants’ performance. 
 
3.4.4 Procedure   
Informed consent was obtained from participants prior to being seated in the 
testing room. Participants were asked to respond which of two sequentially 
presented grating circle patches was oriented more to the right and to respond 
with a left mouse button press to indicate the first interval and a right mouse 
 59 
button press to indicate the second interval. Each participant was required to 
complete a practice condition for both the vertical and oblique conditions before 
continuing to the full test block. There were 6 conditions in total each with 
different mean orientations or stimulus presentation times; 10ms, 36ms, 60ms, 
100ms and 250ms vertical conditions and an oblique condition of 250ms. Each 
condition was completed with a short break in between with a verbal and written 
debrief given on completion of the task.  The task took approximately 30 
minutes to complete. 
 
3.5 Results   
Thresholds were excluded from further analysis if they were 2 standard 
deviations above or below the mean for that condition. Table 3.1 shows the 
remaining number of thresholds for each condition. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1 – Remaining number of thresholds after discarding those +/- 2 
standard deviations from the mean for each condition administered 
 
 
Figure 3.3 shows the mean thresholds for each condition. A within-subject 
repeated measures ANOVA showed a significant main effect of time on 
Condition % remaining 
Vertical 10ms 85% 
Vertical 36ms 83% 
Vertical 60ms 87% 
Vertical 100ms 80% 
Vertical 250ms 80% 
Oblique 250ms 70% 
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orientation discrimination thresholds within the vertical conditions (F(4),26 = 
9.613, P=<.000). The mean threshold difference between the 250ms oblique 
condition and the 250ms vertical condition was also highly significant (t(28) = -
8.219, p=0.001 The 250ms oblique condition also produced much higher 
thresholds than the 10ms vertical condition (t(27) = -5.708, p=<.001). 
 
Figure 3.3– Mean thresholds across stimulus durations. Error bars show +/- 1 
standard error of the mean. Solid data point represents the oblique condition. 
 
Figure 3.4 shows the correlations between each of the vertical conditions and 
the oblique condition. Each of the vertical conditions correlated across 
individuals (see Table 3.2). The 10ms and 250ms conditions in particular were 
very highly correlated (r=0.825, p=0.000). All vertical conditions moderately 
correlated with the oblique condition with 100ms the only condition reaching 
significance.  
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Table 3.2 – Pearson correlations across all stimulus durations and orientations. 
*=p<0.001 (p-value corrected for multiple comparisons) 
 
 
Figure 3.4– Vertical thresholds plotted as a function of the oblique thresholds 
with lines of best fit for each stimulus duration. 
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3.6 Discussion  
This experiment has shown that decreasing the stimulus presentation time of 
the test patch increases participants’ orientation discrimination thresholds. The 
results showed that the mean thresholds from the vertical 10ms condition were 
significantly higher than the 250ms condition indicating a decrease in 
performance as presentation time reduced. 
 
There was also a very high correlation between the 10ms and 250ms vertical 
conditions suggesting that there were no ceiling effects present in the previous 
research by Edden et al (2009).  Further, this and the other strong correlations 
between the conditions, suggest whilst the task got harder, participants 
performed very consistently across all of the conditions.  
  
As the within subjects ANOVA demonstrated time had a main effect on 
threshold, it suggests the reduction in stimulus presentation time did indeed 
make the task harder. The mean threshold from the oblique condition was also 
significantly higher than the 10ms vertical condition, indicating that the oblique 
condition was still much harder than the hardest vertical condition administered. 
In line with this finding, there was a 30% dropout for the oblique condition 
compared to a max dropout of 17% for the vertical conditions (see Table 1). 
This seems high as Edden et al (2009) only reported a 7% dropout rate.  This 
could simply be due to sample size as ours was ~3x larger in comparison. The 
dropout in this experiment demonstrates again that for some people this 
condition to simply too hard to complete. It would be interesting to isolate what 
makes this condition so hard for some people and not others thus it would be 
future use of this task could contain four conditions representing ‘easy’ and 
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‘hard’ for different orientations; 10ms and 250ms for both vertical and oblique 
orientations. This would provide more data regarding the difficulty of the task at 
oblique orientations and how this relates to other measures and levels of data 
loss. 
  
One limitation of this study is the sample used was biased towards 
undergraduate students participating for course credit and were not particularly 
motivated to complete this task satisfactorily. This also made the average age 
of participants very young which could have also biased the results as 
orientation discrimination thresholds have been shown to increase with age 
(Betts, Sekular and Bennett, 2007). Future studies will need to include a much 
broader range of ages in order for this possible confound to not occur. 
  
The results of this experiment demonstrated that the task does work and that 
neither celling effects were present. It also proved relatively easy to perform and 
easy to interpret. As such, it suggests it has significant potential for biomarker 
development in relation to psychiatric disorders such as schizophrenia. 
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3.7 Conclusion 
This experiment suggests that no ceiling effects were present in the original 
research with the additional lack of floor effects found in this sample. This 
makes it a very promising task for future use and for biomarker development in 
healthy controls and in the patient population for which this is intended.  
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Chapter 4 - Investigation of the link between performance on 
the Tilt Illusion and Gamma oscillatory activity 
 
4.1 Rationale  
Performance on a Tilt Illusion task has been shown to negatively correlate with 
GABA levels in healthy controls when administered with the benzodiazepine 
Lorazepam. In this study we looked at the relationship between performance on 
the Tilt Illusion task and gamma oscillatory activity. Gamma measures will be 
used as a proxy measure for GABA levels in this experiment due to a previously 
reported positive correlation between the two measures.  
 
4.2 Background 
Visual perception relies heavily on context and has to adapt to successfully to 
changing surroundings. Gain control is a process that allows the visual system 
to adapt and boost responses to stimuli within a surrounding context by altering 
levels of inhibition and disinhibition to an orientation selective neuron (Clifford, 
2014). Levels of gain control can be measured using methods targeting levels 
of surround suppression, whereby the presence of a surrounding stimulus 
influences the perception of a central target stimulus.  
 
The Tilt Illusion (TI) measures the change in perceived orientation of a test 
patch in the presence of an oriented surround (See Figure 4.1). The size of this 
shift in perceived orientation is dependent on the orientation of the surround, 
with surround orientations between 0° and 45° producing a repulsion effect. This 
is known as the direct effect whereby the test target is perceived to rotate away 
from the orientation of the surround with the largest effect occurring at 15°  
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Figure 4.1 Tilt Illusion stimuli with surround 
 
(Gibson, 1937). If, however, the orientation of the surround is between 45° and 
90° then this produces an attraction effect whereby the orientation of the test 
grating is perceived to rotate towards the surround, with the largest effect 
occurring at 75° (Morant & Harris, 1965). This is known as the indirect effect.  
 
When using this task in healthy controls, the direct effect in relation to vertical 
ranges from ~1.5-3°(Gibson, 1937; Gelbtuch et al., 1986; Wenderoth and 
Johnstone, 1988). This effect is very robust and can even occur when 
participants are prevented from consciously perceiving the surround, for 
example when performing a backward masking task where the presentation of 
one stimulus (masking stimulus) immediately after another brief target stimulus 
leads to a failure to consciously perceive the first stimulus (Clifford and Harris, 
2005). 
 
The direct effect is largest when there is no gap between the test and surround 
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gratings, with the size of the effect diminishing by nearly 50% when a gap of 1° 
is inserted between the two gratings (Wenderoth and Johnstone, 1988). This 
study also reported how altering the spatial frequency between test and 
surround gratings reduced the magnitude of the direct effect, again by nearly 
50%, irrespective of whether there was a gap present. Finally the size of the 
surround grating greatly affected the direct effect.  Reducing the size of the 
surround grating from 3.75° to 0.5° reduced the direct effect from 1.59° to 0.27° 
in this study. Thus, to obtain the best results the centre and surround used must 
have comparable characteristics with no gap present.  
 
Gelbtuch et al (1986) investigated whether the size of the direct effect 
depended on GABAergic processes by administering Lorazepam, a 
benzodiazepine that potentiates activity at GABAa receptors, during a TI task. 
Their results showed a dose related increase in the size of the direct effect. 
Thus, the higher the dose of Lorazepam, the bigger the difference in perceived 
vertical between baseline and surround conditions. Interestingly this result was 
task specific, as Lorazepam had no effect on the results of a Tilt After Effect 
task, which is the same as the TI, but the centre and surround are presented 
sequentially. The effect was also medication specific, as Haloperidol, a 
dopamine D2 receptor antagonist, produced no dose related effect in the size of 
participants’ direct effect in the TI task. This strongly suggests GABAergic 
activity influences the size of participants’ direct effects calculated specifically 
from the TI task. 
 
As discussed in the Introduction chapter of this thesis GABA is strongly linked to 
the production of synchronised oscillatory activity, primarily gamma activity. 
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Edden et al (2009) demonstrated this by showing a positive correlation between 
gamma frequency and occipital GABA levels in healthy controls. It could 
therefore be safe to assume that either measure could be used as a proxy for 
the other. 
 
4.3 Aims and hypotheses  
The purpose of this experiment was to refine the Tilt Illusion task in healthy 
controls and to GABAergic processes. Whilst the literature has focused on 
GABA levels, we used visually induced gamma frequency and amplitude as our 
measure due to ease and speed of testing but also due to its previously 
reported positive correlation with occipital GABA levels (Edden et al, 2009). This 
experiment therefore investigated whether gamma frequency and amplitude 
was correlated with the size of direct effects measured using the Tilt illusion. We 
are expecting to find a positive relationship between the size of the direct effect 
and visual gamma frequency and amplitude as measured by MEG.  
 
4.4 Materials and Methods  
4.4.1 Participants  
Sixteen participants were recruited through the School of Psychology’s 
Experimental Management System (EMS) and five opportunistically from 
CUBRIC, also part of the School of Psychology. The total sample was males 
n=6 (mean age 28 years) and females n=15 (mean age 21.6 years). All 
participants gave informed consent prior to testing. 
 
4.4.2 Inclusion and exclusion criteria 
The inclusion criterion was normal to corrected vision. Exclusion criteria 
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included a diagnosis of photosensitive epilepsy and having any metal in the 
body such as surgical pins or screws, pacemakers or implants. 
 
4.4.3 Stimuli 
The Tilt Illusion was controlled using DELPHI. The stimulus consisted of a 
central circularly-windowed grating of size 2 degrees, with a circularly-windowed 
grating surround of size 6 degrees, both 80% contrast (see Figure 4.1). When 
present, the orientation of the surround was kept constant at 15 degrees 
clockwise. In each trial the centre and/or surround was presented for 250ms. 
The psychometric functions and subsequent PSEs for each condition were 
calculated using MATLAB V.7.  
 
Participants were seated 155.7cm away from the screen to produce the same 
visual angle as that produced in the MEG scanner. Their chin was placed on a 
chin rest to stabilise their head and standardise the distance from the screen 
between participants as best as possible. For the purpose of this study the room 
was kept in complete darkness for the duration of testing so participants could 
not see visible edges and corners, which may have influenced their responses. 
In addition, a board with a circular aperture was attached to the chin rest to 
block as many peripheral orientation cues as possible.  
 
4.4.4 Procedure 
For information on the methods used for the TI please see Chapter 2 section 
2.2. Participants were instructed to rotate a flashing circular grating until they 
perceived the grating as being vertical by pressing the left or right buttons on 
the mouse. Flashing stimulus was used to avoid participants adapting to the 
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orientation of the stimulus. When they perceive the grating as vertical they were 
instructed to press the middle scroll button on the mouse. This was done four 
times to calculate a mean perceived vertical in degrees. The mean perceived 
vertical was used for the second part of the task as a midpoint for seven 
orientations spaced 1° three times either side. Participants were then presented 
with the same circular grating oriented randomly at one of the seven 
orientations calculated previously, for 250ms. They were instructed to respond 
whether they perceived it as being oriented to the right or left of vertical by 
pressing the corresponding button on the mouse. There were 10 trials per 
orientation totalling 70 trials per block with 6 blocks being administered. This 
task lasted approximately 30 minutes.  
 
The output of interest from this task consisted of the calculated point of 
subjective equality (PSE), which in this case refers to when the participant can 
no longer discriminate between right and left and therefore is performing at 
chance level. To measure the size of the direct effect, the baseline ‘no 
surround’ PSE was subtracted from the surround PSE (see Figure 4.2). A 
positive PSE difference in this instance indicates a repulsive effect and reports 
the shift in terms of what direction the test circle would need to rotate in order to 
be at actual vertical.   
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Figure 4.2 Example psychometric function. The top figure shows the no 
surround condition and the bottom figure shows the surround condition. Red 
line represents the PSE in each condition with the red circle representing actual 
vertical (0°). The difference between the two lines is the direct effect. 
 
4.4.5 Magnetoencephalography  
MEG recordings were gathered using a CTF-Omega 275-channel system 
sampled at 1200 Hz. Fiduciary markers were placed on the participant at fixed 
locations 1cm forward of each tragus and centrally between the eyes to enable 
MRI/MEG co-registration during analysis. Refer to Chapter 2 for in-depth 
discussion of MEG and MRI methodology. 
 
The static visual stimulus presented consisted of a flashing full screen square-
wave grating (100% contrast, 8° both horizontally and vertically, refresh rate 
100Hz) with a central red fixation point (see Figure 4.3). This stimulus was 
presented for between 1500ms and 2000ms with a 3000ms resting period 
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between trials. Participants were instructed to press a button with their right 
index finger at stimulus offset. If they did not press the button at the correct time 
then they would receive feedback saying ‘No response detected’ to prompt 
correct performance. Each participant completed 1 block of 100 trials lasting 
approximately 8 minutes.  Stimulus was presented on a Mitsubishi DiamondPro 
2070 monitor at 1024 x 768 resolution at 100Hz. The monitor was situated 
approximately 208cm from the participant. 
 
 
 
 
 
 
Figure 4.3 Static stimulus 
 
Datasets were epoched into individual trials, with data excluded based on 
excessive noise or movement on a trial-by-trial basis. Synthetic aperture 
magnetometry (SAM) beamformer analysis was used to compare activity for 2s 
of baseline (-2 to 0s) and 2s of visual stimulation (0 to 2s). Pseudo t-statistics 
were used to compute any differences between baseline and stimulation 
activity. Volumetric SAM images were computed in six frequency bands, 0-20, 
20-40, 30-70, 40-60, 30-80 and 80-130Hz, but for the purpose of this study 
analysis focused on the gamma band of 30-80Hz. The peak locations of 
gamma activity in each participants visual cortex were located and virtual 
sensors were constructed for these locations using covariance matrices 
bandpass filtered between 0 and 100 Hz. Time-frequency analysis of these 
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virtual sensors was conducted using a Hilbert transform method between 1 and 
100Hz in 0.5Hz steps to produce time-frequency spectra. These spectra show 
peak gamma frequency and amplitude, expressed as percentage change from 
baseline. To determine the relationship between the psychophysics and the 
MEG measurements, the size of the direct effect was separately correlated with 
the transient gamma that occurred 0-0.3s after stimulus onset, and sustained 
gamma that occurred 0.3-0.8s after stimulus onset. Whilst previous research 
has focused on gamma frequency we will also investigate the relationship with 
gamma amplitude as, to my knowledge, this has not been looked at previously. 
  
4.4.6 MEG: Gamma response quality control 
Bootstrapping methods were applied to each dataset to be able to isolate and 
remove bad gamma datasets. For each iteration trials were resampled with 
replacement, and peak frequency was extracted from the power spectrum 
calculated as a percentage change from baseline. The bootstrap returned a 
distribution of 10000 bootstrapped peak frequencies, and the mode of this 
distribution was taken as reference. If at least half of the bootstrapped peak 
frequencies fell within 4hz (2hz either side) of the distribution mode, the dataset 
was classed as good. Bootstrapped mean peak frequencies and amplitudes, 
expressed as a percentage change from baseline, were extracted from the 
bootstrapped data for further analysis. Anyone who was excluded based on 
their sustained data (0.3-0.8s after stimulus onset) would also be excluded for 
their transient data (0-0.3s after stimulus onset) for that particular run.  
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4.5 Results  
All MEG datasets passed quality control measures. All of the direct effects 
calculated were positive, indicating a shift in perception of vertical with the 
surround present (range 0.028-3.697degs). The mean PSE difference was 
1.91degs (SD = 1.15degs). However, no significant relationship was found 
between transient gamma frequency and direct effect (r = 0.082, p=0.796), see 
Figure 4.4. 
 
 
Figure 4.4 Scatter plot showing the relationship between PSE difference and 
transient gamma frequency with line of best fit.  
 
No significant correlation was found between transient amplitude and PSE 
difference (r=0.177, p=0.632), see Figure 4.5. 
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Figure 4.5 Scatter plot showing relationship between PSE difference and 
transient gamma amplitude with line of best fit  
 
No significant relationship was found between sustained gamma frequency and 
PSE difference (r = 0.107, p=0.601), see Figure 4.6. 
Figure 4.6 Scatter plot showing the relationship between PSE difference and 
sustained gamma frequency with line of best fit 
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No significant correlation was found between sustained gamma amplitude and 
PSE difference (r = 0.194, p=0.497), see Figure 4.7. 
 
 
Figure 4.7 Scatter plot showing relationship between PSE difference and 
sustained gamma amplitude with line of best fit  
 
Additional analyses using a repeated measures ANOVA showed no difference 
between the 3 no surround blocks (F(19) = 0.648, p=0.563) and the 3 surround 
blocks (F(19) = 0.459, p=0.352). 
 
4.6 Discussion  
This experiment showed there was no relationship between the psychophysical 
measurement of the direct effect and transient and sustained gamma frequency 
and amplitude. There are several possible explanations as to why these 
patterns of results occurred. One possible explanation is that the visual 
paradigm used to induce gamma oscillations and/or the Tilt Illusion task itself 
did not produce enough variability amongst the participants tested. This 
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however seems unlikely, as there was variability within the results for both spike 
and sustained gamma frequency and for the direct effect. This suggests that 
participants were not performing at ceiling and that the task was indeed a 
reasonable probe of individual variability within the sample tested. The 
measures have been shown to be reliable as analysis in this experiment 
suggested good test-retest reliability between the 3 blocks in each condition, 
although testing over different days would be needed to support this claim. Also 
visual gamma measured using the stimulus used in this thesis has been shown 
to provide highly repeatable results (Muthukumaraswamy et al., 2010). Both of 
these findings suggest the measures used were not responsible for the lack of 
relationship between the two measures.  
 
A possible explanation for these results is that the positive correlation between 
gamma measures and GABA isn’t as robust as first thought. For example 
recent work by Cousijn, Haegens, Wallis, Near, Stocks, Harrison et al., (2014) 
tried to replicate this relationship in 50 healthy controls and found no correlation 
between occipital GABA and gamma frequency. Although it should be 
mentioned that Gelbtuch and colleagues did not measure MRS GABA, which is 
the measure related to gamma frequency by Edden et al., (2009). Instead they 
inferred an increase in GABA from the administration of a GABA agonist, which 
increases the frequency of the opening of the chloride ion channel at the 
GABAa receptors. This does not necessarily mean there was an increase in in 
vivo GABA levels in the synapse but more an increase in activity at the 
synapse. This therefore could account for the lack of relationship between the 
direct effect and gamma activity in this sample. However, a relationship may still 
occur if measuring in-vivo GABA levels specifically, so future work using this 
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task should measure this and gamma activity in the same sample and relate 
this back to psychophysical measures.  
 
The TI results did however validate the task itself, as all the PSE differences 
were positive meaning the repulsive effect occurred and performance was 
shifted when the surround was present. Additionally, our results were 
comparable with previous research (Gelbtuch et al, 1986)  
 
Although the results here do not show a significant relationship between 
gamma and the direct effect this task is still worth pursuing, as there could still 
be group differences when investigating patient groups based on size of direct 
effects alone and a relationship could still be found when looking specifically at 
MRS GABA levels. Further to the possibility of using this paradigm in patient 
groups there are several advantages; it has high test-retest reliability, as 
additional analyses showed no significant differences between the separate 
blocks of each condition in terms of size of direct effect, it is easy to administer, 
and results are easy to interpret. As such, this task has significant potential for 
biomarker development in psychiatric disorders such as schizophrenia.  
 
Finally, there were no differences in the three blocks of either the no surround 
or surround conditions suggesting this task is repeatable and validates the 
averaging of the three blocks of each condition in this and future studies. 
 
4.7 Conclusion 
This experiment showed no relationship between visual gamma frequency and 
PSE difference as measured by the Tilt Illusion. However, due to recent 
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research suggesting the positive relationship between gamma and GABA isn’t 
as robust as first thought, further work in this thesis will still use this task and 
look at the relationship with both GABA levels and gamma frequency in both 
patients suffering with schizophrenia and age and gender matched healthy 
controls.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 80 
Chapter 5 - Estimating disease-related modulations in MRS 
GABA concentration in Schizophrenia 
 
5.1 Rationale 
Current antipsychotic medications derive their therapeutic action via the 
dopaminergic system in the brain. Although these types of antipsychotics are 
effective in reducing the positive symptoms associated with psychosis and 
schizophrenia, they have little or no effect on negative symptoms and cognitive 
deficits, which are arguably the most debilitating aspects of the disorder. Work 
on developing new antipsychotics is therefore targeted at other neurotransmitter 
systems that also interact with dopamine. The GABAergic system has become 
a prime candidate for reasons that are discussed in this chapter. This study will 
investigate whether there are any differences in GABA levels between healthy 
controls and patients with a DSM-IV diagnosis of schizophrenia and whether 
GABA relates to symptom severity in the patient group. 
 
5.2 Background 
Work in healthy controls has shown GABA to be related to several brain 
functions including motor decision speed (Sumner, Edden, Bompas, Evans & 
Singh, 2010), working memory performance using a prolonged delayed match-
to-sample task (Michels, Martin, Klaver, Edden, Zelaya, Lythgoe, et al, 2012), 
BOLD response (Muthukumaraswamy, Edden, Jones, Swettenham and Singh 
2009) and the generation of gamma oscillations, which are thought to play an 
important role in cognitive processes such as working memory (Michels, et al, 
2012) and perceptual processes such as orientation discrimination (Edden et 
al., 2009).  
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The idea of a reduction in GABA levels or GABAergic properties in patients with 
schizophrenia is widely supported. The most consistently reported finding is a 
reduction in the 67-kDa isoform of the GABA synthesising enzyme glutamic acid 
decarboxylase (GAD67); Curley et al., 2011; Guidotti et al., 2000). This 
reduction in GAD67 has been localised to parvalbumin-containing GABAergic 
interneurons, which has been confirmed in post-mortem studies in the motor 
and visual cortex (Hashimoto et al., 2008), hippocampus (Knable et al., 2004) 
as well as the dorsolateral prefrontal cortex (Akbarian et al., 1995). Mouse 
models using GAD67 knockout mice (mice that express no GAD67), supported 
these findings by showing that these mice produced only 7% of the GABA 
concentrations of wild type mice thereby strongly suggesting that a reduction in 
the expression of this enzyme would lead to a reduction in GABA levels overall 
(Asada et al, 1997). 
 
GABA levels are known to be altered in the frontal region in the brains of those 
with schizophrenia (Rowland et al., 2015). Post-mortem studies have identified 
GABAergic chandelier cells to be dysfunctional with changes in their form and 
functionality, and up to a 40% decrease in the axon terminal density shown in 
the frontal brain of patients with schizophrenia (Lewis, Cho, Carter, Eklund, 
Forster, Kelly, et al, 2008; Pierri, Chaudry, Woo and Lewis, 2014). Chandelier 
cells also known to act via GABAa receptors specifically which is relevant to 
schizophrenia as GABAa receptors have been shown to modulate spatial and 
temporal memory performance (Mohler, 2009), something known to be impaired 
in patients affected by schizophrenia (Dreher, Banquet, Allilaire, Paillère-
Martinot, Dubois & Burnod, 2001). 
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Based on the evidence that GABA plays an important role in cognition and 
perception in healthy controls, it is not surprising that is has emerged as an area 
of interest for research into psychiatric disorders. The symptoms associated 
with schizophrenia in particular manifest as a marked reduction in cognitive 
abilities, spanning all cognitive domains but most severe in relation to working 
memory (Chen et al, 2014). Abnormalities are also seen in perceptual 
processes such as surround suppression psychophysical tasks using motion, 
orientation and size related stimuli, (Yoon et al., 2010) and motion detection 
(Chen, Palafox, Nakayama, Levy, Matthysse and Holzman, 1999). Additionally, 
impairments in face perception, especially in relation to identifying emotions 
have been identified (Salem, Kring, & Kerr, 1996). 
 
When looking at GABA levels in vivo, results for patients are mixed with some 
reporting an increase in GABA in chronic patients (Öngür et al., 2010) while 
others report a reduction (Yoon et al, 2010; Marsman et al., 2014). One 
possible reason for these differences could be the level and variety of 
antipsychotic medications being taken by the patients. Evidence from clinical 
studies suggests that antipsychotic medication could affect the GABAergic 
system either at the receptor level or by altering GABA concentrations (Wassef 
et al., 2003). Atypical antipsychotics clozapine and olanzapine reduce 
hippocampal and temporal cortex GABAa receptor density in rats by 
approximately two-thirds whereas there is a reduction of only 10-20% with 
older, ‘typical’ antipsychotics haloperidol or chlorpromazine suggesting that 
antipsychotics are not uniform in their effects on GABAa receptors (Farnbach-
Pralong, Bradbury, Copolov & Dean, 1998). These results relate to the acute 
use of antipsychotics and in contrast for longer term use (more than 7 days), 
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clozapine and haloperidol produced increased GABA turnover rates across 4 
different brain regions that was consistent between the two medications, 
suggesting no difference in their effect on GABA when used in this way (Marco, 
Mao, Revuelta, Peralta & Costa, 1978). This uniform effect on GABA after 
chronic use is reassuring, as patients tend to be on a variety of different 
antipsychotics. However, it does suggest that antipsychotics can influence 
GABAergic mechanisms.  
 
More recently Rowland and colleagues (2015) demonstrated that after 
converting antipsychotic medication dosages to their chlorpromazine 
equivalents, its inclusion as a covariate did not change their finding of a 
reduction in GABA levels in patients with schizophrenic illness, suggesting 
chronic medication use did not explain the difference in MRS GABA levels in 
this sample. 
 
The brain region of analysis for GABA measurement is an important factor to 
consider although the global reduction seen in GAD 67 expression across brain 
areas in patients would suggest this is not the case Curley et al 2011; Guidotti, 
et al, 2000). In contrast using MRS GABA measurement Kegeles and 
colleagues (2012) found conflicting results from two voxels positioned in the 
dorsolateral and medial prefrontal cortex with an increase in GABA levels in 
unmedicated patients in the medial prefrontal region but not in the dorsolateral 
prefrontal cortex. This study also reported no differences in GABA levels 
between healthy controls and medicated patients in both voxels raising the 
possibility that medication, within these brain regions, may reduce GABA in 
patients.  
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Age is also an important factor to consider when measuring MRS GABA as 
levels decline with advancing age in healthy controls (Gao, Edden, Li, Puts, 
Wang, Liu et al, 2013), with this decline appearing to be more rapid in patients 
with schizophrenia (Rowland et al, 2015). It would be logical to assume that 
patients who are medicated would tend to be older than those who are 
unmedicated and this could account for the conflicting results identified by 
Kegeles and colleagues. It would therefore be highly recommended to age 
match controls to patients as best as possible in future research. 
 
5.3 Aims   
As previous studies in patients tend to focus on one brain region with mixed 
results, this study will compare GABA levels between patients with a DSM-IV 
diagnosis of schizophrenia and healthy age and gender matched controls in two 
separate voxels positioned in the occipital/visual cortex and sensorimotor cortex 
(see Figure 5.1). These areas have been shown to produce repeatable and 
sensitive results suggesting these are reliable voxels from which to collect 
GABA data (Evans, McGonigle & Edden, 2009). We predict there will be a 
significant reduction in GABA levels in patients compared to controls in both 
voxels. This study will also look at the relationship between GABA and anti-
psychotic medication as well as symptom severity. 
 85 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Voxel placements used during MRS scans  
 
5.4 Methods 
5.4.1 Participant sample and recruitment 
Participants consisted of 28 patients all of whom had a DSM-IV primary 
diagnosis of schizophrenia (8 female, mean age males = 44.20 (SD = 8.59) 
years, females = 45.88 (SD = 7.97) years) and 30 control participants (11 
female, mean age males = 42.37 (SD = 9.98) years, females = 40.636 (SD = 
10.15) years). Patients were recruited through a previous Cognition in 
Psychosis study also conducted at Cardiff University (Schizophrenia Working 
Group of the Psychiatric Genomics Consortium (2014). Please see Methods 
section for more details on patient recruitment. Controls were recruited primarily 
Sensory motor voxel 
placement 
Occipital voxel 
placement 
Sensory motor 
voxel 
Occipital voxel 
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through an advert placed on the Cardiff University Noticeboard system and 
opportunistically from CUBRIC, Cardiff University.  This study was approved by 
the NHS ethics Board and also the Cardiff University School of Psychology 
Ethics Board. 
 
5.4.2 Inclusion and exclusion criteria 
Inclusion criteria for the patient group consisted of a DSM-IV diagnosis of 
schizophrenia as determined through the SCAN interview, being aged between 
16-75 years, having English as a first language and having normal or corrected 
vision. Inclusion criteria for healthy controls included being between 16-75 
years of age, having English as a first language and normal or corrected vision. 
We ensured that all participants had sufficient capacity to give their informed 
consent to participate. All participants were screened for current drug or alcohol 
abuse. If they did not report current abusive behaviour they were asked to 
refrain from any alcohol or drug use 48 hours prior to testing. 
 
Exclusion criteria for all participants were a diagnosis of epilepsy, any severe 
neurological event such as head injury or stroke, any metal present in their 
bodies or the current use of medication in relation to affective disorders. 
Appendix 1 shows the patients’ current medication in the form of olanzapine 
equivalents. Additionally, healthy controls were excluded if they or if a first-
degree relative had any previous mental health diagnosis of an affective or 
psychotic disorder.  
 
5.4.3 MRS and analyses 
MR data were acquired using a 3 Tesla General Electric Signa HDx scanner 
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with an eight-channel receive-only head RF coil (Medical Devices). Foam 
padding was used to minimise head movement during scanning. A 5-minute 3D 
T1-weighted structural scan (TR/TE/TI = 7.8/3.0/450ms, flip angle=20° FOV = 
256*192*172mm, 1mm isotropic resolution) was obtained for each participant 
for voxel placement during analysis. 
 
Two 3x3x3cm³ voxels located in the occipital lobe and sensory motor area were 
scanned using the MEGA-PRESS method (Mescher et al., 1998) to acquire 
GABA-edited spectra for those areas (TE = 68, TR=1800 with a 20ms Gaussian 
editing pulse applied at 1.9ppm in alternate ON/OFF scans). The occipital voxel 
was placed medially in the occipital lobe, positioned as posteriorly as possible 
but still preventing inclusion of the sagittal sinus. The sensorimotor region was 
defined as being centered on the “hand knob” area of the precentral gyrus, and 
in line with the upper surface of the brain in the sagittal plane (Yousry, Schmid, 
Alkadhi, Schmidt, Peraud, Buettner et al., 1997). See Figure 5.1 for voxel 
placements. Acquisition time was ten minutes thirty-four seconds for each scan. 
 
Quantification of GABA was calculated using Gannet 1.0 toolkit (Edden, Puts, 
Harris, Barker, & Evans, 2014) and in house MATLAB scripts. Spectra were 
excluded if the fit error was above 10% with those remaining being corrected for 
gray matter (GM), white matter (WM) and cerebrospinal fluid (CSF) tissue 
proportions in relation to water. 
 
5.4.4 Questionnaires and diagnostic interviews 
The Beck Depression Inventory – II (BDI-II (Beck, Steer, and Brown (1996)) and 
the Altman Self-Rating Mania Scale (ASRM (Altman, Hedeker, Peterson & 
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Davis (1997)) were used to get a current measure of depression and mania 
symptoms respectively. The MINI International Neuropsychiatric Interview 
(Sheehan, Lecrubier, Sheehan, Morim, Janavs, Weiller, et al, 1998) was 
administered to the control group to gather information on any current or past 
experiences of neuropsychiatric symptoms and disorders. If any were present 
that participant would be excluded. Only the psychosis section was 
administered to the patients and only in relation to the previous two weeks in 
order to get a current measure of psychosis. The author had been trained to 
administer the MINI prior to testing and had previous experience in 
administering the Schedule for Clinical Assessment in Neuropsychiatry (SCAN) 
in-depth clinical interview. This information then informed the ratings on the 
Scale of the Assessment of Positive Symptoms (SAPS (Andreason, N (1984)) 
and the Scale of the Assessment of Negative Symptoms (SANS (Andreason, N 
(1984)) which rate the positive and negative symptoms associated with a 
diagnosis of schizophrenia. Details of antipsychotic medication were recorded 
including daily dosages which were standardised across patients using 
Olanzapine equivalents as calculated by Gardner, Murphy, O,Donnell, 
Centorinno &  Baldessarini (2010) 
 
5.5 Results 
5.5.1 Demographics 
Age and gender did not differ significantly between groups (t(57) = -1.119, p = 
0.268 and t(57) = 0.812, p = 0.420, respectively). In examining the case and 
control groups by gender, no significant differences were found between 
patients and controls in terms of age; males (t(37) = -0.625, p=0.536) and 
females (t(18) = -0.969, p= 0.345).  
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5.5.2 Occipital GABA analysis 
Five patients (4 males and 1 female) and three controls (2 males and 1 female) 
were excluded from Occipital analysis due to excessive movement or a fit error 
of >10%. After exclusion of these participants age and gender still did not 
significantly differ between groups (t(49) = -2.546, p = 0.067 and t(49) = -1.016, 
p = 0.398 respectively).  
 
Occipital GABA levels significantly differed between groups (t(49)=2.389, p= 
0.021) with the patient group having lower GABA levels compared to controls 
(see Figure 5.2). To confirm that these results were not driven by differences in 
tissue ratios in the occipital voxel between groups, we compared the levels of 
CSF, gray matter and white matter. Independent t-tests showed no significant 
differences in the amount of each tissue between groups; t(49), 0.462, p=0.646, 
t(49), 0.097, p=0.923 and t(49), -0.160, p=0.874 respectively. We used Pearson 
correlation to demonstrate that age did not significantly correlate with occipital 
GABA in the sample as a whole (r = -0.189, p=0.184), age accounting for a 
small percentage of the variation of GABA levels (R2=0.0357). Similarly there 
were no effects of age on GABA levels within each group; controls (r=-0.292, 
p=0.131) or cases (r=0.073, p=0.753 see Figure 5.3). For example spectra 
output from Gannet see Figure 5.4. Appendix 2 shows the mean GABA levels 
and standard errors for each group and the sample as a whole for both voxels.  
 
Finally, Pearson correlation demonstrated no significant correlation between 
GABA and medication (defined as olanzapine equivalents) within the patient 
group (r = -0.148, p=0.510) with medication accounting for 2.19% of the 
variance in GABA (R2 = 0.0219). Please see Figure 5.5.  
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Figure 5.2 Mean occipital GABA levels for the Patient and Control groups. Error 
bars show +/- 1 Standard error of the mean. * = p<0.05 
 
 
Figure 5.3. Correlation of age and occipital GABA levels for both patient and 
control groups 
* 
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Figure 5.4 Example Gannet spectra output 
Figure 5.5 Correlation of occipital GABA and olanzapine equivalent anti-
psychotic dosages for cases. 
 
 
GABA 
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5.5.3 Sensory motor GABA analysis 
Six patients and two controls were excluded from sensory motor analysis due to 
excessive movement or a fit error of >10%. Sensory motor GABA levels were 
not significantly different between cases and controls (t(49), -1.236, p=0.222), 
see Figure 5.6). Pearson correlations showed GABA levels from both voxels did 
not correlate within the sample as a whole (r = -0.048, p=0.748) or at group 
level; controls (r = -0.079, p=0.689) and cases (r = 0.162, p=0.495). A paired t-
test showed sensory motor GABA levels were significantly lower than occipital 
within the sample as a whole (t(47)=10.966, p = <.001) and within the control 
group (t(27) = 10.809, p=<.001) and cases (t(19) = 5.465, p=<.001) 
independently (see Figure 5.7).  
 
Figure 5.6 Mean sensory motor GABA levels for Control and Patient groups. 
Error bars show +/- 1 standard error of the mean 
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Figure 5.7 Comparison of mean occipital and sensory motor GABA levels for 
the sample as a whole and each group separately. Error bars show +/- 1 
standard error of the mean. *=p<0.001 
 
5.5.4 Symptom measures 
There were highly significant group differences in BDI scores (t(36) = -4.202, 
p=<.001). For the controls, twenty-nine had scores classed as minimal 
depression (scores 0-13) with one classed as having mild depression (score 14-
19).  For the patients, thirteen were classed as having minimal depression, six 
as mild depression, six as moderate depression (score 20-28) and two as 
having severe depression (score 29-63). There were no between group 
differences in the Altman mania scores (t(55) =-0.501, p=0.618). See Figure 
5.8. For the controls, twenty-four had scores classed as no manic symptoms, 
five classed as hypomanic and one classed as manic. For the patients, twenty-
two were classed as having no manic symptoms, five classed as hypomanic 
and one classed as manic. SAPS and SANS scores were 0 for all control 
* 
* 
* 
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participants and consequently no analyses were performed between groups for 
these measures.  
Figure 5.8 Comparison of mean scores for the BDI-II and Altman Mania scale 
between groups. Error bars show +/- 1 standard error of the mean. * = p<0.001 
 
Within the Patient group, occipital GABA negatively correlated with SAPS 
scores (r = -0.429, p=0.041) and SAPS and BDI scores were positively 
correlated with each other (r = 0.474, p = 0.013). None of the symptom 
measures correlated with sensory motor GABA levels. See Table 5.1 for a 
breakdown of the symptom measures. 
Table 5.1 Breakdown of symptom measure scores 
 
 BDI-II Altman Mania 
scale 
SAPS SANS 
 Cases Controls Cases Controls Cases Controls Cases Controls 
Mean 13.37 4.86 3.59 3.16 3.43 0 3.96 0 
SD 9.58 4.56 2.89 3.45 15.14 0 7.66 0 
Range 0-29 0-14 0-12 0-14 0-12 0 1-12 0 
* 
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5.6 Discussion 
This experiment demonstrates that GABA levels are altered in specific brain 
regions in patients with a DSM-IV diagnosis of schizophrenia compared to 
healthy age and gender matched controls. There were significant between 
group differences in occipital GABA, with patients having decreased levels 
compared to controls, but no such differences in sensory motor GABA levels. 
This result is not unexpected, as other studies have reported differing results 
when quantifying GABA in different voxels in the same patient sample (Zegeles 
et al, 2012).  GABA levels did not correlate between voxels at the group or 
sample level and differed between voxels with sensory motor levels being lower 
than occipital, which replicates previous findings (Evans et al, 2010). 
 
One possible reason for the reduction in only one of the voxels measured is that 
as the patients used in this sample were chronic patients, it could the case that 
the reduction in occipital GABA is a biomarker of chronic illness. Longitudinal 
studies using first episode patients scanned in several different voxels over time 
could indicate if indeed occipital GABA is a biomarker of chronic illness.  
 
Olanzapine equivalents of anti-psychotic medications did not correlate with 
occipital GABA suggesting that this was not the primary source of variation in 
GABA within the patient group and thus not responsible for the observed 
between group difference in GABA levels. This supports the work by Rowland 
et al (2015) that a showed using chlorpromazine equivalent, reduced GABA in 
the frontal region of the brain was not related to anti-psychotic medication. 
Longitudinal studies comparing the same patients before and after anti-
psychotic use in several voxels could answer the question as to what extent 
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GABA is affected by the disease and the medication. The method of 
standardising the medication could have affected the results, however, we also 
calculated chlorpromazine equivalents following the methods of Gardner and 
colleagues (2010) and similarly these dosages showed no association with 
GABA levels in either voxel.  
 
However, this sample size is still relatively small and we were not able to look at 
the effects of different classes of antipsychotics. The class of antipsychotics 
could produce differing effects on GABAergic processes (Farnbach-Pralong et 
al., 1998) and it might be the case that the reduction found in this experiment 
was medication specific. In addition olanzapine equivalents can only produce a 
standardised measure for current usage and does not take into account lifetime 
exposure to antipsychotics. Glial production and hypertrophy of the cerebral 
cortex has been related to antipsychotic exposure over time and are thought to 
play a regulatory role in adjusting neurotransmitter levels (Selemon, Lidow and 
Goldman-Rakic, 1999), potentially impacting on the GABAergic system. Whilst 
olanzapine equivalents is a frequently used measure for standardizing anti-
psychotic treatment, there is a potential underlying confound of lifetime 
exposure that should be measured and accounted for, although there is still 
uncertainty about how this can reliably be done. 
 
As there was only a reduction in GABA in one of the voxels measured, this 
lends further supports to antipsychotic medication not being responsible for the 
reduction in occipital GABA within the patient group. If medication were 
contributing to the reduction in GABA then it is unlikely this would be region 
specific and one would expect reductions across the brain, including the 
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sensory motor area. However, future studies will need larger sample sizes of 
participants taking different classes of antipsychotics as again, this assumption 
could be based on the effects of one class of antipsychotics. 
 
The previous research showing discrepancies in GABA level findings across 
studies were measuring from different cohorts in relation to exposure and 
response to antipsychotics, which makes them harder to compare to this study. 
Elevations were reported in unmedicated patients (Kegeles et al, 2012) 
whereas reductions are most widely reported in chronic medicated patients 
(Yoon et al, 2010; Kegeles et al, 2012; Rowland et al 2015). As this experiment 
used chronic medicated patients it supports previous research. However, it is 
very hard to disentangle medication effects from illness effects, as it is difficult 
to measure every possible combination of patient and medication exposure. For 
example it is extremely difficult to test antipsychotic-naïve first episode and 
chronic patients. Further, the samples used for research such as this utilise a 
subset of patients who are willing to participate and who are responding well to 
treatment. Therefore they could be seen as atypical and representing only a 
small proportion of patients. The current ongoing MRC-funded SPRING study is 
trying to remedy this problem by testing different cohorts of patients with 
different levels of exposure and response to antipsychotics. 
 
Age did not correlate with occipital GABA and based on the group as a whole 
only accounted for 3.57% of the variation in GABA levels. There was a negative 
trend within the control group with GABA decreasing with age but this was not 
the case within the patient group, an unexpected finding as previous research 
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had shown the decline in GABA with age to be accentuated in patients with 
schizophrenia (Rowland et al, 2015). 
 
A potential problem with comparing these results to those reported by Rowland 
et al (2015) is that their participant sample was not limited to patients with a 
diagnosis of schizophrenia but also included those with schizoaffective disorder. 
Thus, their lack of findings between GABA and medication could potentially be 
due to the initial disease state of the participant and additional medications. 
This does not appear to be the case in this sample as there was no difference 
between mania scores as measured by the Altman Mania Scale. This is 
encouraging as it supports the patients’ original diagnosis of schizophrenia and 
does not suggest symptoms related to schizoaffective disorder. Therefore, this 
sample appears to be much better suited to answering the question of whether 
GABA levels differ in patients with a diagnosis of schizophrenia.  
 
Patients reported experiencing much higher levels of depression, with 29% 
currently experiencing moderate to severe levels of depression, as measured 
by the BDI-II compared to the controls group. This is in line with previous 
findings showing approximately 20% of chronic schizophrenia patients 
experience moderate to severe depression using the BDI-II also (Chemerinski, 
Bowie, Anderson & Harvey, 2008).  
 
GABA levels obtained in this experiment were macromolecule contaminated, 
also referred to as GABA+, which could potentially affect the reliability of the 
result. A recent study by Mikkelsen, Singh, Sumner & Edden (2015) has shown 
macromolecule suppressed GABA, GABA’, is no less repeatable than GABA+ 
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suggesting using this method is sufficient to produce reliable GABA results. 
However, GABA’ does produce a purer measure of GABA so should be used if 
possible in future studies.  
 
Whilst tissue correction was performed on the MRS data in this experiment, this 
is not an exact science. Voxel tissue segmentation is calculated by segmenting 
a mask of the voxel on the participants FSPGR image and approximating the 
contribution of CSF, white and gray-matter to that voxel. As it is an 
approximation, by definition the values calculated might not be correct which 
could impact on the GABA levels measured. GABA concentrations have 
previously been found to be higher in gray matter compared to white matter 
(Choi, Lee, Merkle and Shen, 2006; Bhattacharyya, Phillips, Stone, and Lowe, 
2011) and so therefore between participant variability could be affected by the 
methods used for tissue correction.  
 
Another potential limitation of this experiment is the use of water as our 
reference molecule where creatine has been shown to be highly reliable as a 
reference (Bogner, Gruber, Doelken, Stadlbauer, Ganslandt, Boettcher, et al, 
2009). However, MRS research has shown creatine levels to be disrupted in 
this patient group (Öngür et al., 2009). Therefore, the use of creatine as a 
reference molecule in schizophrenia MRS research is problematic unless 
creatine levels have been shown to be comparable between groups 
beforehand.  
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5.7 Conclusion 
This study demonstrated a reduction in occipital GABA but no difference in 
sensory motor GABA in patients with schizophrenia compared to controls. The 
inconsistency between voxels is not surprising, as other studies have also 
found differing results depending on the voxels investigated in this patient 
group.   
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Chapter 6 - Novel low-level oscillatory markers of cortical 
excitation/inhibition in Schizophrenia: An investigation of 
disease sensitivity and optimal task parameters 
 
6.1 Rationale 
Gamma oscillations have previously been linked to connectivity between brain 
regions and levels of cognition in healthy control and patient groups. Therefore, 
gamma measures have become of interest in research investigating possible 
biomarkers for reduced cognition in patient groups. Visually induced gamma 
band oscillations are reliably measured using static grating stimuli. Patients with 
a diagnosis of schizophrenia have reduced gamma activity in terms of 
frequency and amplitude using visual tasks. Moving and attentionally engaging 
stimuli have been shown to increase both visually induced gamma frequency 
and amplitude in healthy controls compared to the use of static stimuli. This 
type of task has not yet been used in patients and due to their reported 
reductions in gamma oscillatory activity, it would be interesting to investigate 
whether this increase occurs for patients also. This experiment could also 
identify a more sensitive measure of gamma activity in general, but one that is 
also better suited to patients. 
 
6.2 Background 
Synchronised activity of neural populations can give rise to oscillations of 
different frequencies, recorded in local field potentials. Neural oscillations 
across different frequency bands are thought to impact on specific brain 
functions including perception and cognition (Engel, Fries & Singer, 2001; Palva 
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and Palva, 2007). Gamma band (30-150Hz) synchronisation has recently 
become of interest as it has been implicated in many important brain functions, 
including visual change detection in primates (Womelsdorf, Fries, Mitra & 
Desimone, 2006) as well as visuomotor control (Aoki, Fetz, Shupe, Lettich & 
Ojemann, 1999; Aoki, Fetz, Shupe, Lettich & Ojemann, 2001), working memory 
(Howard, Rizzuto, Caplan, Madsen, Lisman, Aschenbrenner-Scheibe et al 
2003; Roux, Wibral, Mohr, Singer & Uhlhaas, 2012), and attentional processes 
(Sokolov, Pavlova, Lutzenberger & Birbaumer, 2004; Tallon-Baudry, Bertrand, 
Hénaff, Isnard & Fisher, 2005). 
 
Gamma band synchronisation occurs through a temporal coding scheme 
whereby the firing of groups of neurons within different areas of the visual 
cortex become synchronised, allowing communication between these areas. 
Supporting this idea Gray, Konig, Engel & Singer (1989) showed gamma 
oscillations synchronise intercolumnar input in the cat visual cortex thus 
showing neuronal populations in different areas of the visual cortex would fire in 
phase during a cycle of gamma frequency oscillations. It was proposed that 
these different neuronal populations could be conveying different attributes of 
the visual scene and by firing in phase would help form a unified scene.  
 
    
It is only relatively recently that non-phase locked (induced) gamma band 
activity has been successfully recorded in humans (Tallon-Baudry, Bertrand, 
Delpuech, & Pernier, 1996; Tallon-Baudry, Bertrand, Delpuech, & Pernier, 
1997). Visually induced gamma activity has now become one of the most 
studied areas in relation to neural oscillations as simple high contrast static 
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grating stimuli have been shown to elicit consistent and repeatable occipital 
gamma-band oscillations in healthy controls (Muthukumaraswamy et al., 2010). 
As well as being repeatable, among all frequency bands, they are the most 
susceptible to stimulus changes with increased contrast associated with 
increasing gamma amplitude (Henrie and Shapley, 2005), annulus grating 
stimuli and larger full screen stimuli leading to increased gamma power 
compared to square-wave grating stimuli (Muthukumaraswamy and Singh, 
2013). A reduction in amplitude is also seen when using a plaid grating stimuli 
(Hermes et al., 2014). 
 
Moving grating stimuli have been shown to increase both visual gamma 
amplitude and frequency, whilst additionally producing results with a clearer 
induced sustained effect in both macaque monkey (Ray and Maunsell, 2010) 
and healthy human controls at approximately 65-70Hz (Swettenham et al., 
2009; Muthukumaraswamy and Singh, 2013).  
 
For both of these types of moving stimulus the biggest increase in induced-
frequency was in participants who had the lowest induced-frequencies when 
presented with the static stimuli (Swettenham et al., 2009). This suggests that 
some level of ceiling effect may be occurring, as most participants’ gamma 
frequency response increased to 65-70Hz when presented with a moving 
stimulus, irrespective of their response when presented with a static stimulus. 
 
An attentionally engaging stimulus also produces an increase in gamma 
frequency (Vidal et al., 2006) and when used in conjunction with contracting a 
radial moving stimuli produces similar results with a clear sustained effect 
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between 65-70Hz with an additional separate gamma band at around 40Hz for 
a subset of participants (Hoogenboom et al., 2006). However, the evidence for 
an attention related increase in gamma amplitude/frequency is rather 
contradictory: In a recent paper, Koelewijn, Rich, Muthukumaraswamy and 
Singh (2013) showed that visuo-spatial attention increased broadband higher-
frequency gamma, but did not enhance narrow-band gamma in the 30-70Hz, 
matching similar findings in macaque monkey (Chalk, Herrero, Gieselmann, 
Delicato, Gotthardt and Thiele, 2010). 
 
Given the association between gamma oscillations and cognitive functioning, as 
well as their relation with brain connectivity, the potential of gamma oscillations 
in psychiatric research has begun to be explored and exploited. Among the core 
symptoms of schizophrenia are impairments, in cognitive functioning. In addition 
a prominent theory of the disorder’s pathophysiology is the dysconnectivity 
hypothesis, which states that the symptoms of the illness stem from a 
dysfunction in communication between different brain regions (Friston, 1999). 
Thus, research into schizophrenia and neural oscillations is focusing more on 
the gamma band due to its implication in information transfer between different 
brain regions and cognitive functioning.  
 
Inhibitory parvalbumin+ interneurons are known to work cyclically with 
excitatory pyramidal cells, producing extracellular field potentials that manifest 
as brain oscillations, in particular gamma band oscillations (Gonzalez-Burgos et 
al, 2010; Williams and Boksa, 2010; Buzsaki and Wang, 2012). Therefore 
gamma may be disrupted due to changes in GABAergic function, glutamatergic 
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input to interneurons and membrane properties suggestive of fundamental 
problems within underlying synaptic circuitry impairments. 
Given the above, it is possible that modulation of either gamma amplitude or 
frequency may be predicted to occur in those with schizophrenia. This 
disruption of oscillatory activity may also be reflective of dysfunction across the 
cortex, including within regions not traditionally associated with schizophrenia, 
such as the primary visual cortex.  
 
In support of this, a reduction in gamma oscillatory activity has been widely 
reported in patients with schizophrenia with recent work showing a general 
reduction in induced gamma amplitude both at rest and during working memory 
tasks (Haenschel et al, 2009; Chen, et al, 2014) and backward-masking tasks 
(Wynn et al., 2014). Additional reductions in high gamma power (60-120Hz) 
have been recorded in the visual cortex during the perception of Mooney faces 
(Grutzner et al., 2013) and during auditory stimulation (Hamm et al., 2011).  
 
As it has been demonstrated that visual gamma can be reproducibly and 
robustly induced with low-level grating stimuli (Swettenham et al., 2009; 
Muthukuraswamy and Singh, 2013), it would seem to be a sensible strategy to 
use this type of task to probe synaptic function in schizophrenia – to date, this 
has not been demonstrated and is the key aim of this experimental chapter. A 
subsidiary aim is to investigate the optimum task design to robustly probe these 
measures in both patients and healthy controls.  
 
6.2.1 Medication Confounds 
Antipsychotic medication has been shown to modulate gamma activity 
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irrespective of disease state. Rats under the influence of both first and second-
generation anti-psychotics showed inhibited hippocampal gamma power due to 
the medications interaction with D3 dopamine receptors (Schulz et al., 2012). 
However, the same pattern of results have been found irrespective of 
medication state, as unmedicated first episode patients have demonstrated 
impaired cognitive control related gamma activity and also reduced evoked 
prefrontal gamma-band responses during an auditory task (Minzenberg et al., 
2010; Gallinat et al., 2004 respectively). It could be the case that both 
antipsychotic medication and the disorder itself independently affect oscillatory 
mechanisms and that the combination amplifies the effect.   
 
6.2.2 Dependence on brain structure 
Brain structure has been implicated as a mediating factor in the disruption of 
neural oscillations and has been related to gamma frequency with the surface 
areas of V1 and V2 positively correlating with visually induced gamma in 
healthy controls (Schwarzkopf et al., 2012). Cortical thickness in area V1, peak 
transient and peak sustained gamma frequency have been negatively 
correlated with age (Gaetz et al., 2011). Reductions in cortical volume, 
thickness and surface area in patients have also been reported (Rimol et al., 
2011; Edgar et al., 2014) thus, an assumption could be, based on the above 
control data, that patients would have reduced peak transient and sustained 
gamma frequency. In spite of this assumption, there has been no research 
investigating whether differences in induced visual gamma activity are mediated 
by structural differences in patients with schizophrenia. 
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6.2.3 Gamma and GABA 
GABAergic inhibition has been found to be inextricably linked to gamma-band 
activity as the interplay between inhibitory GABA interneurons and excitatory 
pyramidal cells is both necessary and sufficient for the production of gamma 
oscillations (Traub, Whittington, Stanford & Jefferys, 1996); Wang and Buzsáki, 
1996). In addition, several connected GABAergic inhibitory neuron networks are 
major generators of gamma oscillations. In humans, bulk GABA concentration 
can also be estimated using MRS and GABA concentration has been shown to 
correlate with gamma frequency in healthy controls (Muthukumaraswamy et al., 
2009; Edden et al, 2009) and in patients for gamma frequency and amplitude 
(Chen et al, 2014). However, a recent MRS/MEG study in a large cohort of 
healthy controls failed to find such a relationship (Cousijn et al., 2014)  
 
6.3 Aims 
Our key aim is to investigate whether low-level induced visual gamma 
oscillations within primary visual cortex provide a sensitive marker of the 
underlying pathology in schizophrenia. 
 
Our principal hypothesis is that we will see a reduction in both transient and 
sustained gamma amplitude and frequency in the patient group compared to 
healthy age and gender matched controls. We also investigate whether patients 
demonstrate similar increases in visually induced gamma amplitude and 
frequency when using a moving radial grating task compared to a static grating 
task. Using repeated presentation of the moving radial task, we will also 
investigate the repeatability of this task in both patients and controls over time.  
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In addition we will also investigate the relationship between occipital GABA and 
visually induced gamma-band oscillations to try to replicate previously found 
correlations between the two measures in healthy controls and patients with 
schizophrenia. Additional analyses will examine the relationship between 
positive, negative and affective symptom measures and gamma oscillation 
outcomes. 
 
Due to the association between cortical structure and gamma oscillatory activity 
and the reduction in cortical structure measures in schizophrenia cases, this 
experiment will also gather information on brain structure and correlate with the 
MEG and MRS data. This will demonstrate how much of the variance within the 
MEG and MRS data can be attributed to structural variables. 
 
Finally, olanzapine equivalents will be used to standardise antipsychotic 
medication dosage within the patient group (Gardner et al 2010). Again these 
will be correlated with the gamma measures to demonstrate how much of the 
variance can be attributed to medication effects. 
 
6.4 Methods 
6.4.1 Participant sample and recruitment 
Participants consisted of 31 control participants (12 female, mean age males = 
42.37 (SD = 9.98) years, females = 41.17 (SD = 12.04) years) and 28 patients 
all of whom had a DSM-IV primary diagnosis of schizophrenia (8 female, mean 
age males = 44.20 (SD = 8.59) years, females = 45.88 (SD = 7.97) years. For 
more details on how the patients were recruited and diagnosed please see 
Methods chapter. Controls were recruited primarily though an advert placed on 
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the Cardiff University Noticeboard system and opportunistically at CUBRIC, 
Cardiff University. Patients were recruited through a parent genetics study also 
conducted at Cardiff University. Please see Chapter 2 for more details 
regarding patient recruitment. Patients were age and gender matched to 
controls on a pairwise basis. 
 
6.4.2 Inclusion and exclusion criteria 
Inclusion criteria for the patient group consisted of a DSM-IV diagnosis of 
schizophrenia as determined through the SCAN interview, being aged between 
16-75 years, having English as a first language and having normal or corrected 
vision. Inclusion criteria for healthy controls included being between 16-75 
years of age, having English as a first language and normal or corrected vision. 
We ensured that all participants had sufficient capacity to give their informed 
consent to participate. All participants were screened for current drug or alcohol 
abuse. If they did not report current abusive behaviour they were asked to 
refrain from any alcohol or drug use 48 hours prior to testing. 
 
Exclusion criteria for all participants were a diagnosis of epilepsy, any severe 
neurological event such as head injury or stroke and any metal present in their 
bodies. Additionally healthy controls were excluded if they or if a first-degree 
relative had any previous mental health diagnosis of an affective or psychotic 
disorder.  
 
6.4.3 Magnetoencephalography 
MEG recordings were gathered using a CTF-Omega 275-channel system 
sampled at 1200 Hz. Fiduciary markers were placed on the participant at fixed 
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locations 1cm forward of each tragus and centrally between the eyes to enable 
MRI/MEG co-registration during analysis. 
 
Each participant undertook four experimental visual gamma experiments in 
each measurement session: 
 
6.4.4 Experiment 1: Static Visual Grating 
The static visual stimulus used was identical to that used in Chapter 4 (section 
4.4.5). 
 
6.4.5 Experiments 2, 3 and 4: Moving Radial Grating Stimulus 
This experiment is based on the paradigm of Hoogenboom et al.,2006. Each 
trial of the moving radial stimulus started with the presentation of a fixation point  
(diameter 0.5 °). After 500 ms, the fixation point contrast was reduced by 40 %, 
to warn participants of the upcoming trial. After 1500 ms, the fixation point was 
replaced by a centrally presented, circular sine wave grating (diameter 5°, 
spatial frequency 2 cpd and maximum contrast). The circular grating drifted 
inwards toward the fixation point and the speed of this contraction could 
increase (velocity step at 2.2 deg/s) at any time between 50 and 3000 ms after 
stimulus onset (see Figure 2). The participant was instructed to press a button 
with their right index finger as soon as they noticed the speed of the contraction 
increase. This response would have to be within 500 ms of the increase in 
speed to be recorded as correct. Ten percent of the trials were catch trials in 
which no increase in speed occurred. The stimulus stopped after a response 
was given, or in catch trials 3000 ms after stimulus onset. Stimulus offset was 
followed by a resting period of 1000 ms in which subjects were given visual 
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feedback of either ‘OK’, ‘early’ or ‘late’ depending on their response. Each 
participant completed 3 blocks of 80 trials lasting approximately 25 minutes. 
This stimulus was controlled by Presentation software (Neurobehavioural 
Systems) and presented using a projector located outside of the magnetically 
shielded room, which was then projected back onto a screen within the room 
approximately 60cm from the participants’ eyes at a nominal refresh rate of 
60Hz. Please see Figure 6.1 for task outline. 
 
Figure 6.1 Task outline for the moving radial stimulus (obtained from 
Hoogenboom et al., 2006) 
 
Datasets were epoched into individual trials and were excluded based on visual 
inspection of the data on a trial-by-trial basis. Synthetic aperture magnetometry 
(SAM) beamformer analysis was used to compare activity for 2s of baseline (-2 
to 0s) and 2s of visual stimulation (0 to 2s). Pseudo t-statistics were used to 
compute any differences between baseline and stimulation activity. Volumetric 
SAM images were computed in six frequency bands, 0-20, 20-40, 30-70, 40-60, 
30-80 and 80-130Hz, but for the purpose of this study analysis focused on the 
gamma band 30-80Hz. The peak locations of gamma activity in each 
participant’s visual cortex were located and virtual sensors were constructed for 
these locations using covariance matrices bandpass filtered between 0 and 100 
Hz. Time-frequency analysis of these virtual sensors were conducted using 
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method based on the Hilbert transform (Swettenham et al., 2009) between 1 
and 100Hz in 0.5Hz steps to produce time-frequency spectra in which the 
responses at each time/frequency point were expressed as mean percentage 
change from baseline.  
 
6.4.6 MEG: Gamma response quality control 
Quality control methods used are identical to those in Chapter 4 (Methods 
section 4.4.6) 
 
6.4.7 Magnetic resonance imaging and spectroscopy 
MRI and MRS methods are identical to those used in Chapter 5 section 5.4 
 
6.4.8 Freesurfer structural analysis  
FreeSurfer analsysis was used to estimate the cortical surface area, thickness 
and volume of V1 for each participant from their FSPGR scan. FreeSurfer is an 
automated technique that first identifies the calcarine sulcus and then uses prior 
knowledge of the cortical curvature to estimate the location of V1 (Hinds, 
Rajendran, Polimeni, Augustinack, Wiggins, Wald et al., 2008). These structural 
estimates were calculated for each hemisphere separately.  
 
6.4.9 Questionnaires and diagnostic interviews  
The questionnaires and antipsychotics equivalents used were identical to those 
used in Chapter 5 (section 5.4.4). 
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6.5 Results 
6.5.1 Quality control measures 
Quality control measures were performed on the data to isolate and remove 
‘bad’ gamma datasets. Table 6.1 shows the numbers of participants remaining 
after quality control measures had been performed. 
 Static Radial 1 Radial 2 Radial 3 
Group Patient Control Patient Control Patient Control Patient Control 
 
N (%) 
 
18 (64) 
 
26 (84) 
 
27 (96) 
 
26 (84) 
 
25 (89) 
 
29 (94) 
 
25 (89) 
 
29 (94) 
Table 6.1 Number of participants remaining after removal of bad datasets. 
 
 
6.5.2 Visual gamma 
To identify any differences between the 3 repetitions of the radial block a two-
way repeated measures ANOVA was performed. This showed there was no 
main effect of time on transient gamma for the moving radial blocks for both 
frequency (F(2,49) = 0.708, p=0.495) and amplitude (F(2,49) = 1.911, p=0.153). 
There was no interaction between time and group for frequency (F=0.104, 
p=0.902) and amplitude (F=2.552, p=0.083). Between subjects analysis showed 
a main effect of group on frequency (F(1,49) = 32.570, p=<.001) and amplitude 
(F(1,49) = 4.117, p=0.046). The difference in frequency and amplitude between 
groups for the static block were not significantly different (t(1,42) = 1.595, p = 
0.118; t(1,42) = -0.077, p = 0.939 respectively). Please see Figure 4A-B. 
 
Controls demonstrated higher sustained gamma frequencies and amplitudes 
than patients consistently across all runs of the radial task and the static task. A 
two-way repeated measures ANOVA showed there was no main effect of time 
on sustained gamma for the moving radial blocks for both frequency (F(2,49) = 
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2.254, p=0.110) and amplitude (F(2,49) = 1.124,  p= 0.301). There was also no 
interaction between time and group for frequency (F=0.956, p=0.388) and 
amplitude (F=0.476, p=0.623). Between subjects results showed a main effect 
of group on frequency (F(1,49) = 7.091, p = 0.010) but not amplitude (F(1,49) = 
3.081, p = 0.085). The difference in frequency and amplitude between groups 
for the static block were not significantly different (t(1,42) = 0.839, p = 0.406; 
t(1,42) = 0.479, p = 0.635 respectively). Please see Figure 4C-D. Appendix 2 
shows the means and standard errors for each group and the sample as a 
whole for each gamma measure and run. 
 
6.5.3 Comparison of static and moving radial gratings 
The radial task (Figure 6.2B-D) produced much clearer sustained gamma band 
spectra within both patients and controls compared to the static task (Figure 
6.2A).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2  Example spectra. A) Static task. B-D) Repeated radial blocks 
showing clearer sustained gamma. 
A B
A 
C
A 
D
A 
Sustained 
C
C 
D 
Transient 
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As no differences were found between blocks for the radial stimuli, the results 
reported for the following analyses will be based on averaging measures across 
all three radial blocks.  
 
Using a paired t-test split by group, a significant increase was found for 
transient frequency for the moving task compared to the static within the control 
group (t(25) = -7.203, p=<.001) and patients (t(16) = -4.682, p=<.001).  There 
was also a significant reduction in transient amplitude for the moving task 
compared to the static task for controls (t(25) = 2.817, p=0.009) and patients 
(t(16) = 4.773, p=<.001). Significant increases in sustained gamma frequency 
and amplitude were found for the moving task compared to the static within the 
control group, (t(25) = -6.394, p=<.001; t(25) = -5.416, p= <.001 respectively) 
and the patient group (t(16) = -7.267, p=<.001; t(16) = -4.607, p = <.001 
respectively). Please see Figure 6.3.  
 
We investigated how parameters estimated in the static experiment 
(amplitude/frequency) correlated with those extracted from the average moving 
radial experiment, using Pearson correlation. Transient gamma amplitude was 
not highly correlated within the whole group or in the control group but produced 
a higher moderate correlation in the schizophrenia cases - although this did not 
reach significance. Sustained amplitude showed a significant positive 
correlation within the sample as a whole and within the patient and control 
groups separately. Transient frequency moderately correlated for both stimuli 
with a negative correlation reported within the patient group and a much weaker 
positive correlation reported within the control group. Sustained frequency 
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significantly correlated in the sample as whole and in the patient group with a 
weaker result within the control group (please see Table 6.2 and Figure 6.4).  
 
To summarise, inter-experiment correlations were highest for the sustained 
measures and were the strongest for measures of gamma amplitude. Gamma 
frequency demonstrated a weaker correlation, but this perhaps is to be 
expected as previous studies have shown the change in gamma frequency 
between static and moving paradigms is dependent on the peak response 
frequency for the static condition. As no differences were found between the 
radial blocks for either group, this also suggests a high level of repeatability for 
this stimulus.  
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iFigure 6.3. Transient and sustained gamma frequency (A and C) and Amplitude (B and D) across all 4 experimental runs for Patients. Error bars show 
+/- 1 Standard Error on the Mean. * = p<0.05 ** = p<0.01
* 
* 
* 
** 
** ** 
B 
** 
** ** 
A 
C 
D 
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Table 6.2 Pearson correlation coefficients for transient and sustained gamma. * = p<0.05 (uncorrected) 
 
Sustained All 
Radial 
average 
amplitude 
Radial 
average 
frequency 
Static 
amplitude 
 
Static 
frequency 
Radial average 
amplitude 
 0.308 0.723* 0.492* 
Radial average 
frequency 
  0.246 0.543* 
Static  
Amplitude 
   0.298 
Static 
Frequency 
    
 
Control 
Radial 
average 
amplitude 
Radial 
average 
frequency  
Static 
amplitude 
Static 
frequency 
Radial average 
amplitude 
 0.264 0.762* 0.589* 
Radial average 
frequency  
  0.288 0.451 
Static  
Amplitude 
   0.386 
Static  
Frequency 
    
 
Patient 
Radial 
average 
amplitude 
Radial 
average 
frequency  
Static 
amplitude 
 
Static 
frequency 
Radial average 
amplitude 
 0.225 0.597* 0.271 
Radial average 
frequency  
  0.92 0.705* 
Static 
Amplitude 
   0.082 
Static 
Frequency 
    
 
Transient All 
Radial 
average 
amplitude 
Radial 
average 
frequency 
Static 
amplitude 
Static 
frequency 
Radial average 
amplitude 
 0.331 0.257 0.355 
Radial average 
frequency 
  -0.108 0.213 
Static  
Amplitude 
   0.066 
Static 
Frequency 
    
 
Control 
Radial 
average 
amplitude 
Radial 
average 
frequency  
Static 
amplitude 
Static 
frequency 
Radial average 
amplitude 
 0.159 0.160 0.429 
Radial average 
frequency  
  -0.160 0.193 
Static  
Amplitude 
   0.054 
Static  
Frequency 
    
 
Patient 
Radial 
average 
amplitude 
Radial 
average 
frequency  
Static 
amplitude 
 
Static 
frequency 
Radial average 
amplitude 
 0.278 0.513* 0.069 
Radial average 
frequency  
  0.137 -0.385 
Static 
Amplitude 
   0.120 
Static 
Frequency 
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Figure 6.4 Correlations of transient and sustained gamma frequency (A and C) and amplitude (B and D) for static and radial stimuli. Line show line of 
best fit 
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6.5.4 Symptom measures 
Pearson correlation analyses were performed on both stimuli for both transient 
and sustained amplitude and each of the symptom measures; BDI-II, Altman 
Mania Scale, SAPS and SANS. As scores for the SAPS and SANS were zero 
for each participant in the control group, no analysis was performed on these 
measures for this group. There was a significant correlation between SAPS 
score and sustained radial frequency within the patient group (r=-0.510, 
p=0.028 (p corrected for multiple testing); see Figure 6.5). For all other 
correlations see Appendix 3. 
 
Figure 6.5 Scatter-plot of correlation between sustained radial frequency and 
SAPS score within the patient group. Line shows line of best fit. 
 
6.5.5 Gamma and GABA 
Transient gamma and occipital GABA levels correlated within both groups with 
moderate positive correlations reported for the control group for radial amplitude 
and static frequency and a moderate negative correlation reported for patients 
for radial frequency (see Table 6.3). Sustained gamma and occipital GABA 
levels correlated more within the patient group than the control group with 
moderate positive correlations reported with sustained static amplitude and 
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radial frequency and a moderate negative correlation with sustained static 
frequency (see Table 6.4). However, none of these correlations were significant 
after correction for multiple comparisons (corrected p-value 0.0125).  
 
Transient  Radial 
amplitude 
Radial 
frequency 
Static 
amplitude 
Static 
frequency 
Occipital 
GABA 
Controls 0.385 0.285 0.203 0.353 
Patients -0.231 -0.325 0.111 -0.104 
Table 6.3 Pearson correlation coefficients for transient gamma 
 
Sustained  Radial 
amplitude 
Radial 
frequency 
Static 
amplitude 
Static 
frequency 
Occipital 
GABA 
Controls 0.167 0.072 -0.014 0.081 
Patients 0.130 0.344 0.447 -0.325 
Table 6.4 Pearson correlation coefficients for sustained gamma 
 
6.5.6 Medication effects 
Olanzapine equivalents did not significantly correlate with either task for both 
sustained and transient frequency and amplitude in the patient group with R2 
values ranging from 0.0001-0.1823. 
 
6.5.7 Structural measures 
Freesurfer analysis was performed on the anatomical MRI of each participant to 
derive measures of cortical surface area, thickness and volume for left and right 
hemisphere area V1. Table 6.5 shows the mean values for each of the 
measures for the sample as a whole and for each group. 
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 Left V1 
thickness 
(mm) 
Right V1 
thickness 
(mm) 
Left V1 
area 
(mm2) 
Right V1 
area 
(mm2) 
Left V1 
volume 
(mm3) 
Right V1 
volume 
(mm3) 
All 1.91 1.85 2347.76 2216.82 4886.96 4425.76 
Patient 1.89 1.84 2376.33 2256.48 4944.04 4484.55 
Control 1.93 1.86 2320.21 2178.57 4831.93 4369.07 
Table 6.5 Mean values of cortical thickness, area and volume 
 
 
When correlating the left and right hemispheres each measure was highly 
correlated across the entire sample and within each group. See Table 6.6 and 
Figure 6.6. 
 
  Thickness  Area  Volume 
All r = 
p =  
0.749 
<.001 
0.794 
<.001 
0.764 
<.001 
Patient r = 
p = 
0.795 
<.001 
0.718 
<.001 
0.874 
<.001 
Control r =  
p =  
0.656 
<.001 
0.831 
<.001 
0.602 
0.001 
Table 6.6 Correlation coefficients and p-vales for left and right hemisphere 
measures 
 
 
Finally, Independent sample t-tests showed no between group differences in 
any of these measures and no significant correlations between the structural 
measures and transient and sustained frequency or amplitude were found for 
either task. R2 values ranged from 0.00003-0.19713. 
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Figure 6.6 Scatter plots showing relationship between left and right V1 thickness (A), area (B) 
and volume (C). Line shows x=y.
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6.6 Discussion 
These results reveal a consistent impairment in induced visual gamma 
frequency and amplitude in patients with schizophrenia compared to age 
and gender matched healthy controls, irrespective of task. Whilst the 
differences in amplitude appear more striking, the differences in frequency 
were also highly significant, suggesting both measures will be key for 
investigation in the future. 
 
The lack of a difference between groups when using a static task is 
interesting, as Chen and colleagues also reported no between group 
differences in rest gamma amplitude (Chen et al., 2014). The difference 
only occurred when participants were performing a working memory 
cognitive task. As stated in Chapter 6.2, the moving radial stimulus 
requires more attention than the static, thus, the necessary coordination of 
neural activity needed for strong cognitive performance, thought to be 
reduced in patients, could account for this result. Furthermore, Chen et al 
also found an associated increase in gamma occurs when the cognitive 
demand of the task increases. Our findings somewhat support this theory 
as gamma amplitude and frequency did increase for both patients and 
controls when performing the more demanding task. However, the 
difference between the patients and controls only existed when performing 
the more demanding task suggesting whilst increased cognitive demand 
may increase gamma activity it may also exacerbate the difference 
between patients and controls leading to this pattern of results. 
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Synchrony among large populations of neurons is thought to be essential 
for normal oscillatory activity (Engel et al., 2001; Uhlhaas and Singer, 
2010), particularly in relation to fast-spiking parvalbumin+ interneurons. 
However, reductions in gamma amplitude have also been linked to 
excitatory mechanisms and their effects on inhibitory mechanisms. Work 
with AMPA receptor knock out mice showed the weakening of excitatory 
connections to fast spiking interneurons reduced the amplitude of gamma 
oscillations (Fuchs et al., 2007). In addition to these findings, Wiedholz, 
Owens, Horton, Feyder, Karlsson, Hefner et al, 2008) showed how AMPA 
knockout mice exhibited symptoms and behaviours characteristic of 
schizophrenia. As reductions in AMPA lead to reductions in excitatory 
connections to inhibitory neurons, the reduction in inhibition found in 
schizophrenia could be excitatory in nature. This hypothesis of a reduction 
in excitation could account for our reductions in gamma activity in the 
patient group and the lack of association with occipital GABA levels. 
Future work should relate gamma activity to excitatory glutamate levels as 
well as GABA levels to test this theory. 
 
Reproducibility of the moving radial task was tested through three 
repetitions of the testing block. There were no significant differences 
between any of the three blocks administered in both the patient and 
control groups, suggesting high inter-block repeatability and good task 
compliance across groups. This high inter-block repeatability 
demonstrated in patients suggests that their reduced gamma frequency 
and amplitude is not simply an indication of lack of task understanding 
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given this would lead to random responses which would be inconsistent 
between blocks.  
 
Fatigue may be an issue when the radial task is administered for as long 
as it was in this study. When reviewing the raw data some patients’ 
gamma activity dips slightly whilst performing the final radial block. Whilst 
it could indicate a general lack of performance this would not appear to be 
the case as correct response rate during this block was comparable 
between the two groups. Therefore the amount of time participants are 
asked to complete for this type of task should be considered in future 
research. 
 
As expected from previous research in healthy controls (Hoogenboom et 
al., 2006; Swettenham et al., 2009) the moving radial task demonstrated 
both higher sustained gamma amplitude and frequency for both groups 
compared to the static task. However, it unexpectedly showed lower 
transient onset gamma amplitude. This could be due to the reduced onset 
transient of the stimulus as the static stimuli present at full contrast, within 
one frame, whereas the radial stimuli ramp up in contrast during initial 
presentation. 
 
The increase in gamma frequency from static to moving replicates 
previous findings showing moving and attentionally engaging tasks 
increase gamma frequency and amplitude (Hoogenboom et al, 2006; 
Sweetenham et al., 2009;). However, these results also demonstrated 
possible ceiling effects as most participants’ frequencies were being 
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brought up to approximately 65-70Hz, with a reduction in variation within 
the groups during the moving task, irrespective of their frequencies during 
the static task. Whilst the reduction in variation is small and only within the 
first two radial blocks, this observation needs to be factored in to the 
design of future studies using this task.  
 
We found no evidence that structural measures of V1 cortical surface 
area, thickness or volume correlated with any of the imaging measures. 
This is important because it suggests the between group differences are 
more likely to be due to abnormalities in inhibitory/excitatory circuitry within 
the patient group and not just the result of a reduction in gray matter in this 
group. 
 
We also found no significant correlations between GABA concentration 
and any of our MEG measures. This is perhaps unsurprising as recent 
results have been very inconsistent in controls as well as patients. A 
recent study has failed to replicate the original finding by Edden and 
collegues in healthy controls with a much larger sample (Cousijn, et al, 
2014). However, this relationship has been found when pooling control 
and patient data for both gamma frequency and amplitude (Chen et al, 
2014). However, as this result used a combined sample it should be 
interpreted with caution due to the previously reported differences in 
oscillatory activity between schizophrenia cases and controls in this study.  
 
This and previous experiments may not have, therefore, focused on the 
right measure of GABAergic functioning. Frankle, Cho, Prasad, Mason, 
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Paris, Himes et al (2015) measured radiolabelled flumazenil, a 
benzodiazepine-specific PET radiotracer, before and after administration 
of tiagabine, a GABA membrane transporter (GAT1) blocker in patients 
with schizophrenia and healthy controls. Blocking GAT1 increases 
extracellular GABA, which was measured as an increase in flumazenil 
tissue volume. Flumazenil binding was significantly increased across all 
brain regions in the healthy controls but not in the schizophrenia group 
and was positively associated with gamma power in the healthy control 
group but not the schizophrenia group. Future studies could therefore 
investigate individual variability in Flumazanil binding within the visual 
cortex and relate this to individual measures of visual gamma 
amplitude/frequency in both patient and control groups. 
 
The findings presented here contradict a recent study by Brealy, Shaw, 
Richardson, Singh, Muthukumaraswamy and Keedwell (2014) who found 
increases in sustained gamma amplitude in a schizoaffective bipolar 
disorder sample. Findings in this experiment show quite a marked 
reduction in gamma amplitude in the schizophrenia group, although the 
findings for sustained amplitude did not reach significance. The opposite 
direction of results between these two studies could result from the fact 
that the patient samples were from distinct diagnostic categories and it 
may be that features specific to the two disorders are associated with 
differing GABA profiles. An alternative explanation is that differing 
medication profiles between these patient groups are responsible for the 
differences, for example mood stabilisers, much more commonly 
prescribed in schizoaffective disorders could have contributed ot the 
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results – the effects of these drugs on MRS GABA have not been studied 
and are not reported in the Brealy study. These two different disorders 
should not be combined into one single sample for case/control studies as 
this could prove to be a source of noise in their results.  
 
6.7 Conclusion 
The main finding from this experiment demonstrated patients having clear 
reductions in visually induced gamma amplitude and frequency when 
compared to healthy controls when using a radial task but not when using 
a static task. This is an important finding as it further highlights the 
possibility of disturbed inhibitory/excitatory mechanisms in this patient 
group.  
 
A moving radial task elicited stronger visually induced gamma frequency 
and amplitude in both patients with a diagnosis of schizophrenia and 
controls. Additional analyses showed structural measures and GABA 
levels did not drive these between group differences and did not explain a 
significant amount of individual variability.  
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Chapter 7 - Linking visual behavioural performance to non-
invasive neuroimaging measures of GABAergic function in 
Schizophrenia and healthy controls 
 
7.1 Rationale 
In earlier chapters we have investigated the reliability and parameter 
dependency of psychophysical tasks that probe inhibition across space 
(the tilt illusion) and local inhibitory control (orientation discrimination). 
Animal and human evidence have linked these tasks to GABAergic 
processes, including studies of healthy human controls and patients with 
schizophrenia. Similarly we have shown how MEG and MRS can non-
invasively probe parameters, such as gamma oscillation 
amplitude/frequency, that are also thought to be dependent on GABAergic 
inhibition (as well as glutamatergic excitation). Here, we present the first 
study to look at measuring in-vivo GABA levels, gamma band measures 
and psychophysics measures, in the same population of patients and 
controls. This experiment hopes to investigate two issues; firstly whether 
the patients demonstrate poorer performance in the psychophysical tasks 
and secondly whether there is any relationship between the imaging and 
psychophysics measures. Should a relationship exist, the intention would 
be to develop the psychophysics into possible new biomarkers for patients 
with schizophrenia that are grounded in our knowledge of the underlying 
neurophysiology. These could then be easily administered in a clinical 
setting as a proxy for the imaging measures. 
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7.2 Background 
7.2.1 Orientation tuning and neuronal selectivity 
GABAergic inhibition has been shown to modulate neuronal selectivity in 
different sensory modalities including auditory (Müller and Scheich, 1987; 
Wang, Caspary and Salvi, 2000), somatosensory (Dykes, Landry, 
Metherate and Hicks, 1984; Puts, Edden, Evans, McGlone and 
McGonigle, 2011) and visual (Alitto and Dan, 2010). The tuning of visual 
cortical neurons to different orientations is one of the best understood 
examples of visual selectivity since it was first described by Hubel and 
Wiesel (1959), with GABAergic inhibition heavily implicated in the tuning of 
visual neurons to stimulus orientation. Li, et al (2008) showed how 
administration of GABA agonists to the visual cortex results in sharpening 
of orientation tuning curves whereas administration of GABA antagonists 
resulted in broader orientation tuning curves (Sillito et al., 1980; Wolf, 
Hicks and Albus, 1986; Katzner et al., 2011).  
 
Supporting evidence for the role of GABAergic inhibition in orientation 
tuning has come from both animal and human research, with Ringach, 
Hawken & Shapley (2003) showing that, in macaque monkeys, orientation 
tuning in V1 is a process driven by rapid excitation and equally rapid 
inhibition, possibly GABAergic. As discussed in the General introduction 
chapter, in human research Edden et al (2009) showed a negative 
correlation between GABA levels within the visual cortex and orientation 
discrimination (OD) thresholds demonstrating that increased GABA levels 
resulted in lower thresholds and greater success in completing this task. A 
recent study (Dickinson et al., 2015) investigated the relationship between 
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autistic traits, OD thresholds and peak gamma frequency in a healthy 
sample. In line with previous findings that higher peak gamma frequency 
and lower discrimination thresholds are related to levels of GABAergic 
inhibition (as evidenced also by Edden et al, 2009), they found significant 
negative correlations between thresholds and peak gamma frequency and 
autistic traits. This lends further support to inhibition playing a major role in 
orientation selectivity and the ability to perform well on an OD task. 
 
These findings have also been related to psychiatric disorders consistent 
with findings of a reduction in occipital (visual cortex) GABA levels in 
patients with schizophrenia, patients have been found to have significantly 
wider orientation tuning curves compared to healthy controls (Rokem, et al 
2011). However, there has been very little research conducted with 
patients using the OD task used previously in this thesis to ascertain 
whether a deficit occurs and whether an oblique effect, as defined in the 
General introduction chapter, is present within this patient group.    
 
7.2.2 Tilt illusion/surround suppression and context modulation 
As discussed in the General Introduction, the Tilt Illusion (TI) is an 
example of a perceptual phenomenon where the introduction of an 
additional stimulus modulates the properties of a central stimulus by 
biasing the orientation of the simultaneously presented central stimulus 
(Gibson, 1937). This is also known as contextual modulation. Like Chapter 
4, the experiments in this chapter will focus on the direct effect. This refers 
to an oriented surround producing a repulsive effect on the perceived 
orientation of a central stimulus.   
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Contextual modulation has previously been explained as interactions 
between neighbouring neurons that mutually influence each other, for 
example via lateral inhibition of neurons or sensory gain control (Clifford, 
2014). Sensory gain control is an extension of lateral inhibition referring to 
a process that allows, in this instance, the visual system to adapt its 
responses to stimuli to take into account spatial and temporal context 
(Butler et al., 2008). The level of gain control is proposed to be weaker in 
patients with schizophrenia than in controls (Butler et al, 2008; Phillips and 
Silverstein, 2013) leading to a reduction in contextual modulation as 
demonstrated by Dakin et al (2005); Serrano-Pedraza et al., (2014) who 
found reduced contextual modulation in a patient group when measuring 
perceived contrast and by Yoon et al (2009) when measuring orientation 
selectivity. 
 
Imaging studies have supported the idea of reduced levels of contextual 
modulation in schizophrenia with recent fMRI studies providing strong 
neurophysiological evidence for this theory having shown abnormally 
weak orientation specific contextual modulation in the visual cortex of 
patients with schizophrenia (Seymour et al., 2013). From this it would be 
expected that patients would have weaker direct effects when using the TI 
task. However, as discussed in the General introduction, when 
investigating the direct effect in patients the results are mixed. Both Yang 
et al., (2013) and Tibber et al., (2013) found no difference between 
patients and controls in the magnitude of the direct effect. In addition, 
Yang found that larger direct effects within the patient group were 
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associated with higher symptom severity whereas Tibber and colleagues 
found the opposite when relating to symptom severity. 
 
These results are contrary to what intuitively would be expected given the 
results of Butler et al, 2008; Philips and Silverstein, 2013 and Dakin et al 
(2005), and also Gelbtuch et al (1986) who positively correlated GABA 
levels (using Lorazepam, a benzodiazepine that potentiates activity at 
GABAa receptors) with the size of the direct effect using the tilt illusion in 
healthy controls. Given this demonstrated pharmacological effect, we have 
here chosen the tilt illusion to be our probe of contextual modulation 
effects that we can assume are related to GABAergic processes. Given 
the previous findings of a reduction in GABA levels in patients with 
schizophrenia it would be expected that this group would not be so 
affected by the introduction of a surround when compared to healthy 
controls thereby resulting in weaker direct effects. 
 
There is limited research into the (TI) specifically and schizophrenia. 
Therefore more research is needed using the (TI) within this patient group 
to investigate how contextual modulation relates to this disorder and how 
this could be mediated by neurophysiological factors.  
 
7.3 Aims 
The aim of this experiment was to investigate the differences in 
performance on the OD and TI tasks between patients with a diagnosis of 
schizophrenia and healthy controls. The results from these tasks would 
then be related to imaging measures, specifically occipital GABA levels 
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and gamma band oscillations, and symptom measures. It was expected 
that patients would perform worse on the OD task resulting in higher 
discrimination thresholds, and exhibit smaller direct effects compared to 
controls. In addition, thresholds are expected to positively correlate with 
symptom measures whereas the sizes of participants’ direct effects are 
expected to negatively correlate. 
 
7.4 Methods 
7.4.1 Participant sample and recruitment 
Participants used in the control and patient groups for the psychophysics 
and imaging data are identical to those recruited for Chapters 5 and 6.  
 
7.4.2 Psychophysics methods 
Orientation discrimination methods used for this experiment were identical 
to those described in Chapter 3 with the exception that the conditions 
administered in this experiment were 250ms vertical, 10ms vertical, 250ms 
oblique and 10ms oblique. Tilt Illusion methods used in this chapter are 
identical to those described in Chapter 4. 
  
7.4.3 Imaging methods 
Magnetoencephalography (MEG) methods are identical to those described 
in Chapter 6. Both visual tasks described were used for the purpose of this 
experiment. Magnetic resonance imaging (MRI) and spectroscopy (MRS) 
methods used for this experiment were identical to those described in 
Chapter 5. Only occipital GABA measures were used for analysis in this 
experiment. 
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7.4.4 Behavioural and anti-psychotic medication measures 
All behavioural measures and anti-psychotic medication equivalents used 
for this experiment are identical to those described in Chapter 5. 
  
7.4.5 Correlating psychophysical thresholds with imaging measures 
Participants included for further analysis in each of the imaging measures 
are identical to those identified in Chapter 5 (GABA measures) and 
Chapter 6 (gamma measures). Pearson correlation coefficients were 
calculated on the PSE differences calculated from the TI, thresholds from 
each of the OD blocks and all imaging outcome measures.  
 
7.5 Results 
OD and TI results were excluded from further analysis if they were +/- 2 
standard deviations from the mean of that condition in line with previous 
research (Edden et al, 2009). See Table 7.1 for remaining participant 
numbers for each task and condition.  
Table 7.1 Participants remaining after exclusion of outliers 
 
7.5.1 Psychophysics: The tilt illusion 
As in Chapter 4, the magnitude of the tilt illusion effect in each person was 
quantified using the PSE (point of subjective equality). A PSE of zero 
 N (%) controls 
remaining  
N (%) patients 
remaining  
 
PSE 27 (87) 24 (86) 
250ms vertical 28 (90) 25 (89) 
10ms vertical 28 (90) 26 (93) 
250ms oblique 29 (93) 26 (93)  
10ms oblique 29 (93)  26 (93) 
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represents no tilt illusion. The size of the direct effect was quantified by 
subtracting the baseline no surround condition PSEs from the surround 
PSEs. All PSE differences calculated were positive, indicating a repulsive 
effect. Patients exhibited higher PSE differences (stronger direct effects) 
compared to controls (see Figure 7.1). However univariate ANOVA 
analysis showed this difference was not significant F(49) = 1.616, 
p=0.210).  
Figure 7.1 Mean PSE differences for both control and patient groups. 
Error bars show +/- one standard error of the mean 
 
 
7.5.2 Psychophysics: Orientation discrimination 
Figure 7.2 shows the mean thresholds calculated for each duration 
(250ms or 10ms) and each orientation (vertical or oblique). It also shows 
the difference between the patient and control groups. Univariate ANOVA 
analyses showed highly significant between-group differences in each of 
the four conditions of the orientation discrimination (OD) task; 250ms 
vertical (F(51) = 9.957, p=.003), 10ms vertical (F(53) = 15.034, p=<.001), 
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250ms oblique (F(52) = 25.774, p=<.001 and 10ms oblique (F(52) = 
19.152, p=<.001).  
 
A repeated measured ANOVA demonstrated a significant oblique effect 
when using a stimulus duration of 250ms in controls (F(26) =36.964, 
P=<.001) and in patients (F(23) = 35.279, P=<.001). The oblique effect 
was also present when stimulus was presented for 10ms in controls (F(26) 
= 51.282, P=<.001) and in patients (F(25) = 32.551, P=<.001). There was 
a significant difference in the size of the oblique effect between groups 
with patients having a larger oblique effect for 250ms (F(49) = 20.392, 
p=0.000) and 10ms (F(49) = 20.319, p=0.001). However, expressed as 
proportions, the oblique effects were similar in each group, with the 
vertical to oblique increase for the 250ms and 10ms conditions being 
respectively 3.574 and 3.294 times larger in the control group and 3.431 
and 3.251 times larger in the patient group (see Figures 7.2 and 7.3). 
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Figure 7.2. Mean orientation discrimination thresholds for both controls 
and patients. Error bars show +/- standard error of the mean. 
 
 
Figure 7.3 Bar chart demonstrating the oblique effect based on different 
stimulus durations within the control and patient group 
 140 
An investigation of the dependency of orientation discrimination thresholds 
on stimulus duration produced a borderline significant effect only for the 
vertical condition within the control group (F(27) = 4.236, P=0.049) but no 
significant effect in the control group for the oblique conditions (F(25), = 
2.908, p=0.101) or in the patient group  for both vertical (F(23) = 0.753, 
p=0.395) and oblique conditions (F(24) = 0.002, p=0.967), see Figure 7.2. 
 
Pearson correlation tests of between condition repeatability showed that 
vertical and oblique conditions positively correlated in both groups but 
were much stronger in the patient group (see Tables 7.2-7.3; key 
correlations are highlighted in Figure 7.4). At a 250ms duration, the 
vertical and oblique thresholds were only correlated in the patient group, 
whereas for 10ms, the vertical and oblique thresholds were highly 
correlated for both patients and controls. When combining different 
stimulus durations with different orientations the patient group showed 
significant moderate correlations whereas in the control group only the 
10ms vertical and 250ms oblique conditions correlated. For the means 
and standard errors of these tasks for both controls and patients, see 
Appendix 4. 
 
Control 
group 
250ms 
vertical 
10ms  
vertical 
250ms 
oblique 
10ms 
oblique 
250ms 
vertical 
 0.476* 0.168 0.306 
10ms  
vertical 
  0.495* 0.623** 
250ms 
oblique 
   0.571* 
10ms 
oblique 
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Table 7.2 Correlation coefficients within the control group for each 
orientation discrimination condition. Bold values represent significant r 
values with a uncorrected p-value <.05.  * = p<.05   ** = p<.001  
 
 
Patient 
group 
250ms 
vertical 
10ms  
vertical 
250ms 
oblique 
10ms 
oblique 
250ms 
vertical 
 0.688** 0.614** 0.455 
10ms  
vertical 
  0.460 0.660** 
250ms 
oblique 
   0.652** 
10ms 
oblique 
    
Table 7.3 Correlation coefficients within the patient group for each 
orientation discrimination condition. Bold values represent significant r 
values with a uncorrected p-value <.05  * = p<.05   ** = p<.001 
 
 
7.5.3 Correlations between Transient Gamma parameters and 
behavioural measures 
In both groups the significant Pearson correlation results were for the 
250ms oblique condition of the OD task and static amplitude, with the 
strength of the correlations being very similar between groups (see Tables 
7.4 and 7.5). This result remained significant after correction for multiple 
comparisons in the control group only. In addition, within the patient group 
there was a strong correlation between the 250ms vertical condition and 
radial frequency.  
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Figure 7.4. Scatter-plots of orientation discrimination blocks in the control () and patient () groups. Solid line(       ) shows line of best fit for the control group. 
Dashed line (------) shows line of best fit for the patient group. 
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Table 7.4 Correlation coefficients within the control group for the transient MEG 
imaging and psychophysics measures. Bold values represent significant r 
values with a corrected p-value <.0125 * = p<.0125 ** = p<.001 
 
Table 7.5 Correlation coefficients within the patient group for the transient MEG 
imaging and psychophysics measures. Bold values represent significant r 
values with a corrected p-value <.0125  * = p<.0125 ** = p<.001 
 Controls PSE 250ms 
vertical 
10ms 
vertical 
250ms 
oblique 
10ms 
oblique 
Transient 
static 
frequency 
 
 
-0.382 
 
-0.063 
 
0.090 
 
-0.119 
 
-0.001 
Transient 
radial 
frequency 
 
 
-0.369 
 
0.199 
 
-0.173 
 
-0.432 
 
-0.304 
Transient 
static 
amplitude 
 
 
-0.177 
 
-0.256 
 
-0.087 
 
0.535* 
 
0.089 
Transient 
radial 
amplitude 
 
 
-0.078 
 
-0.0.37 
 
-0.480 
 
0.105 
 
0.075 
Patients PSE 250ms 
vertical 
10ms 
vertical 
250ms 
oblique 
10ms 
oblique 
Transient 
static 
frequency 
 
 
-0.437 
 
-0.283 
 
-0.079 
 
-0.103 
 
-0.082 
Transient 
radial 
frequency 
 
 
-0.081 
 
-0.607* 
 
-0.233 
 
-0.414 
 
-0.817 
Transient 
static 
amplitude 
 
 
-0.335 
 
-0.214 
 
-0.329 
 
-0.568 
 
-0.348 
Transient 
radial 
amplitude 
 
 
-0.284 
 
-0.225 
 
-0.342 
 
-0.368 
 
-0.183 
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7.5.4 Sustained gamma 
Within the control group all of the oscillatory measures produced weak 
correlations with the psychophysics measures (see Tables 7.6, 7.7 and Figure 
7.5). Within the patient group, sustained radial amplitude produced significant 
negative correlations with all blocks of the OD task and only a slightly weaker 
negative correlation with the magnitude of the PSE. The correlations between 
the 10ms vertical and 250ms oblique conditions and sustained radial amplitude 
survived correction for multiple comparisons.   
 
Table 7.6 Correlation coefficients within the control group for the sustained 
MEG imaging and psychophysics measures. Bold values represent significant r 
values with a corrected p-value <.0125     * = p<.0125   ** = p<.001 
 
 
 
 
 
 
 
 
 Controls PSE 250ms 
vertical 
10ms 
vertical 
250ms 
oblique 
10ms 
oblique 
Sustained 
static 
frequency 
 
 
-0.183 
 
-0.157 
 
-0.039 
 
0.058 
 
0.090 
Sustained 
radial 
frequency 
 
 
-0.008 
 
-0.045 
 
0.172 
 
0.043 
 
0.244 
Sustained 
static 
amplitude 
 
 
-0.168 
 
-0.254 
 
-0.006 
 
0.343 
 
0.255 
Sustained 
radial 
amplitude 
 
 
-0.078 
 
0.023 
 
0.027 
 
0.256 
 
0.289 
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Patients PSE 250ms 
vertical 
10ms 
vertical 
250ms 
oblique 
10ms 
oblique 
Sustained 
static 
frequency 
 
 
-0.410 
 
-0.203 
 
-0.238 
 
-0.393 
 
-0.252 
Sustained 
radial 
frequency 
 
 
-0.133 
 
-0.323 
 
0.012 
 
-0.280 
 
-0.190 
Sustained 
static 
amplitude 
 
 
0.011 
 
0.000 
 
-0.104 
 
-0.303 
 
-0.045 
Sustained 
radial 
amplitude 
 
 
-0.397 
 
-0.410 
 
-0.486* 
 
-0.587* 
 
-0.454 
Table 7.7 Correlation coefficients within the patient group for the sustained 
MEG imaging and psychophysics measures. Bold values represent significant r 
values with a corrected p-value <.0125    * = p<.0125 ** = p<.001 
 
Figure 7.5 Scatter plot showing correlation between orientation discrimination 
thresholds and sustained radial amplitude in the patient group. Lines show line 
of best of fit. 
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7.5.5 Occipital GABA 
Table 7.8 shows the only significant correlation found with occipital GABA levels 
were with the 10ms vertical condition of the OD task; and that this was present 
only within the control group. 
Table 7.8 Correlation coefficients within the control group for the sustained 
imaging and psychophysics measures. Bold values represent significant r 
values with a corrected p-value <.01 * = p<.01   
 
7.5.6 Structural effects 
Freesurfer analysis was performed on the imaging data to derive measures of 
cortical thickness, volume and surface area for both hemispheres in the visual 
cortex. Pearson correlation coefficients were calculated on these structural 
measures and the psychophysics measures. There were no significant 
correlations between any of the measures within the control group (all r2 values 
<0.084) and the patient group (all r2 values <0.122). 
 
7.5.7 Medication effects 
Within the patient group olanzapine equivalents did not correlate with any of the 
psychophysics results (all r2 values < 0.117). For medication effects in relation 
to the imaging measures please see Chapter 5 (section 5.5) for relationship with 
GABA levels and Chapter 6 (section 6.5) for gamma measures.  
 PSE 
250ms 
vertical 
10ms 
vertical 
250ms 
oblique 
10ms 
oblique 
Control 
Occipital 
GABA 
 
 
-0.231 
 
0.268 
 
-0.417* 
 
0.158 
 
-0.103 
Patient 
Occipital 
GABA 
 
 
0.211 
 
0.155 
 
0.070 
 
0.081 
 
0.055 
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7.5.8 Behavioural measures 
The behavioural measures showed low negative correlations between the Beck 
Depression Inventory II (BDI-II) and OD thresholds within the control group, 
none of which reached significance. The patients showed the opposite direction 
of effect, with equally low correlation coefficients within the vertical OD 
conditions but with moderate positive coefficients for the oblique conditions with 
the 10ms oblique results reaching significance (r=0.438, p=0.025). Within the 
patient group the SAPS scores also moderately correlated with the 10ms 
oblique condition (r=0.415, p=0.035). However, these results did not survive 
correction for multiple comparisons.  
 
7.6 Discussion 
The results from this experiment show that patients had a clear impairment in 
the OD task across all four conditions. This was hypothesised to be the case, as 
patients with a diagnosis of schizophrenia are known to have broader tuning 
curves impairing their performance on tasks of this type (Rokem et al., 2011). 
However these thresholds only weakly correlated with GABA levels. Previous 
research has strongly implicated reduced inhibition (possibly GABAergic) in the 
broadening of tuning curves in this patient group (Rokem., 2011). Whilst 
difference in OD thresholds taken alone does support the idea of a broadening 
of tuning curves in schizophrenia, the lack of relationship with GABA would 
suggest this is not GABAergic in nature.  
 
Another key finding was a strong negative correlation reported between 
sustained radial amplitude and the orientation discrimination thresholds in the 
patient group. Both of these measures have been strongly related to excitatory 
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mechanisms with AMPA receptor blockade leading to a reduction in gamma 
amplitude Fuchs et al., 2007 and the tuning of orientation curves linked to rapid 
excitation and equally rapid inhibition (Ringach et al., 2003). As the patients 
demonstrated significantly higher thresholds compared to controls, with these 
thresholds correlating with gamma amplitude but not occipital MRS GABA 
levels, it does suggest that these measures could possibly be mediated by 
excitatory mechanisms and focussing on these would provide a more sensitive 
measure of inhibitory/excitatory circuit abnormalities and orientation tuning in 
this patient group. 
 
These results do not replicate those found by Edden et al (2009) in healthy 
control participants. In this control sample the r value for 250ms oblique 
thresholds and GABA was small and in the opposite direction of effect; 0.158 
compared to -0.65.  In contrast we did find a moderately significant negative 
correlation for the 10ms Vertical condition, which is the same direction as the 
Edden correlation but for a different stimulus condition. A similar pattern of non-
replication was found for gamma frequency where our r value was 0.043 
compared to -0.65. The age range in Edden and colleagues study was broad 
(23.5–42.9) but there sample size was small with final n of 13 participants 
compared to our 31. Therefore, there is the possibility that the Edden results 
were produced by chance and that the current study with an increased sample 
size, reflects truer results. 
 
There were no differences between the 10 and 250ms conditions for either 
orientation, which was surprising, as an earlier experiment within this thesis had 
shown a marked increase in thresholds when stimulus duration was decreased, 
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with these two conditions in particular being different to a highly significant 
degree (Chapter 3 Figure 3.3). This cannot be due to simple methodological 
differences, such as order effects or stimuli, because the protocol was identical: 
in both experiments, the order of blocks administered was counter-balanced 
with identical stimulus parameters. This suggests other factors lie behind this 
discrepancy in results such as age of participants. The results from Chapter 3 
were obtained from a very narrow sample with the majority being undergraduate 
students aged between 18-22. The sample in this experiment had a much 
broader age range of 22-58. Betts et al (2007) demonstrated orientation 
thresholds increase with age thus it would be expected the results in this study 
would show increased thresholds compared to those in Chapter 3. This was not 
the case as the 250ms condition was slightly reduced in the older sample and 
the 10ms condition mean thresholds were approximately half the size in the 
older sample compared to the younger. As this is the first study to our 
knowledge that has investigated orientation thresholds at such small stimulus 
durations, it is possible that age improves performance at the smaller stimulus 
durations but has no effect or increases thresholds at the bigger stimulus 
durations. Replication in an independent sample is needed to verify this result. 
 
For the Tilt illusion, patients exhibited slightly larger direct effects when 
compared to controls. However, this trend was not significant, consistent with 
previous research demonstrating no difference between patients and controls 
using this task (Yang et al, 2008; Tibber et al, 2013). In general therefore, our 
results do not support the theory that patients with a diagnosis of schizophrenia 
are not as affected by contextual differences in stimuli when compared to 
healthy controls.  
 150 
 
Due to the nature of their illness, patients with schizophrenia may not fully 
understand instructions given to them on how to perform the psychophysics 
tasks and therefore will not complete them reliably. This lack of understanding 
may then lead to the differences between the groups. However, the strong 
correlations between the conditions in the OD task suggest this is not the case 
and that the reduction in thresholds is a real between group difference. In 
addition the difference between direct effects calculated from the TI was not 
significant suggesting groups are comparable in their ability to complete this 
task. Lack of understanding by the patients does not appear to be an issue for 
this sample. 
 
The reliability of these tasks has also been addressed by these results. The 
high correlations between OD blocks suggest that there is a high level of 
individual repeatability across conditions. In addition, as all of the direct effect 
results were positive, indicating a repulsive effect, in line with previous results 
(Gelbtuch et al, 1986), it appears that the TI task is valid. Therefore, it appears 
both tasks produce reliable results in both healthy and schizophrenia 
populations.  
 
The BDI-II and SAPS positively correlated with the 10ms oblique condition only 
within the patient group. This replicates previous findings showing a significant 
relationship between symptom severity and OD thresholds. It is interesting that 
the measure of positive symptom severity and levels of depression correlate 
with the most difficult condition of the OD task and not the task as whole. The 
BDI-II results replicate previous findings as higher levels of depression have 
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been found to correlate with levels of cognition especially attention, 
concentration and short-term memory (Trivedi and Greer, 2014), all of which are 
needed to complete this task but more so for this particular condition. However, 
results of symptom severity tend to find correlations with negative symptoms 
and cognition but not positive so these results are opposite to what has 
previously been found (Harvey, Howanitz, Parella, White, Davidson, Mohs et al, 
1998; Keefe, Bilder, Harvey, Davis, Palmer, Gold et al, 2006).  
 
 
The psychophysics results did not appear to be explained by structural 
measures or medication within the patient group. This is encouraging and again 
suggests the results shown are true differences in psychophysics performance 
between groups and was not mediated by these factors.  
 
 
For discussion of imaging measures please see the Discussion sections of 
Chapters 5 and 6. 
 
 
 
 
7.7 Conclusion 
Patients exhibited significantly higher orientation discrimination (OD) thresholds 
compared to controls but were comparable when performing the Tilt illusion. 
Thresholds calculated from the OD correlated with sustained radial gamma 
amplitude in the patient group but not with GABA levels. Both of these 
measures have been linked to excitatory processes, as well as inhibitory, which 
may explain the lack of relationship with inhibitory GABA levels and point to a 
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more sensitive measure for linking imaging measures and OD thresholds in the 
future.  
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Chapter 8 - General discussion 
 
This thesis utilised psychophysics, MRS and MEG methods in order to gather 
information relating to cortical inhibition and neural oscillatory activity in patients 
with schizophrenia and healthy controls.  
 
8.1 Summary of findings 
Chapters 3 focused on administering the orientation discrimination (OD) task in 
healthy controls as possible ceiling effects had been identified in Edden and 
colleagues experiment. An additional aim was to find a variant on the vertical 
condition, which produced comparable thresholds to an oblique condition but 
without the associated loss of data. This experiment demonstrated that the 
reduction in stimulus duration increased participants’ OD thresholds, thus 
increasing the difficulty of the task in a healthy control population. The smallest 
and largest stimulus durations correlated very strongly suggesting ceiling effects 
were not present. In addition, performance at every other stimulus duration 
correlated suggesting a high level of repeatability within the task itself. However, 
the hardest vertical condition did not produce comparable thresholds with the 
oblique condition administered, with them still being ~2.5x higher in the oblique 
condition.  
 
Chapter 4 investigated the link between the Tilt illusion (TI) and visual gamma 
whilst additionally piloting the TI in healthy controls. The TI task produced 
positive results indicating a repulsive direct effect and that the task worked. 
However, no relationship was found between the size of participants’ direct 
effects and visual transient or sustained gamma amplitude or frequency.  
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Chapter 5 demonstrated a reduction in occipital GABA levels in patients with a 
diagnosis of schizophrenia when compared to healthy age and gender matched 
controls. This result was limited to this cortical location, as GABA measured in 
the sensory motor region produced no difference between groups. This fits with 
previous research that shows GABA reductions/increases are different 
depending on the region in which they are measured (Kegeles et al, 2012) but 
also level of medication. This experiment found antipsychotic medication had no 
effect on the occipital GABA result. This finding is supported further by the fact 
reductions were found in only one voxel whereas if medications were affecting 
GABA levels across the brain, a reduction should have been found in the 
sensory motor voxel also. 
 
Chapter 6 compared induced visual gamma activity in patients with a diagnosis 
of schizophrenia and healthy controls using a static grating stimulus and a 
moving radial stimulus. Gamma amplitude and frequency were both reduced in 
patients across all runs of a moving radial stimulus but these differences were 
much reduced or not evident at all when using a static stimulus. The reduction 
in gamma activity demonstrated by the patients also replicates previous findings 
by (Chen et al, 2014). Again, no medication effects were found in this 
experiment.  
 
In addition, both groups demonstrated a significant increase in sustained 
frequency and amplitude and transient frequency. These findings compliment 
previous research in healthy controls showing the use of a moving stimulus 
induces higher transient and sustained gamma activity (Hoogenboom et al, 
2006; Sweetenham et al, 2009) and extends them to include patients. However, 
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a reduction was seen in transient amplitude when using the moving stimulus 
compared to the static.  
 
The final chapter of this thesis brought the neuroimaging measures together 
with the psychophysics measures. It investigated whether there was any 
difference in performance in both the OD and TI tasks between groups and 
whether participants’ performance correlated with occipital GABA levels and 
visually induced gamma activity. Results showed patients were significantly 
poorer at the OD task as demonstrated by the much larger thresholds in each of 
the conditions administered. Patients also demonstrated larger absolute oblique 
effects but proportionally they were comparable with the control group. Each 
condition within this task correlated strongly with sustained gamma amplitude in 
the patient group but not in the control group.  
 
Patients demonstrated slightly larger direct effects in the TI, however, this 
difference was not significant when compared with the control group. When 
relating the size of the direct effects to the imaging no correlation was found 
between both GABA levels and the majority of gamma measures in either 
group.  
 
 
8.2 Implications of main findings and future work 
8.2.1 Increase in orientation discrimination due to decrease in stimulus 
presentation time: 
This is the first experiment, that I am aware of, that has identified this link 
between stimulus duration and discrimination thresholds. The hardest and 
easiest conditions are highly correlated, strongly suggesting no ceiling effects 
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were present in using this task, addressing the possibility of this in Edden et al 
(2009). The fact that each of the vertical conditions were highly correlated 
suggests participants were not performing at chance level in the harder 
conditions, indicating all of the conditions administered produced reliable 
thresholds of orientation discrimination.  
 
However, even though this experiment demonstrated the reduction in stimulus 
duration produces increases in thresholds, the oblique condition was still 
producing thresholds ~2.5x higher than the 10ms vertical condition. This 
suggests that there is no comparable vertical condition and that the oblique 
condition is still much harder for participants to complete. In itself this is very 
interesting as the oblique effect is still quite under studied. The fact that 
thresholds continue to be higher in the oblique condition when compared to 
harder vertical conditions strongly suggests a different mechanism for this type 
of orientation discrimination. 
 
8.2.2 No relationship between visual gamma and size of direct effect as 
measured by the tilt illusion: 
This experiment used visual gamma measures as a proxy measure for GABA 
levels due to the previously reported correlation between them (Edden et al, 
2009) and ease and speed of testing. The Tilt illusion was used due to its 
relation with GABAergic properties (Gelbtuch et al, 1986). The lack of findings 
was not unexpected as the relationship between GABA and gamma is proving 
to not be as robust as first thought (Couijsen et al, 2015). The lack of 
relationship is not likely to be due to the task itself as all of the results were 
indicative of an expected direct effect. This was coupled with a high level of 
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variation for both the TI and the gamma measures. Although it should be 
mentioned that Gelbtuch and colleagues did not measure MRS GABA, they 
inferred an increase in GABA from the administration of Lorazepam, a GABA 
agonist, which increases the frequency of the opening of the chloride ion 
channel at the GABAa receptors. This does not necessarily mean there was an 
increase in in vivo GABA levels in the synapse but more an increase in activity 
at the post-synaptic neuron. This therefore could account for the lack of 
relationship between the direct effect and gamma activity in this sample.  
 
8.2.3 Reduction in occipital GABA in patients with a diagnosis of 
schizophrenia but no difference in sensory motor GABA between groups: 
This finding supports the work suggesting that whilst GABA appears reduced in 
certain areas, this does not apply to the brain as a whole (Kegeles et al, 2012; 
Rowland et al, 2015). The reduction in occipital GABA in this sample was not 
due to medication effects as olanzapine equivalents were not correlated with 
GABA levels in the patient group. Further the reduction in GABA being specific 
to one voxel supports the lack of relationship with medication. If medication was 
a driving force behind the reduction in GABA then the assumption would be this 
reduction would occur throughout the brain and would have lead to a difference 
in the sensory motor region also. Further, the finding of no difference in V1 
area, thickness or volume between groups lends further support to the 
reduction in GABA not being the result of a reduction in gray matter within the 
patient group.  
 
One possible reason for this pattern of results is that as the patients used in this 
sample were chronic patients, it could the case that the reduction in occipital 
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GABA is a biomarker of chronic illness. This question can be answered using a 
longitudinal design and scanning first episode patients in several different 
voxels. These same patients would then be followed-up to see how GABA 
measures within these voxels differ over time and if indeed occipital GABA is a 
biomarker of chronic illness.  
 
Structural measures were gathered in this experiment but were only analysed in 
relation to occipital GABA to make sure tissue composition within this voxel did 
not account for the between group results. This is in line with a recent study by 
Gaetz, Bloy, Wang, Port, Blaskey, Levy & Roberts (2014) with children on the 
autism spectrum and typically developing children. They showed reductions in 
auditory and motor MRS GABA levels in the autistic spectrum children but with 
no underlying tissue differences. This demonstrates the differences found were 
not related solely to structural differences between groups, further 
demonstrated in our study. However, in this thesis it would have been beneficial 
to have conducted the same structural analysis on the sensory motor voxel also 
to check for a between voxel as opposed to between group discrepancy in 
tissue composition accounting for the result. 
 
8.2.4 Reduction in gamma oscillatory activity in patients with 
schizophrenia using a moving radial stimulus: 
The reduction in gamma oscillatory activity was found across both frequency 
and amplitude for both transient and sustained gamma, although sustained 
amplitude did not reach significance. This was specific to a radial moving task 
and did not occur for a static task. This reproduces previous research from 
Chen and colleagues (2014) who found reductions in gamma amplitude in 
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patients with schizophrenia. In addition Chen and colleagues related this 
reduction to levels of cognition using a working memory task whilst Grutzner et 
al (2013) have related a reduction to perception of Mooney faces.  
The lack of a difference between groups when using a static task is interesting, 
as Chen and colleagues also reported no between group differences in resting 
gamma amplitude. The difference only occurred when participants were 
performing a working memory cognitive task. As stated in Chapter 6 
Introduction section, the moving radial stimulus requires more attention than the 
static, thus, the necessary coordination of neural activity needed for strong 
cognitive performance, thought to be reduced in patients, could account for this 
result. 
 
The differences between peak frequency and peak amplitude are very 
interesting in their own right. The reduction in gamma frequency, which is the 
product of the cortical inhibitory/excitatory interplay, reflects abnormalities in this 
cycle within the patient group. However, the lack of relationship with GABA 
levels is again confusing. It could indicate that excitatory processes could be 
the important aspect of this cycle with inhibitory processes affected indirectly. 
The STRATA project currently being undertaken at Cardiff, Manchester, 
Edinburgh and Kings College London is investigating this possibility by 
measuring excitatory glutamate levels in distinct schizophrenia samples and 
how this may relate to treatment responsiveness but also gamma measures. 
Results from this project could indicate if excitation as opposed to inhibition 
should be considered  
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The reduction in amplitude in the patient group reflects a reduction in signal, 
thus a reduction in the synchronised firing of neurons.  As synchronised firing is 
also heavily implicated in perceptual and cognitive processes, this could 
account for the significant relationship between the psychophysics and imaging 
measures between sustained gamma amplitude and orientation discrimination 
thresholds only in the patient group. Conducting the psychophysics within the 
MEG scanner may have been beneficial in so much as it would have 
highlighted whether a further reduction in gamma amplitude occurs in the 
patient group under more cognitively demanding conditions. This could have 
replicated Chen et al’s findings in a much larger sample, and consequently 
provide clear evidence for a link between levels of cognitive demand and 
gamma amplitude. 
 
8.2.5 Increase in visually induced gamma frequency and amplitude when 
using a moving radial stimulus compared to a static stimulus in the 
patient and control groups: 
The increase in gamma activity when using a moving radial stimulus replicated 
previous research indicating an attentionally engaging and/or a moving stimulus 
increases both gamma frequency and amplitude in healthy controls 
(Hoogenboom et al, 2006; Sweetenham et al, 2009). The similar result in the 
patients is a novel finding and suggests the mechanisms behind this increase 
are intact but diminished in the patients compared to the controls as evidenced 
by the reduction in gamma activity across all measures. 
 
As part of the analysis pipeline, high end gamma (80-130Hz) was also drawn 
from the results but was not analysed fully given time constraints. Given the 
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extra time needed this analysis could have been interesting as patients have 
been identified as having reduced gamma in this frequency band when 
performing Gestalt perceptual tasks using Mooney faces (Uhlhaas et al., 2006). 
However, high end gamma data should be used with caution as there is a 
strong possibility that activity in these higher frequency bands are not true 
results as they can be generated by muscle artefacts such as jaw clenching 
(Muthukumaraswamy, 2013). This was an additional reason we did not analyse 
this broadband gamma but in future it would be interesting to see how it 
compares with low band gamma activity when controlling for such muscle 
artefacts.   
 
8.2.6 No relationship found between GABA and gamma measures in both 
patient and control groups: 
This finding was not unexpected due to the now mixed results investigating this 
relationship in healthy controls (Edden et al., 2009; Couijsen et al., 2014). The 
mixed results in relation to these two measures could involve the methods used 
to measure GABA. Conventional estimates of GABA, using conventional edited 
MR sequences that are not macromolecule suppressed, can produce noisy and 
unreliable results due to macromolecule contamination (Mikkelsen et al., 2015). 
Although suppressed sequences have poorer signal-to-noise, both methods 
have comparable levels of repeatability. This offers the opportunity to estimate 
cleaner GABA measures, which will become increasingly important as more 
research is conducted using MRS GABA to investigate disease populations. 
 
Specific to this experiment, it could be the case that the lack of relationship was 
due to GABA measures being at rest and the gamma measures being low level 
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visual tasks. Again, Chen et al (2014) demonstrated how the relationship 
between GABA and gamma strengthened when participants were performing a 
working memory task suggesting a critical role for GABAergic processes in the 
synchronised oscillatory activity needed for strong cognitive performance. 
Therefore, a difference in GABA between groups may not have been evident 
using the resting methods within this thesis. Future work should compare rest 
levels with levels whilst performing cognitive or perceptual tasks to verify this 
relationship.  
 
The general lack of relationship between both the imaging and psychophysics 
was disappointing but was based on correlational analyses which may not have 
been the appropriate method based on the still relatively small sample size. 
Interpretation of these results could benefit from analysis using 
neurophysiologically-informed modeling. For example, Dynamic Causal 
modeling (DCM) uses spatiotemporal models designed to answer questions 
about the underlying neuronal architecture and to make inferences about 
associated neuronal parameters and, in this instance, how these differ between 
patients and controls, as well as predicting gamma oscillation parameters, 
GABA levels and performance on the orientation discrimination task (Kiebel, 
Garrido, Moran, Chen and Friston, 2009). Recently awarded ISSF Wellcome 
Trust funding will focus on this analysis using this sample. 
 
 
 
8.2.7 Patients demonstrate poorer performance in an orientation 
discrimination task compared to healthy controls: 
This finding lends support to the broadening of orientation tuning curves in 
patients with schizophrenia (Rokem et al., 2011). The mechanisms behind this 
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however, require further investigation, as occipital GABA levels did not correlate 
with any of the conditions. This was unexpected as GABAergic processes are 
strongly implicated in the tuning of orientation curves. It is unlikely in this sample 
that medication had an effect, as olanzapine equivalents again did not correlate 
with any of the conditions administered. It could be the case that this study 
didn’t measure the right variable, and other GABAergic properties, such as 
receptor density, glutamate levels, levels of re-uptake enzymes would be a 
better indicator of orientation tuning. Alternatively this could lend support to 
resting in-vivo levels of GABA having little to no effect on tuning curves, but the 
mechanism behind or ability to pharmacologically manipulate GABA could 
provide more of an insight into orientation tuning of neurons.  
 
All of the conditions correlated within both the control and patient group 
suggesting the patients’ performance was very repeatable and likely not due to 
chance. 
 
8.2.8 Patients and controls have comparable magnitudes of direct effects 
as measured by the Tilt Illusion 
This result was unexpected due to previous findings within this thesis of a 
reduction in occipital GABA levels, patients were expected to have reduced 
levels of contextual modulation. This did not occur for the TI task with patients 
demonstrating larger direct effects, albeit not significantly larger, compared to 
the control group.  
 
The initial hypothesis relating to the TI was based on a pharmacological study 
so again it may not be baseline in-vivo GABA that is related to performance on 
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this task, but more the mechanism behind pharmacologically manipulating the 
levels of GABA that is driving this result. A comparison MRS during a no-drug 
and drug condition in the same sample would highlight if this is the case. 
 
It, again, is unlikely in this sample that medication had an effect, as olanzapine 
equivalents again did not correlate with the size of the direct effects. Future 
work relating this task to GABAergic properties may need to focus on difference 
aspects of the GABAergic system such as measures of excitation, GABA 
receptor density etc. 
 
However, the difference between groups being marginal and not reaching 
significance argues that the patients had a good understanding of the task. This 
is an important finding as it indicates the TI can be used to gain reliable results 
from this patient group. The issue with this task based on this thesis is whether 
it is a reliable proxy measure for cortical inhibition, which given the fact it did not 
correlate with either imaging measure would suggest it’s not. It’s future use 
could come from the fact patients could complete this task well and as such 
could be used as a control task to ensure patients are completing tasks 
satisfactorily.   
 
8.2.9 Participants used 
The controls used for this study were screened using the MINI interview to rule 
out current affective and psychotic disorders. In addition all participants were 
asked to complete a depression and mania questionnaire. Some of the control 
group demonstrated rather high self-report mania scores using the 
questionnaires. These participants were not excluded from the experiment as 
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the variation within the group was quite large and so no one reached +/- 2 SD’s 
from the mean score, which is a widely used cut off point for exclusion of 
participants. However, it does highlight whether these participants scoring at the 
higher end of this scale should have been included in the study based purely on 
these self-report measures.  
 
The patients used in this thesis all had a DSM-IV diagnosis of schizophrenia 
with no other diagnoses included in any of the experiments. This sample 
therefore represents a single pathology and is better suited to answering the 
above questions. However, when looking at the depression and mania scores 
there is quite a large range of scores. This could have represented different 
phenotypic subsets within the same diagnosis. Given ample time this thesis 
could have investigated these potential different subsets separately and how 
they related to the imaging and psychophysical measures.  
 
The power of this study does need to be considered, as the samples sizes were 
moderate but not large within this thesis. A-priori power calculations were not 
performed during this thesis as the time limits imposed on testing made these 
almost pointless as we simply tested as many people as possible in the time 
given. For any future studies with less stringent time frames, it would be highly 
advisable to use a-priori power calculations to inform necessary sample sizes 
as post-hoc power tests are not advisable due to being simply a one-to-one 
function of the p-value obtained.  
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8.3 Conclusion 
This thesis has demonstrated abnormalities in both in vivo GABA levels and 
oscillatory activity in the brains of patients with schizophrenia. Through the 
additional use of psychophysics and the findings of a reduction in performance 
by patients using an orientation discrimination task, it highlights the possibility 
and appropriateness of these measures for biomarker development in the 
future. This is very important as the development of biomarkers can be used in 
several ways within this patient group; the orientation discrimination task can be 
developed as an indication of levels of cortical inhibition without the need for a 
brain scan, these measures can be used as a measure of disease progression, 
could indicate appropriate future treatments and finally could be used to monitor 
treatment effectiveness. The orientation discrimination task specifically could be 
implemented in clinical settings with ease, as they are cheap and simple to 
administer with outputs easy to interpret.  
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Appendices 
Appendix 1 -Diagnosis and medication profile of patient group (Chapters 5-7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Participant Diagnosis Olanzapine equivalents (mg)  
1 Schizophrenia 20.1 
2 Schizophrenia 32.5 
3 Schizophrenia 7.5 
4 Schizophrenia 15 
5 Schizophrenia 0.54 
6 Schizophrenia 15 
7 Schizophrenia 32.5 
8 Schizophrenia 0.24 
9 Schizophrenia 0 
10 Schizophrenia 1.79 
11 Schizophrenia 53.28 
12 Schizophrenia 38.4 
13 Schizophrenia 15 
14 Schizophrenia 13.4 
15 Schizophrenia 15 
16 Schizophrenia 10 
17 Schizophrenia 8.33 
18 Schizophrenia  0 
19 Schizophrenia 26.8 
20 Schizophrenia 21.25 
21 Schizophrenia 5.4 
22 Schizophrenia 9.99 
23 Schizophrenia 1.07 
24 Schizophrenia 13.4 
25 Schizophrenia 0.71 
26 Schizophrenia 0.89 
27 Schizophrenia 2.78 
28 Schizophrenia 15 
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Appendix 2 – Descriptive statistics for imaging measures (Chapters 5-7) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sustained 
Frequency 
(Hz) 
    
Sustained 
Amplitude 
(%)       
 Standard Radial1 Radial2 Radial3 
Radial 
Average Standard Radial1 Radial2 Radial3 
Radial 
average 
Occipital 
GABA(iU) 
Mean all 49.843 55.936 56.313 56.282 56.086 65.167 92.582 105.134 103.782 100.287 1.740 
St error all 1.172 0.788 0.737 0.750 0.689 5.992 9.164 9.375 9.434 8.859 0.032 
Mean 
controls 50.552 57.339 57.207 58.034 57.466 71.517 108.143 124.224 120.172 118.017 1.802 
St error 
controls 1.410 1.142 0.951 1.100 1.026 8.755 13.853 13.604 14.352 13.001 0.040 
Mean 
patients 49.020 54.481 55.352 54.327 54.605 57.800 76.444 84.630 85.500 81.244 1.667 
St error 
patients 1.975 1.056 1.142 0.906 0.862 8.179 11.676 12.153 11.526 11.340 0.048 
  
Spike 
Frequency 
(Hz)  
   
Spike 
Amplitude 
(%) 
   
 
 
  Standard Radial1 Radial2 Radial3 
Radial 
Average Standard Radial1 Radial2 Radial3 
Radial 
average 
Sensory 
motor 
GABA 
(iU) 
                       
Mean all 52.574 59.000 60.179 60.273 59.734 67.546 42.764 50.295 45.709 46.144 1.295 
St error all 1.228 1.134 1.164 1.248 1.011 6.224 3.744 4.741 4.029 3.921 0.12 
Mean 
controls 53.328 58.929 60.379 61.948 60.371 73.397 49.179 58.586 53.310 53.767 1.26 
St error 
controls 1.449 1.467 1.708 1.652 1.463 9.043 5.451 6.811 6.074 5.648 0.12 
Mean 
Patients 51.700 59.074 59.963 58.404 59.049 60.760 36.111 41.389 37.231 37.957 1.33 
St error 
patients 2.096 1.790 1.637 1.886 1.434 8.624 5.012 6.396 4.923 5.183 0.14 
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Appendix 3 - Correlations of MEG imaging and symptom measures (Chapter 6) 
 
 
  BDI Altman 
Mania scale 
SAPS SANS 
Transient 
static 
amplitude 
r value 
p value 
-0.438 
.069 
0.127 
.614 
-0.147 
.561 
0.379 
.120 
Transient 
radial 
amplitude 
r value 
p value 
0.044 
.829 
-0.231 
.256 
0.169 
.400 
-0.006 
.978 
Transient 
static 
frequency 
r value 
p value 
0.015 
.952 
-0.001 
.995 
-0.166 
.511 
0.99 
.696 
Transient 
radial 
frequency 
r value 
p value 
-0.066 
.747 
0.321 
.110 
0.349 
.075 
-.352 
.072 
Sustained 
static 
amplitude 
r value 
p value 
-0.268 
.282 
0.378 
.122 
-0.043 
.864 
0.152 
.546 
Sustained 
radial 
amplitude 
r value 
p value 
-0.218 
.286 
0.153 
.456 
-0.180 
.368 
-0.334 
.089 
Sustained 
static 
frequency 
r value 
p value 
-0.094 
.709 
-0.041 
.872 
 
-0.046 
.855 
0.276 
.268 
Sustained 
radial 
frequency 
r value 
p value 
-0.156 
.447 
0.091 
.657 
-0.510 
.028 
0.113 
.574 
Bold values represent significant uncorrected r-values at p<0.05 
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Appendix 4 – Descriptive statistics for the psychophysics measures (Chapter 
7) 
 
Control 
group 
PSE-
difference OD-250 OD-10 OD-250o OD-10o 
Mean 
(degrees) 2.4744 0.7490 0.9926 2.6776 3.2693 
SE 
(degrees) 1.8053 0.6756 0.5133 1.6606 1.8988 
Control psychophysics descriptive statistics 
 
 
 
Patient 
group 
PSE-
difference OD-250 OD-10 OD-250o OD-10o 
Mean 
(degrees) 3.1986 2.7691 2.9130 9.5000 9.4690 
SE 
(degrees) 2.2585 3.3150 2.5901 6.9081 7.2377 
Patient psychophysics descriptive statistics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
